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Abstract 
 Infection and pathogenesis of Toxoplasma gondii depend on well-coordinated and cGMP-
mediated regulation of subcellular events. Cyclic GMP signaling is known as one of the master 
regulators of diverse functions in eukaryotes; however, its architecture and functioning in 
protozoans including T. gondii remain poorly understood. In the scope of this thesis, an exclusive 
guanylate cyclase coupled with N-terminal P4-ATPase was reported in a common and clinically 
relevant obligate intracellular parasite T. gondii that can infect almost all nucleated cells of warm-
blooded organisms. In silico analysis indicated an activation of the guanylate cyclase by 
heterodimerization of its two cyclase domains and offered valuable insights into possible 
functions of its ATPase domain. This bulky protein (477-kDa), termed in this study as 
TgATPaseP-GC to fairly reflect its envisaged multifunctionality, localizes in the plasma 
membrane at the apical pole of the parasite, whereas the corresponding cGMP-dependent protein 
kinase (TgPKG) is distributed in the cytomembranes. TgATPaseP-GC is refractory to genetic 
deletion, and its CRISPR/Cas9-assisted disruption aborts the lytic cycle of T. gondii. Besides, 
Cre/loxP-mediated knockdown of TgATPaseP-GC reduced the synthesis of cGMP in the fast-
replicating tachyzoite stage and inhibited the parasite growth due to impairments of motility-
dependent egress and invasion events. Equally, repression of TgPKG by a similar strategy 
recapitulated phenotypes of the TgATPaseP-GC-depleted mutant. Notably, despite its temporally 
restricted function, TgATPaseP-GC is expressed constitutively throughout the lytic cycle, 
entailing a post-translational regulation of cGMP signaling. Not least, the occurrence of 
TgATPaseP-GC orthologs in several other alveolates implies a divergent functional repurposing 
of cGMP signaling in protozoans. 
 Besides native signaling, an optogenetic approach was also utilized by expressing a light-
activated rhodopsin-guanylate cyclase (RhoGC) from an aquatic fungus Blastocladiella 
emersonii in T. gondii. The system enabled a light-control of cGMP elevation on crucial steps of 
lytic cycle in a fast, spatial and reversible manner. Excitation of RhoGC which was expressed 
under different conditions resulted in at least 2-fold increase in motile fraction and three times 
longer average trail lengths of parasites in comparison to dark cultures. The impact of gliding 
motility was also observed in host-cell invasion and egress, which is consistent with the genetic 
knockdown studies of TgATPaseP-GC and TgPKG mentioned above. Having established 
optogenetically modified parasite strains now allows to identify mediators of cGMP signaling via 
phosphoproteomic analysis.  
Keywords: Egress, guanylate cyclase, invasion, motility, optogenetics, P4-ATPase, Toxoplasma 
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Zusammenfassung 
Infektion und Pathogenese von Toxoplasma gondii beruhen auf einer gut koordinierten und 
cyclisches GMP-vermittelten Regulierung subzellulärer Ereignisse. Der cGMP-Signalweg ist als 
einer der Hauptregulatoren von diversen Funktionen in Eukaryoten bekannt; allerdings ist seine 
Architektur und Funktionsweise in Protozoen wie T. gondii immer noch wenig verstanden. Im 
Rahmen dieser Arbeit wurde eine exklusive Guanylatcyclase, gekoppelt mit einer N-terminalen 
P4-ATPase, in einem weit verbreiteten und klinisch relevanten, obligat intrazellulären Parasiten 
T. gondii, der fast alle Kern-haltigen Zellen warmblütiger Tiere infizieren kann, gemeldet. Eine 
in silico-Analyse wies auf eine Aktivierung der Guanylatcyclase durch Heterodimerisierung ihrer 
beiden Cyclasedomänen hin und ermöglichte wertvolle Einsichten in mögliche Funktionen ihrer 
ATPase-Domäne. Um die vorgestellte Multifunktionalität dieses massigen Proteins (477 kDa) 
gerecht widerzuspiegeln, wurde es in dieser Studie als TgATPaseP-GC bezeichnet. Es ist in der 
Plasmamembran am apikalen Pol des Parasiten lokalisiert, während die entsprechende cGMP-
abhängige Proteinkinase (TgPKG) in den Zellmembranen verbreitet ist. TgATPaseP-GC ist 
unempfänglich gegenüber genetischer Deletion und seine CRISPR/Cas9 unterstützte Spaltung 
beendet den lytischen Zyklus von T. gondii vorzeitig. Darüber hinaus reduzierte ein Cre/loxP-
vermittelter Knockdown von TgATPaseP-GC die Synthese von cGMP im sich schnell-
replizierenden Tachyzoiten-Stadium und inhibierte das Parasitenwachstum aufgrund von 
Beeinträchtigungen Motilitäts-abhängiger Prozesse des Austretens und Eindringens. Die 
Phänotypen des TgATPaseP-GC-armen Mutanten wiederholten sich durch eine ähnliche Strategie 
der Hemmung von TgPKG. Trotz seiner zeitlich beschränkten Funktion ist TgATPaseP-GC 
konstitutiv während des ganzen lytischen Zyklus exprimiert, welches eine post-translationale 
Regulierung des cGMP-Signalweges bedingt. Nicht zuletzt impliziert das Vorhandensein von 
TgATPaseP-GC-Orthologen in anderen Alveolata eine divergente Umfunktionierung der cGMP-
Signalwege in Protozoen. 
Neben dem natürlichen Signalweg wurde auch ein optogenetischer Ansatz genutzt, indem 
eine Licht-aktivierte Rhodopsin-Guanylatcyclase (RhoGC) aus dem aquatischen Pilz 
Blastocladiella emersonii in T. gondii exprimiert wurde. Dieses System erlaubte eine 
kontrollierte Erhöhung von cGMP durch Licht an entscheidenden Schritten des lytischen Zyklus 
in einer schnellen, räumlich-beschränkten und reversiblen Weise. Die Anregung von RhoGC, das 
unter verschiedenen Bedingungen exprimiert wurde, steigerte den motilen Anteil mindestens ums 
doppelte und verlängerte die mittlere Spurlänge ums dreifache im Vergleich zu den dunklen 
Kulturen. Der Einfluss der Gleitmotilität wurde auch beim Eindringen in sowie Austreten aus den 
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Wirtszellen beobachtet und befindet sich in Einklang mit den oben genannten Knockdown-
Studien von TgATPaseP-GC und TgPKG. Die Etablierung optogenetisch modifizierter 
Parasitenstämme ermöglicht es jetzt, die Vermittler des cGMP-Signalwegs durch 
phosphoproteomische Analysen zu identifizieren. 
 
Schlagwörter: Austreten, Guanylatcyclase, Eindringen, Motilität, Optogenetik, P4-ATPase, 
Toxoplasma 
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1 Introduction 
1.1 Apicomplexa: The group of obligate intracellular parasites 
The phylum Apicomplexa (lat. apex + complexus) is a diverse taxonomic group of 
single-celled protists that comprises more than 6000 obligate intracellular parasite species 
infecting a large number of organisms including livestock and humans (1). The infection by 
most common members of apicomplexan parasites, i.e. Plasmodium sp., Cryptosporidium 
sp., and Toxoplasma gondii has considerable impact on the global health since they cause 
severe diseases in human. For example, malaria caused by Plasmodium sp. alone inflicts 
about 0.45 million deaths per year according to the latest WHO report (2). Besides, many 
other members of this phylum, such as Neospora, Eimeria, Theileria, Babesia are known to 
have a significant veterinary importance (3).  
Apicomplexan parasites have a complex life cycle including both sexual and asexual 
reproduction. While some of the members maintain the entire life in one host (e.g., Eimeria, 
Cryptosporidium), some of the others (e.g., Toxoplasma, Plasmodium) need two different 
hosts (one is usually defined for sexual reproduction) to complete their development (4). 
Extracellular, infective stages of parasites are named as “zoite”, which are found at various 
phases of life cycle. One successful round of life cycle can only be ensured by processing 
three distinct processes; sporogony, merogony (schizogony) and gamogony that lead to the 
production of sporozoites (infectious), merozoites (infectious) and gametes, respectively 
(Figure 1) (5).  
All life cycle forms hold a haploid genome except for the zygote/ookinete formation 
but differ by morphological features and organelle compositions. Apicomplexan parasites 
have a distinctive structure called “apical complex” that consists of a group of secretory 
organelles, micronemes and rhoptries, as well as microtubules connected to a polar ring. The 
apical complex plays a crucial role in gliding motility and host-cell invasion by the parasite 
(6,7). Besides, most of apicomplexans possess a unique, non-photosynthetic but plastid-like 
organelle termed apicoplast, which is needed for several essential metabolic pathways (8).   
12 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Summarized schematics of life cycle stages and developmental processes in 
Apicomplexa.  Complex life cycle of apicomplexan parasites can be completed either in one host or 
in two hosts containing sexual and asexual developmental stages, as depicted. Host cell infection 
starts typically with releasing of sporozoites (infective stage) which are formed in thick-walled oocyst 
via sporogony (sexual reproduction) process. Following infection, sporozoites develop into 
merozoites (infective form) and multiply themselves by schizogony/merogony (asexual 
reproduction). Some of the merozoites can differentiate into male and female gametes by means of 
gamogony that allows fertilization to generate a zygote. Modified from Striepen et al. 2007 (5). 
1.2 Toxoplasma gondii: One of the most common zoonotic parasites 
1.2.1 Global distribution, pathogenesis and prevention strategies 
Toxoplasma gondii was first isolated from a North African rodent in 1908 and called 
as Ctenodactylus gundi by Nicolle and Manceaux (9). The first T. gondii infection case in 
human was recognized however at the end of 1930s (9,10). It is one of the most prevalent 
and successful species of the phylum apicomplexa, which can infect almost all nucleated 
cells of warm-blooded vertebrates including wild and domesticated animals (11). Although 
seroepidemiology substantially varies between countries, even between different 
geographical areas within a country based on nutritional and hygienic conditions, an 
estimated 30% of the human population has been exposed to this pathogen worldwide. The 
prevalence of Toxoplasma infection in Africa and South America is notably much higher 
13 
 
revealing clinical importance of this parasite (9). While T. gondii is the only species in 
Toxoplasma genus, molecular analysis showed that globalization and differences between 
population structures caused a genetic diversity within the species, that resulted in arising 
four ancestral clonal lineages (type I-IV) including six recently identified major clades (12-
14). The majority of the Toxoplasma isolates (I, II, III) are distributed in the Europe and North 
America. Although only <5% natural genetic recombination is observed amongst ancestral 
lineages, the severeness of infectivity considerably varies between each other (12,15).  On 
the other hand, the clonality of parasites in South America has been found reflecting more 
recombination frequency, which gives rise to a separation to distinct clades (13-15).  
T. gondii is the causative agent of toxoplasmosis. In most of the cases, the infection of 
parasite remains asymptomatic or emerges as flu-like mild symptoms in immunocompetent 
individuals (16), which is usually controlled by Th1 cytokine interferon gamma (IFN-γ) 
mediated adaptive immune response (17). The immune response forces parasite to 
differentiate into a dormant cyst form (bradyzoite) (16,18). However, in case of debilitated 
immune response, the tissue cyst can be reactivated. In immunocompromised people, such 
as AIDS patients or transplant recipients, acute or reactivating infections by fast replicating 
tachyzoite stage may cause severe complications including encephalitis and psychiatric 
disorders, ocular diseases like retinitis and retinochoroiditis, sepsis syndrome, myocarditis 
and hepatitis (9,16). The morbidity caused by Toxoplasma infection imposes an extraordinary 
burden of public health (19). If the primary infection of T. gondii takes place during the 
pregnancy, the parasite can be transmitted to the fetus leading a congenital toxoplasmosis 
with severe neurological disabilities, retinal lesions in infants or even stillbirths and abortions 
(9,19,20).  
The most common pathways proposed for the transmission of parasite are through the 
consumption of (i) raw or undercooked meat containing tissue cysts and (ii) oocyst-
contaminated water, raw vegetables or fruits in the environment; that makes toxoplasmosis a 
food- and/or waterborne disease (21). So far, several strategies have been applied to cope 
with toxoplasmosis. For instance, a vaccination using live but attenuated tachyzoites in sheep 
and goat successfully generated protective immunity against acute infection however was not 
able to prevent tissue cyst formation (22). Such a vaccine with avirulent parasite strain is not 
accepted as an appropriate protection method for humans, since the attenuated strain can be 
reverted, which leads to a disease and side effects on fetus (21). An oral vaccine was 
14 
 
developed for cats as they are definitive host reservoirs of T. gondii, however the commercial 
production of this vaccine was ceased shortly after because of the high cost and less interest 
by owners of cats (21,23). Recently, a mutant parasite that is unable to produce oocysts due 
to defective fertilization was generated and inoculated to cats as a potential transmission-
blocking vaccine (24). Apart from that, a combination therapy of pyrimethamine, 
sulfadiazine and folic acid is recommended to treat acute toxoplasmosis, although it is 
ineffective against the chronic infection (25). 
1.2.2 Life cycle of T. gondii 
The life cycle of T. gondii includes sexual and asexual reproduction as depicted in 
Figure 2. Sexual development takes place only in the members of the genus Felidae as 
definitive hosts, whereas asexual propagation can be performed in a wide range of 
intermediate hosts including humans and farm animals (18). Successful pathogenesis as an 
opportunistic parasite can partly be assured by its ability to switch between fast-multiplying 
tachyzoite stage (acute phase of infection) and latent bradyzoite-containing tissue cyst form 
(chronic phase of infection) during the asexual reproduction (Figure 2), which enables the 
parasite to spread in a wide range of hosts (26).  
Sexual reproduction starts in the intestine of felids when they ingest prey animals 
harboring tissue cysts (27). After ingestion, bradyzoites (Greek, brady = slow; slowly 
multiplying form into tissue cyst) (28) are released from the cysts, penetrate themselves to 
the epithelial cells of small intestine and replicate themselves via several rounds of merogony 
during 3 to 7 days (29). Following asexual proliferation, the merozoites differentiate into 
male (micro) and female (macro) gametes by gamogony. Microgametes swim by means of 
their flagella to fertilize mature macrogametes. The fusion of micro- and macrogametes 
forms a zygote that later develops into an environment-resistant oocyst with five-layered wall 
(30) (Figure 2). The oocysts shed in the environment sporulate under proper aeration and 
temperature conditions to constitute two sporocysts each containing four sporozoites (30). 
The sporulated oocysts are quite infectious for intermediate hosts, and they can survive for 
years under harsh environmental conditions (16,31).  
In case of the sporulated oocyst uptake from contaminated vegetables or water, the 
sporozoites are released to the intestine of intermediate host during digestion. They invade 
the epithelial cells of gut and differentiate into fast-replicating tachyzoite stage (Greek, tachy 
15 
 
= fast) (32). Tachyzoites are the agents of acute infection. They multiply themselves in an 
intermediate host, followed by spreading through the body via blood or lymph (16). In 
immunocompetent individuals, upon immune stress tachyzoites turn into slowly replicating 
bradyzoites which are surrounded by a thick wall (<0.5 µm) and form tissue cysts (Figure 2).  
Figure 2. Life cycle of T. gondii. Sexual and asexual reproduction of Toxoplasma take place in felids 
and warm-blooded intermediate hosts, respectively. Oocysts are formed by the fusion of micro- and 
macrogametes in the gut epithelium of cats, followed by shedding to the environment. Oocyst 
sporulation occurs under convenient climate conditions. The uptake of sporulated oocyst by 
intermediate host via food- or waterborne transmission initiates asexual reproduction. Following 
ingestion, sporozoites are released from oocyst, penetrate to the epithelial cells of small intestine and 
differentiate into tachyzoites causing acute infection. Short after, tachyzoites are disseminated to the 
whole body and turn into bradyzoite-containing cysts leading chronic infection mostly in neural and 
muscular tissues. Predation of a cyst-containing animal by cat followed by merogony process 
completes the life cycle of parasite. Adapted from Hunter and Sibley 2012 (18). 
Tissue cysts can be developed in all visceral organs, such as lung, liver or kidney; 
however parasite has a tropism mostly to neural (brain-eyes) and muscular (skeletal-cardiac) 
tissues (32). Chronic infection caused by such cysts does not harm the healthy people and 
persists for the entire life (26,32). However, a relapse into acute infection because of the 
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immunosuppression can be fatal. Another ingestion of cyst-containing animal by cat causes 
the completion of full life cycle. Predation of an infected animal by another intermediate host 
is another way of parasite transmission that increases the prevalence of toxoplasmosis. 
1.2.3 Lytic cycle and parasite organelles 
Toxoplasmosis occurs by proliferation and persistence of the two asexual stages of T. 
gondii. The acute infection caused by tachyzoite stage is hallmarked by successive rounds of 
lytic cycles, which starts with the invasion of the host cell, proceeds with intracellular 
replication and ends by lysing the cell in order to infect neighboring host cells. 7-10 days 
post-infection, fast-replicating tachyzoites differentiate into bradyzoite-containing tissue 
cysts, which is the onset of chronic phase (33). Successful lytic cycle events and 
interconversion between tachyzoite and bradyzoite stages are tightly regulated by signaling 
pathways (34) (Figure 3). 
Tachyzoites are around 2-6 µm long crescent-shaped developmental forms of T. gondii, 
which have a pointed anterior (conoidal) and rounded posterior ends (30). The morphological 
features of tachyzoites include a flexible cytoskeletal structure containing (i) a spirally 
arranged fibrillary conoid, (ii) a pellicle that consists of an outer plasma membrane (PM) and 
inner membrane complex (IMC), and (iii) longitudinal subpellicular microtubules originating 
from apical polar ring, all of which coordinate a specialized form of parasite motility called 
“gliding motility” (35-37) (Figure 4). Gliding enables the parasite to navigate through the 
host and penetrate to the host-cell surface, followed by an active invasion. These events rely 
on the coordinated release of adhesion proteins and regulation of actin-myosin 
motor/complex (36,37). Once invaded, parasite resides within a non-fusogenic membranous 
structure called “parasitophorous vacuole (PV)” which is initially formed using the lipids of 
the host cell, plasma membrane along with secreted proteins and lipids of the parasite (38,39). 
Three distinct secretory organelles i.e. micronemes, rhoptries and dense granules (Figure 4) 
excrete their protein contents to facilitate invasion, PV maturation and establishment of a 
parasite-friendly environment in the host cytoplasm that allows the parasite replication in the 
PV (6,30).  
Tachyzoites utilize a unique way of cell division in the PV known as “endodyogeny”, 
in which two daughter cells are formed by a specialized mitosis of nucleus and organelle 
division within the cytoplasm of mother cell (5,34,40) (Figure 3).  Each endodyogeny varies 
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between 6 to 8 h and continues successively inside the mother cell until reaching 32-64 
progeny per vacuole, that leads to burst of host cell (egress), and thereby completing one 
round of lytic cycle process (33) (Figure 3). Egress process requires a synchronized secretion 
of proteins from secretory organelles. Besides, it is known to be regulated by multiple 
signaling pathways (41,42).  
Figure 3. Lytic cycle and stage differentiation of T. gondii. During acute infection of T. gondii, 
motile tachyzoites actively invade their host cell, followed by formation of a parasitophorous vacuole. 
Parasite replicates itself exponentially in parasitophorous vacuole to generate 32-64 progenies in 48 
h time frame, which leads to the lysis and egress out of host (left). Immune stress compels the parasites 
to differentiate into thick-walled dormant bradyzoite stage, which can reconvert to acute stage in 
declining stress conditions (right). The cooperation of cyclic nucleotide and calcium signaling 
regulates both lytic cycle and stage conversion during asexual replication. Modified from Zhang et 
al. 2013 (43).  
Formation of a non-fusogenic PV is an essential task for tachyzoites to assure the 
parasite survival from lysosomal activity of hosts (44,45). The membrane of PV also 
functions as an interface to facilitate the exchange between the parasite and host, allowing 
nutrient acquisition from host to the parasite and discharge from the parasite to its host cell 
(44,46). Small molecules, whose uptake is crucial for T. gondii tachyzoites, can be scavenged 
from the host cell by crossing through the membrane of the PV. These precursors are used 
for de novo synthesis of macromolecules in various organelles (47,48). 
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Figure 4. The major organelle structures of T. gondii tachyzoite. Tachyzoite is a crescent-shaped 
parasite stage with a pointed anterior (conoidal) and rounded posterior ends. It has a complex 
membrane structure containing an outer plasma membrane (PM) and a bilayer inner membrane 
complex (IMC). The apical complex structure consists of a spirally organized conoid, secretory 
organelles (micronemes and rhoptries) and microtubules connected to a polar ring. Besides, 
tachyzoites contain a four-membranous plastid-like organelle, apicoplast, which plays a major role in 
carbon metabolism. Acidocalcisomes are acidic compartments responsible for ion flux and calcium 
storage. Additionally, tachyzoites include a full set of eukaryotic cell organelles like nucleus, 
mitochondrion, endoplasmic reticulum and Golgi complex.  Adapted from Gupta 2018 (49). 
 
1.2.4 Genetic manipulation of the parasite genome 
T. gondii is the most common model organism used to study intracellular parasitism by 
virtue to its (i) well-established in vitro culturing techniques, (ii) proficiency to invade almost 
all types of nucleated cells, (iii) feasibility to apply a range of molecular approaches to 
manipulate the target genes, (iv) available complete genome sequence information in an 
accessible database (ToxoDB) (50), which allows a direct comparison with other members 
of apicomplexans.The first manipulation of T. gondii was performed by chemical 
mutagenesis approach to make temperature-sensitive clonal lines. This pioneer study formed 
a basis for the optimization of basic protocols for in vitro cultivation and making clonal lines 
of tachyzoites (51). Afterwards, classic genetic recombination method was applied in cats to 
correlate observed phenotype with single or multiple genomic loci to find out gene functions 
(52). Following this forward genetics approach, the restriction fragment length 
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polymorphism linkage map was constructed using 64 markers for T. gondii, which resulted 
in defining genes responsible for drug resistance as distributed in different regions of 11 
chromosomes (53). In another research, T. gondii chromosomes were separated by pulsed 
field gel electrophoresis. The linkage groups were assigned by hybridization to construct a 
molecular karyotype of the parasite, which reveals that T. gondii has a ~80 Mb haploid 
nuclear genome (54). The applications of modern reverse genetics approach to understand 
the roles of genes became possible only after developing electroporation technologies.  
First electroporation trials were performed for introducing exogenous DNA fragments 
in T. gondii (55,56). Several expression vectors have been designed to enable both tagging or 
deletion of genes by homologous recombination and non-homologous random integration of 
transgenes. For this purpose, a wide range of selectable markers were developed to choose 
only successfully transfected parasites from the stable drug-resistant pool. The most common 
selection markers available for T. gondii include dihydrofolate reductase/thymidylate 
synthase (DHFR/TS) conferring pyrimethamine resistance (56); hypoxanthine-xanthine-
guanine phosphoribosyltransferase (HXGPRT) which can be used both for positive and 
negative selection using mycophenolic acid-xanthine and 6-thioxanthine treatments, 
respectively (57); uracil-phosphoribosyltransferase (UPRT) that can be negatively selected 
by 5-fluorouracil (FudR) (58); and chloramphenicol acetyltransferase (CAT) providing a 
resistance to chloramphenicol (59). Cre-loxP mediated recombination system from 
bacteriophage P1 has also been successfully adapted to T. gondii to excise the target DNA 
fragment flanked between loxP sites and/or introduction of aforementioned selectable 
markers by the activity of site-specific Cre-recombinase (Figure 5A) (60). Yet, the success 
rate of homologous recombination for gene replacement was still quite low in wild-type 
parasites. To overcome this problem, non-homologous end joining (NHEJ) pathway, which 
repairs double-strand DNA breaks, was inactivated by deleting Ku80 protein first in type I 
(61,62) and then in type II (63) strains to increase the efficiency of homologous-
recombination-mediated gene- tagging and knockout without effecting the virulence features 
of parasites.  
On the other hand, studying the function of essential genes that are refractory to direct 
genetic deletion required a conditional system. The implementation of RNA interference 
(RNAi) technology, which was applicable in many other organisms, did not work in T. gondii 
due to the absence of DICER complex (64). Another milestone occurred in the research field 
when tetracycline repressor based transactivator system (TetR) was reported for 
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downregulation of essential genes (65). A parasite line carrying transactivator elements 
(TATi-1) was generated to perform conditional knockdown of a gene of interest (GOI) by 
anhydrotetracycline (aTc) treatment. Soon after, DD/Shield1 conditional system was 
implemented successfully in T. gondii (66). In principle, human rapamycin-binding protein 
FKBP12-derived destabilization domain (ddFKBP) was used as an epitope, whose fusion 
with GOI causes a rapid, efficient and reversible degradation of a protein of interest. On the 
contrary, the supplement of Shield1, a cell-permeable analogue of rapamycin, can stabilize 
the protein expression in a dose-dependent manner (Figure 5B) (67).  
Figure 5. Illustration of commonly used genetic manipulation strategies applied in T. gondii. 
(A) Simplified example of Cre-loxP site-specific recombination method for gene deletion. A GOI is 
flanked by 34 bp long loxP sequences. Parasite is transfected with a Cre-recombinase expressing 
vector, which will recognize loxP sites, resulting in excision of floxed sequence. (B) Conditional 
protein expression using DD/Shield1 system. A GOI is tagged with destabilization domain (DD). The 
fusion of DD to a POI causes a rapid protein degradation by the proteasome in the absence of its 
ligand. However, the supplement of Shield1 stabilizes a DD-fused POI. (C) CRISPR/Cas9 technology 
for introducing a mutation in the genome via non-homologous end joining (NHEJ). A single-guide 
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RNA (sgRNA) is designed to target a particular genomic locus and direct Cas9 protein to induce site-
directed double strand break, which is repaired by NHEJ causing random insertion and/or deletion. 
(D) The auxin-inducible degron (AID) system for conditional protein depletion. The protein 
expression of an AID-tagged GOI within the auxin receptor (TIR1-complex as shown in green) 
expressing parasite can be successfully performed in the absence of auxin (IAA). However, 15 min 
IAA treatment causes proteasomal degradation of POI. GOI: gene of interest, POI: Protein of interest  
Clustered regularly interspaced short palindromic repeats (CRISPR) naturally exist in 
Bacteria and Archaea as an adaptive defense system (68), which can recognize the foreign 
phage DNA and break double strands of DNA by means of CRISPR-associated protein 9 
(Cas9). The targeted site for the genome cleavage is guided by a single RNA (sgRNA) which 
contains a site-specific complementary sequence (Figure 5C) (69). Modifying prokaryotic 
CRISPR/Cas9 system and thereby adapting as a large spectrum of genome editing tool in T. 
gondii was the recent breakthrough in the field. Recently, two pioneer studies were 
successfully performed in T. gondii using CRISPR/Cas9-based genome editing system and 
paved the way for high-throughput genome engineering to investigate the function of genes:  
1) For gene insertion or deletion in laboratory-adapted T. gondii strains as well as in 
natural isolates, i.e. type I GT1 strain by homology-directed repair (HDR) approach (70),  
2) For introducing mutations as well as epitope-tagging of a target gene by non-
homologous end joining (NHEJ) and HDR approaches, respectively (Figure 5C) (71).  
The latest, a state of the art method has emerged and been adapted to T. gondii research 
by coupling CRISPR/Cas9 technology with a conditional expression system called auxin-
inducible degron (AID) to study essential proteins (Figure 5D) (72-74). Auxins are plant 
hormones which are involved in a signaling transduction pathway to induce degradation of 
auxin-family transcription repressors (75). A research group from Japan found out that other 
eukaryotes apart from plants also contain the same degradation pathway (TIR1 complex) 
without auxin. From this point of view, they expressed the small AID molecule in a various 
of non-plant cells to conditionally control of the protein stability (76). Following that, a T. 
gondii strain stably expressing the auxin receptor (ΔKu80/TIR1) was generated in 2017, and 
certain essential gene of interests were tagged with AID-3xHA using CRISPR/Cas9 
technology to downregulate their expression by auxin (indole-3-acetic acid, IAA) treatment 
(Figure 5D) (72,74). The efficient combination of novel systems for genome editing and 
analysis of importance of proteins have become pivotal to understand the parasite biology. 
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1.3 Signal transduction via cyclic nucleotides 
Signal transduction pathways are critical for regulation of essential cellular processes, 
such as neurotransmission, muscle contraction/relaxation, chemotaxis, optical perception or 
phototransduction in higher organisms as well as sensing and adaption to the changing 
environment conditions in microorganisms (77). The complex signal transduction pathways 
are initiated by the recognition of signals through receptors and processed with the production 
of second messengers, such as cyclic nucleotides (cNMPs), Ca2+ (77), diacylglycerol (DAG) 
or inositol triphosphate (IP3) (78). The signal transduction mechanisms typically proceed 
with the phosphorylation or dephosphorylation of target proteins by kinases to relay the effect 
of second messengers. 
Cyclic nucleotides [3’5’- cyclic adenosine monophosphate (cAMP) and 3’5’- cyclic 
guanosine monophosphate (cGMP)] are universal single-phosphate nucleotides (Figure 6), 
existing from prokaryotic bacteria to humans in almost all organisms. They convey the 
endogenous and exogenous cues to the downstream mediators (kinases, ion channels etc.), 
and thereby regulate a wide range of important events (79,80). Initiating a physiological 
response to a biological cue requires a complex mechanism based on the modulation of 
intracellular level of cNMPs that is tightly controlled by mainly three distinct type of enzymes 
(Figure 6):  
(1)  Nucleotide cyclases: cAMP and cGMP are synthesized from the adenosine- or 
guanosine triphosphate (ATP or GTP) by the catalytic action of adenylate (adenylyl)- and 
guanylate (guanylyl) cyclase (AC and GC), respectively (Figure 6).  
(2)  cNMP-dependent protein kinases: Protein kinase G (PKG or cGMP-dependent 
protein kinase) and protein kinase A (PKA or cAMP-dependent protein kinase) are the major 
mediators of cNMP signaling. They phosphorylate a repertoire of effector proteins to exert a 
consequent subcellular response. Besides, cyclic-nucleotide gated (CNG) ion channels can 
also be directly activated by cNMPs to balance ion concentrations by changing polarization 
of the membrane to control  physiological events in many eukaryotes (80,81). An additional 
cAMP-binding protein called “Exchange protein directly activated by cAMP (ePAC)” is also 
described as one of the direct effectors of cAMP signaling, which fulfils the need for diverse 
biological functions in mammalian cells (Figure 6) (82). 
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(3)  cNMP-specific phosphodiesterases (PDEs): The levels of cGMP and cAMP are 
strictly counterbalanced by phosphodiesterase enzymes which degrade cGMP into 5’-GMP 
and cAMP into 5’-AMP by hydrolyzing the 3’-phosphoester bonds (83) (Figure 6). 
Figure 6. Molecular structures of cyclic nucleotides (cAMP and cGMP), their precursors and 
degraded products. 3’5’-cyclic AMP and 3’5’-cyclic GMP are single-phosphate nucleotides that are 
produced by adenylyl- (adenylate) and guanylyl- (guanylate) cyclases from ATP and GTP, 
respectively. They contain a cyclic bond between the hydroxyl group of the ribose sugar and the 
phosphate group. cNMP-dependent protein kinases and cyclic nucleotide-gated ion channels are 
downstream targets of cyclic nucleotides. The intracellular concentration of cAMP and cGMP are 
counterbalanced by cNMP-phosphodiesterases which degrade them to 5’-AMP and 5’-GMP 
depending on their substrate specificity. Adapted from https://basicmedicalkey.com/second-
messengers/ 
 
1.3.1 Cyclic nucleotide signaling in mammalian cells 
Much of our understanding about cNMP-induced signal transduction is derived from 
higher organisms, namely mammalian cells which harbor 4 soluble guanylate cyclase 
subunits (α1, α2, β1, β2) and seven membrane-bound guanylate cyclases (GC-A to GC-G). The 
soluble guanylate cyclase (sGC) isoforms function as heterodimers and consist of an amino-
terminal heme-binding regulatory domain, a dimerization region and a carboxyl-terminal 
catalytic domain (Figure 7A). In contrast, all known particulate GC (pGC) proteins occur as 
homodimers except for GC-C which exists as a homotrimer in the basal state. pGCs typically 
possess the successive domains: An extracellular ligand binding site formed by two amino 
terminal domains followed by a transmembrane, a kinase homology, a dimerization and 
finally a catalytic domain comprising two functional catalytic sites  (80,84,85) (Figure 7A).  
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Nitric-oxide (NO) is the best-characterized activator of sGCs, while a variety of the 
ligands, such as atrial natriuretic peptides (ANPs), guanylin or bicarbonate were reported for 
the activation of pGCs (80,84) (Figure 7B). The cGMP produced can be used consequently 
by three classes of intracellular target proteins: PKGs and CNG channels as effectors, cGMP-
specific PDEs as regulators of cGMP (85). CNG channels are usually described as 
photoreceptors, being activated by cGMP in phosphorylation-independent manner and play 
important role in visual perception by regulating influx/efflux of Ca2+ and Na+ ions (85,86). 
The closure of CNG ion channels in response to light leads to the activation of PDEs. Not 
only cGMP-specific PDEs but also cAMP-specific PDEs which use cGMP as a substrate for 
activation but hydrolyze specifically cAMP to AMP, can be stimulated by CNG channels 
(Figure 7B). Besides, phosphorylation events performed by PKGs can also activate PDEs 
(83,85). 
Figure 7. The basic mechanism of cGMP signaling and its regulation in mammalian cells. (A) 
Molecular structures of particulate and soluble guanylate cyclases (pGC and sGC) including the 
domain structure from N-terminal (amino) to the C-terminal (carboxyl) end. Adapted from Lucas et 
al. 2000 (80). (B) Simplified illustration of cGMP signaling involving the extracellular stimulus (NO 
and/or ANPs, guanylin) and major downstream mediators responsible from its synthesis (pGC and/or 
sGC), function (PKG and/or CNG channels) and degradation (PDEs), respectively. ANPs, atrial 
natriuretic peptides; NO, nitric oxide; pGC, particulate guanylate cyclase; sGC, soluble guanylate 
cyclase; PKG, cGMP-dependent protein kinase; CNG channels, cyclic nucleotide gated ion channels; 
PDEs, phosphodiesterases. From Beavo and Brunton 2002 (77).  
 
On the other hand, 9 closely related-adenylate cyclase isoforms (AC1-AC9) with 2 
splice variants of AC8 have been identified, all of which are membrane-anchored (87). Only 
one soluble AC has been reported in the male germ cells so far (88). Each AC isoform 
contains two hydrophobic domains at the N-terminal, which consist of six transmembrane 
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spans, and follows two catalytic regions at the C-terminal in the cytosol (87,89). All known 
PKAs and PKGs belong to the serine/threonine kinases. In mammals, there are 2 variants of 
PKG (PKG I and PKG II) described, while a single PKA has been identified (90,91). The 
type I PKGs with two soluble alternatively-spliced isoforms (α and β) is expressed more 
generally and function as homodimers. It is employed as a major regulator of the 
cardiovascular system and often associated with the pathways controlling subcellular Ca2+ 
levels (85,91,92). The type II PKGs are membrane-bound proteins that are predominantly 
expressed in the epithelial cells of intestine to regulate ion and water transport (91,93). 
Although type II PKG protein isolated from pig intestine was shown to behave as a 
monomeric membrane protein (94), the same recombinant protein in rat intestine was found 
as a dimer (91). In contrast, human PKA protein is a tetrameric holoenzyme when it is in the 
inactive state. It includes a dimeric regulatory subunit at the N-terminal and two catalytic 
subunits at the C-terminal (90). 
1.3.2 cGMP signaling in T. gondii  
Unlike mammalian cells, little is understood about the overall architecture and 
functioning of cyclic nucleotide signaling in protozoans. The cyclic GMP signaling pathway 
in the parasite T. gondii is the particular focus of this thesis. 
The cGMP pathway in protozoans shows a marked divergence from mammalian cells 
(95-97), which is suggested to underlie microbial pathogenesis (95). Apicomplexa, as one of 
the protozoan phyla, exhibits an even more intriguing design of cGMP signaling. 
Toxoplasma, Plasmodium and Eimeria as key apicomplexan parasites display a complex life 
cycle regulated by interconnected signaling pathways in nature, assuring their successful 
infection, reproduction, stage-conversion, adaptive persistence and inter-host transmission. 
Cyclic GMP cascade has been shown as one of the most central mechanisms to coordinate 
the key steps during the parasitic life cycle (95,98-101). In particular, the motile parasitic 
stages, e.g., sporozoite, merozoite, ookinete and tachyzoite deploy cGMP signaling to enter 
or exit host cells (98,100) or traverse tissues by activating secretion of micronemes which are 
the apicomplexan-specific secretory organelle (102-104). Micronemes secrete adhesive 
proteins required for the parasite motility and subsequent invasion and egress events 
(100,102-104). Microneme secretion was shown to be triggered in in vitro cultures by 
external stimuli, such as low level of potassium (105) or pH (106), and a host protein serum 
albumin (103). The process is mainly controlled by a programmed PKG activity. 
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The work of Gurnett et al. (107) demonstrated that T. gondii and E. tenella harbor a 
single PKG gene encoding for two alternatively-translated isoforms (soluble and membrane-
bound). The physiological essentiality of PKG for the asexual reproduction of both parasites 
was first revealed by a chemical-genetic approach (108), whereas the functional importance 
of this protein for secretion of micronemes, motility and invasion of T. gondii tachyzoites and 
E. tenella sporozoites was proven by Wiersma et al.(109). Successive works in T. gondii have 
further endorsed a critical requirement of TgPKG for its asexual reproduction by various 
methods (42,72,108,110). PKG is also needed for the hepatic and erythrocytic development 
of Plasmodium species (98,111,112). It was shown that PKG triggers the release of calcium 
from endoplasmic reticulum and other storage organelles, such as Golgi apparatus, 
mitochondria or endosome-like compartments like plant like vacuoles, in Plasmodium (113) 
and Toxoplasma (103). Calcium can in turn activate calcium dependent protein kinases 
(CDPK1 and CDPK3) (42,114), and thereby exocytosis of micronemes as shown in the 
Figure 8. The Ca2+ stores can be stimulated to be released into the cytosol via calcium 
ionophores, such as A23187 or ethanol, eventually inducing microneme exocytosis (115). On 
the contrary, chelating intracellular Ca2+ by BAPTA-AM treatment causes a blockage of 
microneme discharge (116), which subsequently leads to an inhibition of gliding motility 
(117) as well as host-cell invasion (118). 
The effect of cGMP signaling on calcium depends on inositol 1,4,5-triphosphate (IP3) 
that is produced by phosphoinositide-phospholipase C (PI-PLC), a downstream mediator of 
PKG (Figure 8) (102). Besides IP3, diacylglycerol (DAG) is also generated as a product of 
PI-PLC and converted to phosphatidic acid (PA) by diacylglycerol kinase1 (DGK1) to induce 
microneme secretion via an alternative way (104). The TgAPH protein (acylated-peleckstrin-
homology domain) located onto the microneme surface has been identified as the first PA-
sensor. Once PA is recognized by TgAPH, DOC2.1 protein anchored in plasma membrane of 
T. gondii gets involved to initiate membrane fusion during exocytosis (104,119) (Figure 8). 
The membrane fusion machinery is also known to take place in a Ca2+-dependent manner for 
exocytosis of micronemes (119).  
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Figure 8. Coordinated control of microneme secretion via interconnected network of cAMP, 
cGMP, calcium and lipid signaling pathways. In the presence of cGMP synthesized by GC, PKG 
activates PLC to produce both IP3 and DAG, and thereby stimulating microneme exocytosis. While 
IP3 can be recognized by yet unknown receptor in the ER to release calcium in the cytoplasm, DAG 
is phosphorylated by DGK1 to generate PA. Eventually, microneme secretion and gliding motility of 
parasites are induced by both pathways. ACs (ACα and ACβ) produce cAMP, which is bound by 
PKAr causing the release of PKAc1. cGMP-specific PDE is phosphorylated by active PKAc1 to 
degrade cGMP, which in turn blocks the PKG and subsequent microneme secretion. (Abbreviations: 
AC, adenylate cyclase; APH, acylated-peleckstrin-homology domain containing protein; CDPK, 
calcium dependent protein kinase; DAG, diacylglycerol; DGK, diacylglycerol kinase; ER, 
endoplasmatic reticulum; GC, guanylate cyclase; PA, phosphatidic acid; PDE, phosphodiesterase; 
PKAc1, catalytic subunit of protein kinase A; PKAr, regulatory subunit of protein kinase A; PKG, 
protein kinase G; PLC, phospholipase C; IMC, inner membrane complex; IP3, inositol 1,4,5-
triphosphate) Image adapted from Jia et al. 2017 (120). 
Recently, a crosstalk between TgPKA and TgPKG was revealed to regulate timely 
egress of T. gondii tachyzoites (120). The catalytic and regulatory subunits of PKA (PKAc1 
and PKAr) are present as linked with each other in the parasite membrane when PKAc1 is 
inactive as depicted in the Figure 8. The increase of cAMP level by the action of ACs in the 
parasite is employed by PKAr, which induces the release of PKAc1. The active PKAc1 
phosphorylates the cGMP-specific PDE causing a decline in the cGMP level of parasite, 
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which blocks TgPKG and subsequently inhibit microneme secretion (Figure 8). 
Downregulation of PKAc1 in contrast, triggers premature egress from host cells by 
modulating phosphorylation profile of a putative cGMP-dependent PDE. Besides, the 
inhibition of TgPKG by specific compounds (compound 1 and 2) (121) ceases the egress 
event stimulated by PKAc1 inactivation. However,  the treatment with a cGMP-specific PDE 
inhibitor, BIPPO (122) rescues the egress blocked by activation of PKAc1 (Figure 8) (120). 
Consequently, PKAc1 acts as a balancing regulator of PKG and Ca2+ signaling, and thereby 
negatively controlling microneme secretion and egress (120). PKA was also shown to 
suppress cytosolic calcium after invasion immediately, leading to a repressed motility before 
the onset of intracellular replication (123). 
In brief, cAMP, cGMP, lipid and Ca2+ signaling pathways constitute a complex and an 
interconnected network to regulate crucial events during the lytic cycle.  
1.3.3 Optogenetic tools to manipulate cGMP-mediated signaling  
Optogenetics is a rapidly developing discipline that combines techniques of Optics and 
Genetics to tightly control cellular processes both in living cells and in the whole organism 
in a cell-specific manner. The term “Optogenetics” was first coined by Deisseroth et al. (124) 
to designate genetically-encoded photoreceptor proteins in neuron cells for manipulating 
(either activate or inhibit) neuronal activities. The research techniques of this field have been 
improved greatly in the last decade and overridden conventional chemical methods to study 
cellular signaling in spatial and temporal manner (125). This has become feasible by means 
of a variety of bioengineered photosensitive proteins serving as actuators (to light-
dependently control the cell actions) and sensors (to monitor ongoing actions in cell) 
(125,126). Currently, more than 40 actuators and about 30 biosensors are present in the 
“Addgene” data repository (www.addgene.org), most of which are substantially applied in 
Neurobiology research (127). 
Optogenetic actuators, also known as sensory photoreceptors, enable fast, non-invasive 
and reversible modulation of second messenger signaling, membrane potential, gene 
expression and protein-protein interaction (128). There are seven such protein classes: 
rhodopsins, photoactive-yellow proteins, light-oxygen voltage (LOV) sensors, blue-light 
receptors containing flavine adenine dinucleotide (BLUF), cryptochromes, phytochromes 
and UV-B receptors (UVR8). All aforesaid photoreceptors except for UVR8 rely on their 
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respective chromophore that absorbs a specific frequency of light ranging between 300 and 
800 nm and subsequently undergo a conformational change to initiate the catalytic activation 
(125).  
For cyclic nucleotide signaling research, two naturally existing photoreceptors 
possessing soluble adenylate cyclase/s were firstly described as potential optogenetic tools 
in Euglena gracilis (129) and Beggiatoa sp.(130), both of which comprise a N-terminal 
BLUF domain involved in blue-light (455 nm) sensing. Photo-activated AC from Beggiatoa 
(bPAC) is the most commonly used optogenetic tool due to its simple design and soluble 
nature to stimulate cAMP production by blue light in various models. The mutagenized 
version of this protein acting as a light-activated guanylate cyclase (bPGC) was generated by 
Ryu et al. (131). Although cGMP synthesis could be induced by blue light in bPGC-
expressing systems, a minor increase in cAMP level was also detected, which limited its 
application. Subsequently, light-activated phosphodiesterases (LAPDs), which can be 
activated by red light to degrade cNMPs, (132) were engineered by combining bacterial 
phytochrome from Deinococcus radiodurans with the human phosphodiesterase 2A as 
effector. However, they have not yet gained wider application due to dual specificity of both 
cyclic nucleotides. 
Rhodopsins constitute one of the main photoreceptor groups expressed in the great 
majority of all living organisms (133). They are classified into two groups; type I (microbial) 
and type II (metazoan), both of which are membrane proteins containing seven 
transmembrane α-helices. They use all-trans retinal as the chromophore (134). Lately, a 
microbial rhodopsin class with an enzymatic activity to regulate cGMP concentration with 
an additional output domain has been explored. One of the representatives of this fusion 
proteins containing a C-terminal GC catalytic domain and N-terminal microbial rhodopsin 
domain linked via 40 aa long coiled coil (RhoGC) was discovered in an aquatic fungus 
Blastocladiella emersonii (Figure 9A) (135). It was shown that the green light (520-530 nm) 
can activate RhoGC to synthetize cGMP in various systems with a negligible dark activity, 
which proposes RhoGC as an excellent optogenetic tool (128,136,137). Another rhodopsin 
protein with a C-terminal cytoplasmic PDE domain, which are connected to each other by a 
linker (40-50 aa) (RhoPDE), was reported in a Choanoflagellate, Salpingoeca rosetta. 
RhoPDE was found to degrade cGMP 10 fold more than cAMP as substrate; however, its 
hydrolytic activity is also observed in the dark (Figure 9B). Besides, the illumination with 
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blue-green light (492 nm) did not show any additional induction of cNMP degradation in 
mammalian systems (138,139).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Schematic structures of representative optogenetic tools. (A) Model of dimeric photo-
activated rhodopsin-guanylate cyclase gene fusion (RhoGC) from fungus Blastocladiella emersonii. 
Microbial rhodopsin containing 7 transmembrane domains (red) is linked to soluble guanylate cyclase 
(blue) through a coiled-coil domain (black). Two additional membrane-spanning helices were shown 
in beige. Rhodopsin senses green light (520-530 nm) and activates guanylate cyclase to synthesize 
cGMP from GTP. Adapted from Scheib et al. 2015 (136). (B) Illustration of membrane-anchored 
rhodopsin (green) with phosphodiesterase (blue) of RhoPDE from Salpingoeca rosetta in dimer form. 
PDE catalytic domain constantly hydrolyses cAMP and cGMP in the dark condition. The blue-green 
light illumination (492 nm) does not show an additional increase in its activity. Adapted from Yoshida 
et al. 2017 (139). (C) Demonstration of working principle of cGi500 sensor to detect cGMP. FRET-
based indicator depicting cGMP-binding domain of protein kinase G, which is sandwiched between 
cyan- and yellow- fluorescent proteins, CFP and YFP, respectively. The bound of cGMP (gray) leads 
to a conformational change of protein and decrease in FRET, causing reduced emission from YFP 
(535 nm) and increased emission from CFP (480 nm). Figure source is Paolillo et al. 2018 (140). (D) 
The structure of single fluorophore calcium sensor GCaMP. Calcium (Ca2+) binding causes a 
conformational change in calmodulin-M13 complex, leading to an increase in the fluorescence of 
circularly permuted enhanced GFP (cpEGFP). Figure was acquired from Knöpfel et al. 2010 (141). 
On the other hand, optical sensor proteins including environment-sensitive fluorescent 
proteins, e.g., pH-sensitive GFP, and bioluminescent indicators allow the monitoring of a vast 
number of cellular factors, such as membrane voltage, changes in metabolite or ion 
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concentrations and enzyme activities. Besides, several sensors engineered by mutation, 
permutation or integration of two fluorescent proteins are also available to track dynamics of 
the molecules of interest (125,142). Interaction with a specific-molecule leads to a structural 
change in protein-complex, causing an alteration in fluorescence -spectra, -intensity or -
resonance energy transfer (FRET) efficacy between acceptor and donor (125). Hence, the 
fluorescence response can be monitored either according to the intensity change or 
ratiometrically (FRET-based) with two-different wavelengths (one excitation and two 
emission or two excitation and one emission) (142).  
The designing and application of gene encoded cGMP-sensitive biosensors facilitate 
real time monitoring of cGMP changes in living cells, which is difficult otherwise because 
of the transient nature of cGMP. Recently engineered FRET-based cGMP-sensors (Figure 
9C) (named as cGi500, cGi3000 and cGi6000 depending on their sensitivity to cGMP 
concentrations) (143) were designed based on the type I PKG flanked by cyan- and yellow- 
fluorescent proteins, CFP and YFP, respectively. The bound of cGMP causes a 
conformational change leading a decrease of FRET from CFP to YFP as seen in Figure 9C. 
The estimation of cGMP concentration is done by calculation of CFP/YFP emission ratio. 
Although these cGMP indicators showed fast binding kinetics and an excellent specificity to 
cGMP in mammalian systems (140), FRET-based sensors have not yet been widely utilized 
because of the complexity of multiple emission parameters by a dual emission fluorescence 
microscopy. Instead, circularly permuted GFP-based cGMP sensors, such as FlincG3, are 
employed to timely monitor cGMP dynamics (144). Similarly, the usage of genetically-
encoded calcium indicators (GECI) with single fluorophore (Figure 9D) has been also found 
pretty valuable to monitor intracellular Ca2+ homeostasis of various cell types (145-147). 
GCaMPs family proteins, the most widely used GECIs, are composed of a circularly 
permuted enhanced green fluorescent protein (cpEGFP), the calcium binding calmodulin 
(CaM) and CaM-interacting myosin light-chain kinase domain (M13) (146). An enhance in 
calcium level causes a conformational change in CaM, followed by activation of M13 and 
blocking the hole in the cpEGFP β-barrel, which leads to an increase in the fluorescence of 
cpEGFP as shown in Figure 9D (147,148). 
Despite the fact that optogenetic technologies seem to provide several advantages to 
address convoluted questions, their application in infection research remained quite limited. 
A few years ago, Hartmann et al. (149) successfully expressed bPAC (130) to regulate cAMP 
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signaling by light in T. gondii. Recently, possible applications of available tools were 
proposed by Arroyo-Olarte et al. (127) to study various paradigms in intracellular pathogens. 
Given the benefits, such as (i) specific and quantitative regulation of cNMP levels within the 
parasite, (ii) efficient and reversible modulation of cNMP, (iii) rapid and spatiotemporal 
induction of signaling pathways, wider implementation of optogenetics in infection biology 
is very much expected. 
1.4 Objective of this study 
Cyclic GMP is a universal second messenger, regulating vital processes in the parasite. 
The function of PKG in T. gondii has been studied in details up to now. However, the onset 
of cGMP cascade remains underappreciated, partly due to complex structure of guanylate 
cyclases, as described in Plasmodium (97,150). Two distinct guanylate cyclases, PfGCα and 
PfGCβ (96,150,151), were identified in P. falciparum. Lately, Gao et al. (152) demonstrated 
the essential role of GCβ for the motility and transmission of P. yoelii. It was aimed in this 
thesis to characterize the native guanylate cyclase of T. gondii and test the physiological 
importance of cGMP signaling for the asexual reproduction of its acutely infectious 
tachyzoite stage. Our findings along with other independent studies published during the 
course of this work (99,153,154)  as discussed elsewhere in this thesis, provide significant 
new insights into cGMP signaling during the lytic cycle of T. gondii. 
Much of the cyclic-nucleotide signaling research is so far based on the usage of chemical 
activators and inhibitors targeting protein kinases and phosphodiesterases in conjunction with 
reverse genetics approach. The implementation of such chemical modulators is not optimal 
in this kind of two-organism (host-parasite) system to examine the organism-specific 
pathways, because they target proteins in both organisms due to the ubiquitous nature of 
cNMP signaling. As a consequence, there is no evidence yet showing real-time induction of 
cGMP cascade within the parasite and its direct relationship with the lytic cycle. To overcome 
such issues, we intended to take advantage of optogenetics by recombinantly expressing a 
light-activated rhodopsin-guanylate cyclase fusion protein (RhoGC) (135,136) in T. gondii 
tachyzoites to modulate only the parasite-specific cGMP pathways by light without 
perturbing its host cell. It allowed a rapid, reversible and spatial regulation of cGMP during 
the lytic cycle of parasite.  
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2 Materials and Methods 
2.1 Materials  
2.1.1 Biological resources 
Cell line Source 
Human foreskin fibroblasts               
(HFFs)                 
Carsten Lüder, Georg-August University, 
Göttingen, Germany  
T. gondii tachyzoites                   
(RHΔku80-hxgprt- strain) 
Vern Carruthers, University of Michigan, Ann 
Arbor, USA (62) 
E.coli (XL-1blue) Stratagene, Germany 
E. coli (M15/pREP4) Qiagen, Germany 
E.coli (BTH101) Qiagen, Germany 
2.1.2 Vectors 
Vectors Source 
p3’IT-HXGPRT John Boothroyd, Stanford School of Medicine, 
USA 
pSAG1-Cre 
(Cre-recombinase expressing vector) 
John Boothroyd, Stanford School of Medicine, 
USA 
pTKO-DHFR/TS modified from p3’IT-HXGPRT 
pGRA1-UPKO  modified from p3’IT-HXGPRT 
pDHFR-UPKO modified from p3’IT-HXGPRT 
pGP-SIU-GCaMP6s-GFP Loren Looger, Howard Hughes Medical Institute, 
USA 
pU6-Universal Sebastian Lourido, White Institute for Biomedical 
research, USA (71) 
pQE60  Qiagen, Germany 
pGEM-RhoGC Suely L. Gomes, Universidade de Sao Paulo, Brazil 
(135) 
  
2.1.3 Oligonucleotides 
All oligonucleotides used in this study were synthesized by Thermo Fisher Scientific 
(Germany) and listed in Table 1. 
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Table 1. Oligonucleotides used in this study  
Primer name 
(Restriction site) 
Primer Sequence 
(Restriction site underlined) 
Objective 
(Cloning vector) 
3’HA tagging of selected Toxoplasma genes (Δku80-Δhxgprt strain) 
TgATPaseP-GC-COS-F1 
(XcmI) 
CTCATCCCACCGGTCACCTGGGC
ATGAGTGTGGCGGAGT 
 
 
Cloning of 
crossover 
sequence for 3’-
HA tagging  
(p3’IT-HXGPRT) 
TgATPaseP-GC-HA3`IT-COS-R1 
(EcoRI) 
CTCATCGAATTCCTACGCGTAGT
CCGGGACGTCGTACGGGTACGA
CCCGAGTGCAGAGC 
TgPKG-COS-F1 
(NcoI) 
CTCATCCCATGGGAAAACTCGTT
TTCCCGC 
TgPKG-HA3`IT-COS-R1 
(EcoRI) 
CTCATCGAATTCCTACGCGTAGT
CCGGGACGTCGTACGGGTAGAA
ATCCTTGTCCCAGTCATACT 
3’UTR cloning in the TgATPaseP-GC-HA3`IT and TgPKG-HA3`IT vector constructs 
TgATPaseP-GC-3`UTR-F1 
(EcoRI+loxP) 
CTCATCGAATTCATAACTTCGTAT
AGCATACATTATACGAAGTTATAA
CGCAGCTTTTGTCAGC  
 
Cloning of 3’UTR 
for the native 
expression 
(p3’IT-HXGPRT) 
TgATPaseP-GC-3`UTR-R1  
(SpeI) 
CTCATCACTAGTTTATGTACGTAT
ATACGCACATGTATG 
TgPKG-3`UTR-F1 
(EcoRI+loxP) 
CTCATCGAATTCATAACTTCGTAT
AGCATACATTATACGAAGTTATTT
TTTCAGCTTAGGTGTTTGTTCC  
TgPKG-3`UTR-R1  
(SpeI) 
CTCATCACTAGTGCTTTTCTGCG
ACTCTGCTC 
Screening for 3’UTR excision of TgATPaseP-GC-HA3’IT and TgPKG-HA3`IT mutants 
TgATPaseP-GC-HA3`IT-Scr-F1 CTGGTCTCCGCAGAGATGCT Screening primers 
of 3’UTR 
excision for the 
gene knockdown 
(p3’IT-HXGPRT) 
Scr-TgPKG-HA3`IT-Scr-F1 GTTCATGTGCGGACCTCTCC 
3`UTRexcised-loxP-Scr-R1 
(TgATPaseP-GC/TgPKG) 
CAGTGAGCGCAACGCAATTA 
Overexpression of catalytic domains GC1 and GC2 of TgATPaseP-GC in E. coli 
TgATPaseP-GC1-F1  
(BglII) 
CTCATCAGATCTATGCTCGATAAG
AAGTACTTGCCCCCAC 
 
 
 
 
Cloning of 
TgATPaseP-GC 
cyclase catalytic 
domains for E. 
coli expression 
(pQE60-6xHis) 
 
 
TgATPaseP-GC1-R1  
(BglII) 
CTCATCAGATCTCGACGACGCAC
CCGCAGT 
TgATPaseP-GC2-F1  
(BglII) 
CTCATCAGATCTATGACGATGAG
CTTAACGTTCATCATC 
TgATPaseP-GC2-R1  
(BglII) 
CTCATCAGATCTTTGAGGGATCG
CACCGCC 
TgATPaseP-GC1+2-F1  
(BglII) 
CTCATCAGATCTATGCTCGATAAG
AAGTACTTGCCCCCAC 
TgATPaseP-GC1+2-R1  
(BglII) 
CTCATCAGATCTTTGAGGGATCG
CACCGCC 
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pQE60-Sequencing-F1 CGGATAACAATTTCACACAG 
pQE60-Sequencing-R1 GTTCTGAGGTCATTACTGG 
Making the ΔTgATPaseP-GC mutant (TgATPaseP-GC-HA3`IT strain) 
TgATPaseP-GC-KO-5’UTR-F1 
(XcmI) 
CTCATCCCACCGGTCACCTGGTG
CTTGGCTGATTGATGG 
Cloning of 5’UTR 
for the 
TgATPaseP-GC 
knockout (pTKO-
DHFR/TS) 
TgATPaseP-GC-KO-5’UTR-R1 
(SpeI) 
CTCATCACTAGTTTTCGTCGTATT
CGATAGCTCC 
TgATPaseP-GC-KO-5’Scr-F1 CGAGACGAGATTCTTGAACGA 
Screening of 5’ 
recombination  
TgATPaseP-GC-KO-3’UTR-F1 
(HindIII) 
CTCATCAAGCTTAACGCAGCTTT
TGTCAGCG  
Cloning of 3’UTR 
for the 
TgATPaseP-GC 
knockout (pTKO-
DHFR/TS) 
TgATPaseP-GC-KO-3’UTR-R1 
(ApaI) 
CTCATCGGGCCCGACGGCTAGTC
GAGACCCTG  
TgATPaseP-GC-KO-3’Scr-R1 AAGGATGATATTGCACCTCACA  
Screening of 3’ 
recombination  
Genetic disruption of TgATPaseP-GC by CRISPR/Cas9 in  TgATPaseP-GC-HA3`IT strain 
TgATPaseP-GC-sgRNA-F1 
AAGTTCGTTGACTCTGTTCACCG
CCG 
Cloning of 
sgRNA for editing 
of TgATPaseP-GC 
(pU6-sgRNA-
Cas9) 
TgATPaseP-GC-sgRNA-R1 
AAAACGGCGGTGAACAGAGTCA
ACGA 
Making of optogenetic strain expressing RhoGC in T. gondii  (Δku80-Δhxgprt) 
RhoGC-F1 
(NsiI) 
CTCATCATGCATATGAAAGATAA
GGATAATAACCTGAGA 
Cloning of 
RhoGC-HA in 
pTKO-DHFR/TS 
for randomly 
insertion  
RhoGC-HA-R1 
(PacI) 
CTCATCTTAATTAACTACGCGTAG
TCCGGGACGTCGTACGGGTATTT
TCTGCCCAGCACCCAAT 
Making of optogenetic strain conditionally expressing RhoGC in T. gondii (Δku80-Δhxgprt) 
ddFKBP-F1 
(NsiI) 
CTCATCATGCATATGGGAGTGCA
GGTGGAA 
Cloning of 
ddFKBP to the N-
terminal of 
RhoGC in pTKO-
DHFR/TS  
ddFKBP-R1 
(PstI) 
CTCATCCTGCAGAGGTTCCGGTT
TTAGAAGCTCC 
Sequencing for full-length of RhoGC in pTKO-DHFR/TS 
pTKO-EsPri-F1 TATAGACGCAACTCGGTTTGCT 
Sequencing 
primers for 
verification  
RhoGC-Rho-EsPri-R1 GTTCTCCAGTTCCTCTGCGA 
RhoGC-GC-EsPri-F1 CTTGGAGCCTGTTCCCCATT 
pTKO-EsPri-R1 CTGATCGGCTTTGTAGACTTCTC 
Ectopic expression of RhoGC in T. gondii  (Δku80-Δhxgprt) 
RhoGC-F1 
(NsiI) 
CTCATCATGCATATGAAAGATAA
GGATAATAACCTGAGA 
Cloning of 
RhoGC-3xHA in 
pDHFR-UPKO 
vector for 
RhoGC-3xHA-R1 
(PacI) 
CTCATCTTAATTAATTAGGCATAA
TCTGGAACATCGTAAGGATACGC
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ATAATCGGGCACATCATAGGGAT
AGCCAGCGTAGTCCGGGACGTC
GTACGGGTATTTTCTGCCCAGCA
CCCAAT 
moderate 
expression 
pDHFR-UPKO-EsPri-F1 ATTTTACCACACGGCAGTG Sequencing 
primers of 
pDHFR-UPKO 
for verification 
pDHFR-UPKO-EsPri-R1 GGGTCTCTGGCACCCCCT 
Screening of RhoGC expression in optogenetic strains 
RhoGC-Scr-F1 
ATGAAAGATAAGGATAATAACCT
GAGAGG 
Primers for gDNA 
and cDNA 
screening  RhoGC-Scr-R1 TTTTCTGCCCAGCACCCAATAAG 
Ectopic expression of GCaMP6s in T. gondii  (Δku80-Δhxgprt strain) 
GCaMP6s-F1 
(NsiI) 
CTCATCATGCATTCTCATCATCAT
CATCAT 
Cloning of 
GCaMP6s-ORF 
in pGRA1-UPKO 
vector 
GCaMP6s-R1 
(PacI) 
CTCATCTTAATTAATCACTTCGCT
GTCATC 
Co-expression of GCaMP6s with RhoGC-3xHA in T. gondii  (pDHFR-RhoGC-3xHA strain) 
GCaMP6s- cassette-F1 
(NotI) 
CTCATCGCGGCCGCCGTCTCAGC
TGCGCGAGGC 
 
Cloning of 
GCaMP6s-
cassette flanked 
with TgGra1-
5’UTR and 
TgGra2-3’UTR to 
pDHFR-RhoGC-
3xHA vector 
GCaMP6s-cassette-R1 
(NotI) 
CTCATCGCGGCCGCCACCGCGGT
GGGATCCGT 
 
2.1.4 Antibodies 
Antibody Dilution Source 
α-TgSag1 (mouse) 1:10000 Dubremetz et al. 1985 (155) 
α-TgISP1 (mouse) 1:2000 Beck et al. 2010 (156) 
α-TgGap45 (rabbit) 1: 3000 Plattner et al. 2008 (157) 
α-TgRop2 (mouse) 1:1000 Sadak et al. 1988 (158) 
α-TgHSP90 1:1000 Echeverria et al. 2005 (159) 
α-GFP (mouse) 1:1000 Thermo Fisher Scientific, Germany 
α-GFP (rabbit) 1:5000 Thermo Fisher Scientific, Germany 
α-HA (mouse) 1:3000 Invitrogen, Germany 
α-HA (rabbit) 1:200 Thermo Fisher Scientific, Germany 
α-6xHis mAb IgG1 (mouse) 1:2000 Dianova, Germany 
Alexa Fluor 488 α-mouse IgG (goat) 1:3000 Thermo Fisher Scientific, Germany 
Alexa Fluor 488 α-rabbit IgG (goat) 1:3000 Thermo Fisher Scientific, Germany 
Alexa Fluor 594 α-rabbit IgG (goat) 1:3000 Thermo Fisher Scientific, Germany 
Alexa Fluor 594 α-mouse IgG (goat) 1:3000 Thermo Fisher Scientific, Germany 
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IRDye 680RD α-rabbit (goat) 1:15000 LI-COR Biosciences, USA 
IRDye 800CW α-mouse (goat) 1:15000 LI-COR Biosciences, USA 
2.1.5 Enzymes 
Enzyme Company 
AnzaTM Alkaline Phosphatase Invitrogen, Germany 
Dream TaqTM Polymerase Fermentas, Germany 
Restriction Endonucleases New England Biolabs, USA 
Q5-High Fidelity DNA Polymerase New England Biolabs, USA 
T4 Ligase New England Biolabs, USA 
Proteinase K Sigma Aldrich, Germany 
2.1.6 Chemical reagents 
Chemicals Manufacturer 
1,4-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-
triazolo(4,5-d)pyrimidin-7-one (Zaprinast) 
Sigma-Aldrich, Germany 
1,4-Dithiothreitol (DTT)  AppliChem, Germany 
4’,6’-Diamidino-2-phenylindol-dihydrochloride 
(DAPI)/Fluoromount G® 
Southern Biotech, USA 
4-[7-[(dimethylamino) methyl]-2-(4-fluorophenyl) 
imidazo [1,2-α] pyridin-3-yl] pyrimidin-2-amine 
(Compound 2) 
Oliver Billker, Wellcome Trust Sanger 
Institute, UK (160) 
5-Benzyl-3-isopropyl-1H-pyrazolo [4,3d] 
pyrimidin-7(6H)-one (BIPPO) 
Philip Thompson, Monash University, 
Melbourne, Australia (122) 
5-Fluoro-2’-deoxyuridine (FudR) Sigma-Aldrich, Germany 
6-thioxanthine (6-TX) Sigma-Aldrich, Germany 
Acetic acid 96% Merck, Germany 
Acrylamide (Rotiphorese gel 30) Carl Roth, Germany 
Adenosine triphosphate (ATP) Sigma-Aldrich, Germany 
Agarose Carl Roth, Germany 
All-trans retinal Sigma-Aldrich, Germany 
Ammonium persulfate (APS) Carl Roth, Germany 
Ampicillin (Amp) Carl Roth, Germany 
Bovine serum albumin (BSA) Carl Roth, Germany 
Bromophenol blue Merck, Germany 
Calcium chloride (CaCl2) Carl Roth, Germany 
Chloroform Carl Roth, Germany 
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Crystal violet Sigma-Aldrich, Germany 
Deoxynucleotide-triphosphate(dNTPs)  Rapidozym, Germany 
Dimethyl sulfoxide (DMSO) Carl Roth, Germany 
Disodium phosphate (Na2HPO4) Sigma-Aldrich Chemie GmbH, Germany 
Distilled water (HPLC-purified) Carl Roth, Germany 
Dithiothreitol (DTT) Carl Roth, Germany 
DNA loading dye (6x) Thermo Fisher Scientific, Germany 
Dulbecco’s Modified Eagle medium (DMEM)  PAN-Biotech, Germany 
Dulbecco’s phosphate buffered saline (PBS) PAN-Biotech, Germany 
Ethanol ≥ 99,8% p.a. Roth, Germany 
Ethylenediaminetetraacetic acid (EDTA)  Sigma-Aldrich, Germany 
Fetal bovine serum (FBS) PAN-Biotech, Germany 
Gene Ruler DNA-Ladder (1 kb) Thermo Fisher Scientific, Germany 
Glucose Carl Roth, Germany 
Glutathione (GSH) Sigma-Aldrich, Germany 
Glycerol Carl Roth, Germany 
Glycine Sigma-Aldrich, Germany 
Guanosine triphosphate (GTP) Thermo Fisher Scientific, Germany 
Hank’s balanced salt solution (HBSS)  PAN-Biotech, Germany 
HEPES (4-(2-hxdroxyethyl)-1-piperazineethane-
sulfonic acid) 
Carl Roth, Germany 
Iodoacetamide (IAA) Sigma-Aldrich, Germany 
Isopropanol AppliChem, Germany 
Isopropyl-beta-D-thiogalactopyranoside (IPTG) AppliChem, Germany 
Kanamycin sulfate AppliChem, Germany  
L-glutamine (200mM) PAN-Biotech, Germany 
MacConkey-Agar Carl Roth, germany 
Magnesium chloride (MgCl2) Carl Roth, Germany 
MEM non-essential amino acids (100x stock) PAN-Biotech, Germany 
Methanol ≥ 99,9% p.a. Carl Roth, Germany 
Milk powder Carl Roth, Germany  
Mycophenolic acid (MPA) AppliChem, Germany 
PageRuler-Prestained protein ladder Thermo Fisher Scientific, Germany 
Paraformaldehyde (PFA) Merck, Germany 
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Penicillin/Streptomycin (100x) PAN-Biotech, Germany 
Phenylmethylsulfonyl fluoride (PMSF) Carl Roth, Germany 
Phosphatase inhibitor cocktail Sigma Aldrich, Germany 
Potassium chloride (KCl) Carl Roth, Germany 
Potassium dihydrogen phosphate (KH2PO4) Carl Roth, Germany 
Pyrimethamine Sigma-Aldrich, Germany 
Roti®Safe-GelStain Carl Roth, Germany 
Shield1 Chemin Pharma, USA 
Sodium chloride (NaCl) Carl Roth, Germany 
Sodium dodecyl sulfate (SDS) Carl Roth, Germany 
Sodium pyruvate, 100mM PAN-Biotech, Germany 
Streptomycin sulfate AppliChem, Germany 
Tetramethylethylenediamine (TEMED) Carl Roth, Germany 
Trifluoroacetic acid (TFA) Sigma-Aldrich, Germany 
Tris-Hydrochloride  Promega, USA 
Triton-X100 Carl Roth, Germany 
TRIzol® Reagent Life Technologies Corporation, USA 
Trypsin (TPCK-treated)  Thermofisher Scientific, Germany 
Trypsin/ EDTA  PAN-Biotech, Germany 
Tryptone AppliChem, Germany 
Tween 20 AppliChem, Germany 
Xanthine Sigma-Aldrich, Germany 
Yeast extract AppliChem, Germany 
α-Toxin from Clostridium septicum List Biological Laboratories, USA 
β-mercaptoethanol Carl Roth, Germany 
2.1.7 Instruments 
Instrument Manufacturer 
Camera system (E.A.S.Y. RH) Herolab, Germany 
Cell counting chamber (Neubauer-improved) Carl Roth, Germany 
Centrifuges (5417R, 5424, 5810R) Eppendorf, Germany 
Cryo container (Nalgene, Mr. Frosty) Thermo Fisher Scientific, Germany 
Electric pipetting aid (Accu-jet Pro) Brand GmbH, Germany 
Electrophoresis Power Supply (EPS 200/300)  Pharmacia Biotech, Sweeden 
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Electroporator (Amaxa Nucleofector) Lonza, Switzerland 
ELISA microplate reader Biotek, Germany 
Freezer (-80°C) (UF85-360T) Colora, Germany 
Gel electrophoresis system (Easy Phor) Biozym, Germany 
Gel documentation system (E.A.S.Y.®-CAST) Herolab, Germany 
High performance liquid chromatograph (HPLC)-
LC-20AD 
Shimadzu, Japan 
Ice machine (ZBE 110-35) Ziegra, Germany 
Incubator- CO2 (HERACELL 150i) Thermo Fisher Scientific, Germany 
Incubators (SE200-400) Memmert, Germany 
Infrared imaging system (Odyssey FC) LI-COR Biosciences, USA 
Microscope-fluorescence (Axio Image.Z2) Carl Zeiss, Germany 
Microscope-inverted (LABOVERT) Leica, Germany 
Microscope-light optical (DM750) Leica, Germany 
Microwave (M805 Typ KOR-6115) Alaska, Germany 
Mini centrifuge (Sprout® Mini-Centrifuge) Heathrow Scientific, USA 
Mini vertical SDS-PAGE electrophoresis system 
(Hoefer™ Mighty Small™ II) 
Hoefer Inc., USA 
Multichannel pipette (Transferpipette® -8/-12)    
(50-200 μl) 
Brand, Germany 
NanoDrop® spectral photometer (ND-1000) Peqlab, Germany 
PCR Thermocycler (Flex Cycler) Analytic Jena, Germany 
PerfectBlueTM ‘Semi-Dry’ blotter (SEDEC M) Peqlab, Germany 
Photometer (BioPhotometer) Eppendorf, Germany 
Pipettes Eppendorf, Germany 
pH-meter (pH528 MultiCal®) Xylem Analytics, Germany 
Precision scale (PCB 1000-2) Kern & Sohn, Germany 
Precision scale (BP 110 S) Sartorius, Germany 
Safety work benches (HERA safe) Heraeus Instruments, Germany 
Shaker (WS5) Edmund Bühler, Germany 
Shaking incubator (Innova 4000) New Brunswick, Germany 
Steam-sterilizer (VARIOKLAV) Thermo Fisher Scientific, Germany 
Ultrasonic bath (Biorupter Sonication System) Diogenode, Belgium 
UV-transilluminator (UVT-20 M/W) Herolab, Germany 
Thermoshaker (Thermomixer comfort/ 5436) Eppendorf, Germany 
Vortex (MS 1 shakers) IKA®-Werke, Germany 
Waterbath (1002) GFL, Germany 
Waterbath (U 3/8) Julabo, Germany 
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2.1.8 Commercial kits 
Kit Company 
Direct cGMP ELISA kit (ADI-900-014) Enzo Life Sciences GmbH, Germany 
DetectX High Sensitivity Direct cGMP (K020-C1) Arbor Assays Headquarters, USA 
innuPREP DNA Mini Kit 2.0 Analytik Jena AG, Germany 
innuPREP DOUBLEpure Kit Analytik Jena AG, Germany 
innuPREP Plasmid Mini Kit 2.0 Analytik Jena AG, Germany 
innuPREP RNA Mini Kit 2.0 Analytik Jena AG, Germany 
Pierce BCA Protein Assay Kit Thermo Fisher Scientific, Germany 
PureLink HiPure Plasmid Midiprep Kit Invitrogen, Germany 
RevertAid H Minus First Strand cDNA Synthesis Kit Thermo Fisher Scientific, Germany 
2.1.9 Plastic ware and other disposables  
Consumable items Company 
24 well glass bottom plate-black wall IBL Baustoff + Labor GmbH, 
Austria 
Cell culture dishes  (60x15 mm) Sarstedt, Germany 
Cell culture flasks (T25, T75, T175, T300) Sarstedt, Germany 
Cell culture plate (6, 24, 96 well) Sarstedt, Germany 
Cell scraper (30 cm) TPPTM, Switzerland 
Centrifugal filters (0.22-µm, Corning Costar Spin-X) Sigma Aldrich, Germany 
Cryotube preservation tubes (2 ml) Greiner Bio One, Germany 
Disposable StericanTM blunt end needles, (27 G, 23 G) Braun, Germany 
DuraSeal laboratory sealing film Diversified Biotech, USA 
Electroporation cuvettes (2 mm) PEQLAB, Germany 
Falcon Tubes (15 ml/ 50 ml), CELLSTARTM Greiner Bio One, Germany 
Filter (5 μm), Millex® syringe-compatible Merck Millipore, Germany 
Filter sterilizer (0.22 μm) Schleicher Schuell, Germany 
Filter tubes (Amicon Ultra-0.5 ml) Merck Millipore, Germany 
Glass cover slips (10 mm diameter) VWR International, Germany 
Glass slides, microscopic (76x26 mm) Carl Roth, Germany 
Latex gloves AQL 1.5 SempermedTM, Austria 
Microtube (8x0.2 ml) Biozym, Germany 
Microtube lid (8x0.2 ml) Biozym, Germany 
Ni-NTA columns for protein purification (Novex) Thermo Fisher Scientific, Germany 
Nitrile gloves AQL 1.5 SempermedTM, Austria 
Nitrocellulose transfer membrane AppliChem, Germany 
Parafilm® Pechiney Plastic Packaging, USA 
PCR-tube-stripes (0.2 ml)  Biozym, Germany 
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Pipette-pasteur  A. Hartenstein, Germany 
Pipette tips (10 µl, 20 µl, 200 µl, 1ml) Sarstedt, Germany 
Protein low bind reaction tube (0030108116) Eppendorf, Germany 
Reaction tubes (0.2 ml, 0.5 ml, 1.5 ml, 2 ml) Sarstedt, Germany 
RNAase free barrier tips (10-1000 μl)  Biozym, Germany 
Rotilab blotting paper Carl Roth, Germany 
Serological pipettes, sterile (5 ml, 10 ml, 25 ml) Sarstedt, Germany 
Size exclusion columns (10-kDa, 30-kDa cut-off) Merck Millipore, Germany 
Syringes Omnifix® (3 ml, 5 ml, 10 ml) B. Braun Melsungen AG, Germany 
UV-cuvettes Carl Roth, Germany 
Whatman paper (3 MM)  A. Hartenstein, Germany 
2.1.10 Buffer and medium compositions 
Medium or buffers  Composition 
T. gondii - D10 medium 500 ml 
50 ml 
5.5 ml 
5.5 ml 
5.5 ml 
5.5 ml 
DMEM (high glucose 5g/l without L-glutamine) 
iFCS (heat-inactivated) 
penicillin/streptomycin (100x) 
non-essential amino acids (100x) 
sodium pyruvate (100 mM) 
L-glutamine (200 mM); stored at 4 °C 
   
T. gondii - freezing medium  10% DMSO in heat-inactivated FBS; stored at -20 °C 
   
Lysogeny Broth (LB) 
medium 
10 g 
5 g 
10 g 
15 g 
tryptone 
yeast extract 
NaCl  
agar (optional for plates)  
in 1 liter of deionized autoclaved water  
   
Super Optimal Broth with 
Catabolite repression 
(SOC) medium  
20 g 
5 g 
0.5 g 
0.186 g 
0.952 g 
 
20 mM 
tryptone 
yeast extract 
NaCl 
KCl 
MgCl2  
in 1 liter of deionized water, autoclaved 
glucose; filter-sterilized with 0.22 µm filter 
   
Cytomix 120 mM 
25 mM 
5 mM 
2 mM 
0.15 mM 
10 mM 
KCl 
HEPES (pH 7.6) 
MgCl2 
EDTA 
CaCl2 
K2HPO4/KH2PO4 (pH 7.6) 
in deionized autoclaved water 
adjusted to pH: 7.6, filter-sterilized with 0.22 µm filter 
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4% paraformaldehyde 
(PFA) 
10 g PFA  
in 0,25 liter of PBS (heat-treatment at 60 °C) 
adjusted to pH: 7.6 
   
PBS (10x) 25,6 g 
80 g 
2 g 
2 g 
Na2HPO4·7H2O 
NaCl 
KCl 
KH2PO4 
adjusted to pH: 7.4 
in 1 liter of deionized water, autoclaved 
   
TAE-Buffer (1x) 40 mM 
0.1% 
1 mM 
Tris-HCl 
acetic acid 
EDTA in deionized water 
   
SDS-loading buffer (5x) 0.25% 
0.5 M 
50% 
10% 
0.25 M 
bromophenol blue 
dithiothreitol (DTT) 
glycerol 
sodium dodecyl sulfate (SDS) 
Tris-HCl (pH 6.8) in deionized water 
   
SDS-running buffer (5x) 1.25 M 
0.5% 
125 mM 
glycine 
SDS 
Tris-HCl (pH 8.3); in 1 liter of deionized water 
   
5% stacking gel  
(SDS-PAGE) 
1.4 ml 
0.33 ml 
0.25 ml 
20 µl 
20 µl 
10 µl 
dH2O 
30% acrylamide 
1 M Tris-HCl (pH:6.8) 
10% SDS 
10% APS 
TEMED 
   
12% resolving gel  
(SDS-PAGE) 
1.6 ml 
2 ml 
1.3 ml 
50 µl 
50 µl 
2 µl 
dH2O 
30% acrylamide 
1.5 M Tris-HCl (pH:8.8) 
10% SDS 
10% APS 
TEMED 
   
8% resolving gel  
(SDS-PAGE) 
2.3 ml 
1.3 ml 
1.3 ml 
50 µl 
50 µl 
3 µl 
dH2O 
30% acrylamide 
1.5 M Tris-HCl (pH:8.8) 
10% SDS 
10% APS 
TEMED 
   
44 
 
Semi-dry blot transfer 
buffer 
38 mM 
20% 
0.0037% 
48 mM 
glycine 
methanol 
SDS 
Tris-HCl (pH:8.3); in deionized water 
   
TBS buffer (10x) 1.5 M 
0.5 M 
NaCl 
Tris-HCl (pH:7.6); in deionized water 
   
TBS-T buffer (1x) 10% 
0.2% 
10x TBS buffer 
Tween 20; in deionized water 
2.1.11 Software and web resources 
Software/ website Company/ address 
AxioVision Rel. 4.8.  Carl Zeiss Mikroskopie GmbH, Germany 
Geneious® 6.1 Biomatters Ltd., New Zealand 
GraphPad Prism 6.0 GraphPad Software Inc, USA 
ImageJ win 32  https://github.com/fiji 
Ligation calculator tool  http://www.insilico.uni-
duesseldorf.de/Lig_Input.html 
Protein molecular weight calculator https://www.bioinformatics.org/sms/prot_mw.html 
FigTree v1.4.3 http://tree.bio.ed.ac.uk/software/figtree/ 
MS Office 2010 Microsoft Cooperation, USA 
Arduino 1.8.8 Arduino AG, Italy 
ToxoDB: Toxoplasma Genomic Resource http://toxodb.org/toxo/ 
ZEN 2012 (blue edition) Carl Zeiss Mikroskopie GmbH, Germany 
TMHMM Server, v. 2.0 DTU Bioinformatics, Denmark 
SMART (Simple Modular Architecture 
Research Tool) 
http://smart.embl-heidelberg.de/ 
Phobius http://phobius.sbc.su.se/ 
NCBI conserved domain search https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.
cgi 
TmPred server -EMBnet https://embnet.vital-
it.ch/software/TMPRED_form.html 
Clustal Omega-Sequence alignment https://www.ebi.ac.uk/Tools/msa/clustalo/ 
UniProt  https://www.uniprot.org/ 
SWISS-MODEL-homology modelling https://swissmodel.expasy.org/ 
CLC Genomics Workbench v12.0 Qiagen Bioinformatics, USA 
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2.2 Methods – Molecular cloning and nucleic acid isolation 
2.2.1 Polymerase chain reactions (PCR) 
All targeted DNA fragments were amplified by Q5 polymerase (New England Biolabs) 
either from a vector or genomic DNA of T. gondii RHΔku80-hxgprt- strain. Template 
concentrations ranged between 10-200 ng for standard reactions as manufacturer’s 
recommendation. Dream TaqTM Polymerase (Fermentas) was only used for colony PCR to 
detect positive E. coli colonies following transformation. Briefly, single bacterial colonies 
were resuspended in 20 µl of sterile dH2O, and only 2 µl of suspension was used as template 
for the screening. The mastermix and PCR samples were prepared according to the 
manufacturer’s protocols, and reactions were run by setting programs based on the amplicon 
size and primer features in Thermocycler (FlexCycler, Analytik Jena).  
2.2.2 Agarose gel electrophoresis  
The PCR amplicons, digested vectors or DNA fragments were mixed with DNA 
loading buffer (1:6 volume) and run on 1% agarose gel stained with Roti®Safe-GelStain at 
120 V in TAE buffer. Visualization was performed using Herolab camera system and UV-
transilluminator. 
2.2.3 Purification of DNA fragments 
After verification with agarose gel electrophoresis, PCR products showing expected 
band sizes were directly purified by passing through column or extracted from gel using the 
innuPREP DOUBLEpure kit (Analytik Jena) according to the manufacturer’s instruction. The 
purified insert was eluted in sterile dH2O followed by measuring the concentration via 
NanoDrop® spectral photometer (ND-1000). 
2.2.4 Restriction endonuclease digestion  
Vector DNA was isolated from overnight E. coli cultures by innuPREP Plasmid Mini 
Kit 2.0 (Analytik Jena); the purity and concentration of DNA were determined at 260 nm 
using NanoDrop. 1-15 µg of purified PCR product and vector DNA were digested using 
corresponding restriction enzymes, 5 units of which was used to cut 1 µg of DNA in 1x 
enzyme specific reaction buffer. Reaction tube was incubated for 3 h in an appropriate 
temperature as it is suggested by manufacturers. Dephosphorylation was performed by 
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alkaline phosphatase (Invitrogen) during vector digestion for non-directional cloning (using 
the same restriction enzyme for N-terminal and C-terminal sites). Subsequently, vector was 
run on agarose gel to see the digestion efficiency, and backbone was purified from gel; 
whereas digested insert was exposed to column purification as stated in section 2.2.3 
followed by elution in sterile dH2O. 
2.2.5 Ligation and transformation of E. coli  
Digested plasmid DNA and insert were ligated in a molar ratio 1:3 (fmol of 
plasmid:fmol of insert) by using 5 units of T4 DNA ligase in a ligase buffer. The vector 
amount was always set as 45 ng, and insert amount was calculated depending component’s 
size using online ligation calculator tool (http://www.insilico.uni-
duesseldorf.de/Lig_Input.html). Ligation mixture was incubated either for 1 h at 22 °C or 
overnight at 4 °C prior to transformation. 10 µl of ligation reaction was mixed with 100 µl of 
fresh-thawed competent cells immediately. E. coli XL-1blue (Stratagene) cells were used for 
regular cloning prepared for T. gondii transfections, whereas M15 and BTH101 (Qiagen) 
strains were deployed for recombinant expression of T. gondii proteins. Bacterial cells were 
incubated on ice for 30 min and heat-shocked for 45 sec at 42 °C followed by chilling on ice 
for 3-5 min. Thereafter, 700 µl of pre-warmed SOC medium was added into the reaction tube 
and incubated for 1 h by shaking at 450 rpm, 37 °C. Cells were centrifuged at 8000xg for 2 
min, and pellet was dissolved in 100 µl SOC. Cell suspension was plated on selective LB-
agar containing ampicillin (100 μg/ml), kanamycin (50 μg/ml) and/or streptomycin (100 
µg/ml) depending on the resistance of strain or plasmid. Plates were incubated then overnight 
at 37 °C, and single colonies were screened for plasmid expression. Colony PCR was set 
using insert specific primers, and overnight cultures of selected positive colonies were 
prepared for plasmid isolation. 
2.2.6 Isolation of plasmid DNA and preparation of freezer stocks 
5 ml of overnight cultures prepared from positive colonies were used for both preparing 
freezer stocks and plasmid DNA isolation. 500 µl of bacterial culture was mixed with an 
equal volume of autoclaved 50% glycerol in a cryo-preserving tube under sterile work bench 
and stored at -80 °C. Afterwards, plasmid DNA was isolated from the left over overnight 
culture by innuPREP Plasmid Mini Kit 2.0 (Analytik Jena) following the instructions, which 
yields 4-5 μg of DNA in general. The constructed plasmid was verified by DNA sequencing 
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to eliminate any mutation risk. 200 ml of overnight cultures were prepared for large-scale 
plasmid isolation by PureLink HiPure Plasmid Midiprep Kit (Invitrogen). Plasmid DNA was 
eluted in 120-150 μl of sterile dH2O and stored at -20 °C.  
2.2.7 Precipitation of plasmid DNA 
The vectors were precipitated by adding 200 μl of isopropanol in a reaction tube and 
centrifuged at 18000xg, 4 °C for 30 min following incubation for 1 h at -20 °C. Supernatant 
was discarded after centrifugation, and the pellet was washed with 200 μl of 70% ethanol 
(ice cold). After a short centrifugation (18000xg, 4 °C, 5 min) supernatant was discarded 
again, and pellet was dried inside a sterile work bench. Eventually, the pellet was dissolved 
in 20 μl of sterile dH2O and stored at -20 °C. 
2.2.8 Isolation of genomic DNA from T. gondii tachyzoites  
Fresh lysed out parasites (5-10x106) were pelleted at 12000xg for 10 min from the 
cultures. The parasite pellet was then either stored at -80 °C or directly processed by 
innuPREP DNA Mini Kit 2.0 (Analytic Jena). At first, parasite pellet was resuspended in 
lysis buffer (400 μl), and proteinase K treatment was performed by incubating samples for 
30 min at 50 °C. Afterwards, kit protocol was applied to isolate genomic DNA. DNA 
concentration was measured by nanodrop and used as a template for PCR. 
2.2.9 Extraction of RNA from T. gondii tachyzoites and cDNA synthesis 
Total RNA was extracted from extracellular or freshly syringe-released parasites, and 
RNAase free plastic wares were used during the extraction. Briefly 5-20x106 parasites were 
pelleted and lysed in 1 ml of TRIzol followed by either storing at -80 °C or directly processed 
by innuPREP RNA Mini Kit 2.0 (Analytic Jena). Briefly, 200 μl of chloroform was added 
into eppendorf and vortexed for 15 sec by holding the lid tightly. Sample was centrifuged at 
12000xg for 15 min at 4 °C, causing separation of two layers. The upper aqueous layer 
containing RNA was transferred into another reaction tube and mixed with an equal volume 
of 70% ethanol (diluted with DEPC-treated water) by mixing thoroughly for 5 sec. This 
composition was transferred into spin filter R supplied by RNA kit, and kit protocol was 
followed. The RNA was eluted eventually in 20 μl of DEPC-treated sterile water and used 
immediately as a template for cDNA synthesis. RevertAid H Minus First Strand cDNA 
synthesis kit protocol (Thermo Fisher Scientific) was applied using oligo-dT primers 
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provided by kit. Synthesized cDNA was used for screening of protein transcripts and stored 
at -20 °C. 
2.3 Methods – Overexpression, purification and functional assays of T. gondii 
proteins in E. coli 
2.3.1 Heterologous expression of proteins in E. coli 
Heterologous expression of TgATPaseP-GC nucleotide cyclase domains, termed as 
GC1 and GC2, was performed in the M15 and BTH101 strains of E. coli. The open reading 
frames of GC1 (2850-3244 bp), GC2 (3934-4242 bp) and GC1+GC2 (2850-4242 bp) 
domains starting with the first upstream start codon (ATG) were amplified from the mRNA 
of RHΔku80-hxgprt-strain. The first-strand cDNA used for ORF-specific PCR was generated 
from the total RNA by oligo-dT primers as described in section 2.2.9. The ORFs were cloned 
into the pQE60 vector at the BglII restriction site resulting in a C-terminal 6xHis-tag fusion 
(see vector maps in Appendix 8). To express the indicated proteins, 5 ml culture of the 
recombinant M15 strains (grown overnight at 37°C) were diluted to an OD600 of 0.1 in 100 
ml of LB medium containing 100 µg/ml ampicillin and 50 µg/ml kanamycin, and incubated 
at 37°C until OD600 reached to 0.4-0.6 (4-5 h). The cultures were then induced with 0.1 mM 
Isopropyl β-D-1-thiogalactopyranoside (IPTG) overnight at 25°C. The OD600 of cultures then 
normalized for protein purification.  
2.3.2 Recombinant protein purification from E. coli 
The recombinant proteins expressed in E. coli M15 strain were purified under 
denaturing conditions using Ni-NTA column according to the manufacturer’s protocol 
(Novex, Thermo Fisher Scientific). Briefly, cells were harvested by centrifugation at 3000xg, 
20 min, 4 °C, and pellet was resuspended in 8 ml of lysis buffer containing 6 M guanidine-
HCl, 20 mM NaH2PO4, 500 mM NaCl, (pH 7.8) followed by incubation at 4 °C by shaking 
for 10 min. Subsequently, probe sonication (5 pulses, each for 30 sec, with intermittent 
cooling on ice-water) was performed in order to disrupt the cells. Sonicated samples were 
flash-frozen in liquid nitrogen and thawed at 37°C in three iterations. Intact cells were 
eliminated by pelleting at 3000xg for 15 min. Lysate-containing supernatant (cell-free 
extract) was loaded on Ni-NTA column pretreated with binding buffer (8 M urea, 20 mM 
NaH2PO4, 500 mM NaCl, pH 7.8) and washed twice by 4 ml of washing buffer (8 M urea, 
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20 mM NaH2PO4, 500 mM NaCl) with pH 6.0 and pH 5.3, respectively. Proteins were eluted 
in 5 ml of elution buffer (20 mM NaH2PO4, 100 mM NaCl, 10% Glycerol, pH 7.8) by 
incubating tubes on ice, and protease inhibitor cocktail (50 µl) was added to the eluate. The 
eluate was then concentrated and dialyzed by 30-kDa cut-off centrifugal filters (Amicon ultra 
filters, Merck Millipore, Germany). A refolding of the purified proteins led to precipitation. 
The amount of urea was thus gradually reduced down to 0.32 M by adding 4x volume of 
buffer including 20 mM NaH2PO4, 100 mM NaCl and 10% glycerol in successive 
centrifugation steps. The final purified protein preparation was stored at -80°C until using. 
The quantitation of protein in samples was specified by bicinchoninic acid (BCA) assay that 
was performed by a commercial kit (Thermo Fisher Scientific). 5 µg of purified proteins were 
exposed to SDS-PAGE and following Western Blot analysis by using α-His antibody. 
2.3.3 Making of bacterial cell lysates 
5 ml of overnight cultures from GC1, GC2 and GC1+GC2 expressing E. coli M15 
strains were grown overnight at 37 °C, and cultures were handled as stated in 2.3.1 until the 
last step. When OD600 reached to 0.5 at 37 °C incubation, the cultures were kept at 4 °C for 
30 min and then induced with 0.1 mM IPTG in 10 ml LB medium overnight at 25°C. After 
OD600 was adjusted to 1.0 for all strains, cells were pelleted at 3000xg for 20 min (4 °C) and 
incubated in 500 µl of lysis buffer containing 50 mM HEPES (pH 7.5), 100 mM NaCl, 1 mM 
PMSF, 10 mM β-mercaptoethanol and 10 mM imidazole at 4 °C for 1 h by shaking (600 
rpm). The samples were sonicated for 30 sec with successive 5 pulses including intervals 
between each pulse for cooling on ice-water. Following centrifugation at 15000xg, 4 °C for 
20 min, the pellet was discarded, and the supernatant was used immediately to set in vitro 
functional assay. 20 µl of remaining lysate was run on SDS gel and following Western Blot 
by staining with α-His antibody. 
2.3.4 Guanylate cyclase assay with purified proteins and cell lysates 
5 µg of purified GC1 and GC2 proteins and 50 µl of cell lysates from E. coli M15 
strain (preparation of samples was described in section 2.3.2 and 2.3.3, respectively) were 
examined by in vitro guanylate cyclase assay. The enzymatic reaction was carried out in 50 
mM HEPES buffer (pH, 7.5) containing 100 mM NaCl, 2 mM MnCl2 and 2 mM GTP. The 
reaction volume was completed to 100 µl, and the assay was performed at 22 °C for 10 min. 
Negative controls (-protein/+GTP and +protein/-GTP) were also included in both cases to the 
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assay. The reaction was quenched by adding 200 µl of 0.1 M HCl, and samples were stored 
at -20 °C until measurement by high performance liquid chromatography (HPLC).  
2.3.5 Adenylate cyclase assay on MacConkay agar 
The function of GC1, GC2 and GC1+GC2 as being potential adenylate cyclases was 
tested in the E. coli BTH101 strain lacking an adenylate cyclase (cya), and thus unable to 
utilize maltose as a carbon resource (161). The pQE60 constructs encoding indicated ORF 
sequences were transformed into the BTH101 strain. The bacterial cultures were grown 
overnight in 5 ml of LB medium containing 100 µg/ml ampicillin and 100 µg/ml 
streptomycin at 37 °C. Protein expression was induced by 200 µM of IPTG (2 h, 30 °C) 
followed by serial dilution plating on MacConkey agar (pH 7.5) supplemented with 1% 
maltose, 200 µM IPTG and 100 µg/ml of each antibiotic. The strain harboring the empty 
pQE60 vector served as a negative control, whereas the plasmid expressing CyaA (native 
bacterial adenylate cyclase) was included as a positive control. Agar plates were incubated at 
30 °C (~32 h) to examine the appearance of colonies. cAMP could be produced if the catalytic 
domains are functioning as adenylate cyclase, causing the complement of maltose pathway. 
This will result in formation of red colonies on MacConkey agar. If the pathway is not 
complemented, the bacteria strains are expected to form slow growing white colonies. 
2.4 Methods – Cell culture and transfection 
2.4.1 Cultivation of host cells 
Human foreskin fibroblast (HFF) cells were cultivated in Dulbecco’s modified Eagle’s 
medium (DMEM) with glucose (4.5 g/L) supplemented with 10% heat-inactivated fetal 
bovine serum (iFBS, PAN Biotech, Germany), 2 mM glutamine, 1 mM sodium pyruvate, 1x 
minimum Eagle’s medium non-essential amino acids (100 µM each of serine, glycine, 
alanine, asparagine, aspartic acid, glutamate, proline), penicillin (100 U/ml), and 
streptomycin (100 µg/ml) in a humidified incubator (37 °C, 5% CO2). Briefly, host cells were 
cultured in T300 flasks and grown to confluence. They were harvested by trypsinization 
(0.25% trypsin-EDTA) every 2-3 weeks and seeded in flasks, plates or dishes, as a 
requirement of experiments. 
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2.4.2 Parasite culture and preparation of extracellular parasites for assays 
T. gondii tachyzoites were propagated by serial passaging routinely every 2-3 days in 
confluent HFF monolayers. Cultures were incubated in D10 medium at 37 °C with 5% CO2 
supplement. All experiments were set by using fresh syringe-released extracellular parasite, 
unless otherwise specified. Host cells grown as confluent monolayers in standard culture 
medium in dishes, flasks or plates were infected with T. gondii tachyzoites in multiplicity of 
infection (MOI) of 1.5 and incubated for 40-42 h. Late stage cultures with mature parasite 
vacuoles were washed with PBS to eliminate extracellular parasites and host debris. Cells 
were scraped in fresh medium and mechanically extruded through 27G syringe (2x) followed 
by filter-passing (5 µm) to eliminate host cell debris. Eventually, number of extracellular 
parasites were counted using Neubauer counting chamber after an appropriate dilution in 
medium.  
2.4.3 Transfection of T. gondii tachyzoites 
To make transgenic lines, fresh egressed or syringe released parasites (10-20x106) were 
washed with PBS, pelleted by centrifugation at 420xg for 10 min and suspended in filter-
sterile cytomix (100 µl) supplemented with fresh ATP (2 µM) and glutathione (5 µM). After 
adding 15 µg of circular or linearized vector, parasite suspension was transferred into an 
electroporation cuvette followed by transfection of tachyzoites using the Amaxa 
Nucleofector electroporator (T-016 program; voltage, 1700 V; resistance, 50 Ω; pulse 
duration, 176 µs; number of pulses, 2; interval, 100 ms; polarity, unipolar). Transfection 
mixture was then swiftly transfused to a dish containing an HFF monolayer. The medium 
was changed to fresh D10 8-16 h post-transfection to eliminate dead parasite and remaining 
transfection reagents. Drug selection was performed depending on the selection cassette 
introduced into expression vector. Transgenic parasites expressing HXGPRT (hypoxanthine 
phosphoribosyltransferase) selection cassette were selected with mycophenolic acid (MPA, 
25 µg/ml) and xanthine (50 µg/ml) (57). On the other hand, 6-thioxanthine was used for 
negative selection of HXGPRT cassette (162). Similarly, for DHFR/TS (dihydrofolate 
reductase/thymidylate synthase) and UPRT (uracil phosphoribosyltransferase) selectable 
markers, 1 μM pyrimethamine (56) and 5 μM FudR (58) were added into the cultures, 
respectively. MPA + xanthine and pyrimethamine selections were applied 24 h post-
transfection, while 6-thioxanthine treatment was done after first passage (~48 h post-
transfection). For FudR selection, parasites were maintained in D10 medium ~96 h (two 
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passages) prior to drug selection. Transfected and drug-selected cultures were kept in the 
same dish until having a stable pool, which usually takes 7-15 days.  
2.4.4 Making of clonal transgenic lines 
Stable and drug-resistant transgenic parasite cultures were then subjected to limiting 
dilution in 96-well plates with confluent HFF cells to obtain single clonal lines. 1000 
parasites were diluted in 1 ml of D10 medium containing selection. The first columns of 96-
well plate were infected with 100 μl of parasite suspension (100 parasites) followed by 
sequential 1:2 dilutions until sixth well. Afterwards, plate was kept at 37 °C in 5% CO2 
containing incubator for 7 days without any movement. Wells containing single plaques were 
selected from the plate and transferred into 24-well plate for further analysis and future 
assays. 
2.5 Methods – Lytic cycle assays 
All assays were set up essentially with fresh syringed-released parasites as described 
in section 2.4.2.  
2.5.1 Plaque assay 
HFF monolayers grown in 6-well plates were infected with extracellular tachyzoites 
(150 parasites/well) and incubated for 7 days without perturbation (37 °C, 5% CO2).  Cultures 
were fixed with ice-cold methanol (-80°C, 10 min) after removing media and stained with 
crystal violet solution (12.5 g dye in 125 ml ethanol mixed with 500 ml 1% ammonium 
oxalate) for 15 min followed by washing with PBS. Plaque numbers of each strains were 
counted under an inverted microscope (Leica), and plaque sizes of all single plaques were 
measured by using ImageJ software (NIH, USA). 
2.5.2 Replication assay 
In order to check replication rate of parasites, host cells grown on glass coverslips 
placed in 24-well plate were infected with 3x104 parasites and incubated 24 h and 40 h before 
fixation with 4% PFA. Following permeabilization, neutralization, blocking and 
immunostaining steps with α-TgGap45(1:8.000) and Alexa594 antibodies were performed 
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the same as explained in section 2.6.1 for indirect immunofluorescence assay. The cell 
division was assessed by enumerating parasite numbers replicating in their vacuoles. 
2.5.3 Motility assay 
To measure the gliding motility, 4x105 freshly syringe-released parasites were 
suspended in calcium-free Hank’s balanced salt solution (HBSS) with or without drug 
treatment (BIPPO, 55 µM; zaprinast, 500 µM; compound 2, 2 µM). Parasites were incubated 
at room temperature for 15 min to let them settle down before gliding on BSA-coated (0.01%) 
coverslips (37 °C, 15 min). Afterwards, parasite samples were fixed with 4% PFA and 
subjected to standard IFA protocol using α-TgSag1 (1:10.000) and Alexa488 antibodies, as 
mentioned in 2.6.1. Motile fractions were counted on the microscope, and trail lengths were 
quantified by using the ImageJ software. 
2.5.4 Invasion and egress assays 
For invasion and egress assays, host-cell monolayers cultured on glass coverslips were 
infected with MOI: 10 for 1 h, or with MOI: 1 for 40, 48 and 64 h, respectively. The effect of 
BIPPO (55 µM), zaprinast (500 µM) and compound 2 (2 µM) treatments on the invasion rate 
of parasites were tested over the 1 h incubation time, while samples were treated with 
aforementioned drugs only for 5 min 30 sec 40 h post-infection to observe the change of 
egress profile. After incubation, cells were fixed with 4% PFA for 15 min, neutralized by 0.1 
M glycine/PBS for 5 min, and then blocked in 3% BSA/PBS for 30 min. Afterwards, non-
invading parasites or egressed vacuoles were stained with α-TgSag1 antibody (mouse, 
1:10.000, 1 h) prior to detergent permeabilization. Cultures were washed 3x with PBS, 
permeabilized with 0.2% Triton-X 100/PBS for 20 min, and stained with α-TgGap45 
antibody (rabbit, 1:3.000, 1 h) to visualize intracellular parasites (invaded parasites and intact 
vacuoles). Samples were then washed with 0.2% Triton-X 100/PBS three times and 
immunostained with Alexa488 and Alexa594-conjugated antibodies (1:10.000, 1 h). 
Eventually, the fraction of invaded parasites was counted by immunostaining with α-
TgGap45/Alexa594 (red), but not with α-TgSag1/Alexa488 (green). The percentage of lysed 
vacuole on the other hand was scored directly by counting α-TgSag1/Alexa488 (green) and 
dual-colored parasites. 
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2.5.5 Sample collection for cGMP measurements by commercial kit 
Confluent HFF monolayers were infected with MOI: 1.3-2 depending on the growth of 
the T. gondii parasite strain and incubated for 40 hours. For sample collection, infected cells 
containing mature parasite vacuoles were washed twice with ice-cold PBS to eliminate free 
parasites, scraped by adding 2 ml of colorless DMEM, and extruded through a 27G syringe 
(2x). Parasite suspension was centrifuged (420xg, 10 min, 4°C), and the pellet was then 
dissolved in 100 µl of cold colorless DMEM for counting of parasites. The parasite number 
was adjusted to 5x106 in 100 µl volume for cGMP extraction and mixed with 200 µl of ice-
cold 0.1 M HCl to lyse the cells (20 min). Samples were then flash-frozen in liquid nitrogen 
and thawed before they were squirted through pipette to disrupt the parasite membranes. The 
colorless DMEM and HFF cells, treated similarly, were used as negative controls. Samples 
were transferred onto centrifugal filters (0.22 µm, Corning Costar Spin-X, CLS8169, Sigma) 
to eliminate the membrane particulates (20800xg, 10 min, 4 °C). The flow-through was 
filtered once more via 10-kDa filter units (Amicon Ultra-0.5 ml filters, Millipore) (20800xg, 
30 min, 4°C), and samples were subjected to ELISA using the commercial ‘Direct cGMP 
ELISA kit’ (ADI-900-014, Enzo Life Sciences) to measure basal cGMP levels of parasites. 
2.6 Methods – Biochemical assays 
2.6.1 Indirect Immunofluorescence assay (IFA) 
Immunofluorescence assay was performed both with intracellular and extracellular 
parasites. For extracellular parasite staining, fresh egressed tachyzoites were incubated for 
20 min on the BSA-coated (0.01%) coverslips. On the other hand, intracellular parasites were 
stained within confluent monolayers of HFFs grown on glass coverslips (24 h post-infection). 
Samples were fixed with 4% paraformaldehyde (PFA) for 15 min and neutralized with 0.1 M 
glycine in PBS for 5 min. In the ongoing process of standard IFA of extra-and intracellular 
parasites, samples were permeabilized with 0.2% triton-X 100/PBS (20 min), and nonspecific 
binding was blocked by 2% BSA in 0.2% triton X-100/PBS (20 min). Afterwards, coverslips 
were stained with specified primary antibodies diluted in 2% BSA in 0.2% triton-X 100/PBS 
for 1 h. Samples were then washed 3x with 0.2% triton X.100/PBS and incubated with 
appropriate Alexa488- and 594-conjugated secondary antibodies for 1 h. Following 3x 
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washing steps with PBS, coverslips were mounted with Fluoromount G including DAPI for 
nuclei staining and then imaged with Zeiss Apotome microscope (Zeiss, Germany).  
 
To resolve the C-terminal topology of TgATPaseP-GC, about 5x104 parasites were 
released on BSA-coated coverslips, incubated for 20 min and fixed using 4% PFA with 0.05% 
glutaraldehyde. Samples were stained either with the combination of rabbit α-HA (1:200) and 
mouse α-TgSag1 (1:10.000) antibodies or with rabbit α-TgGap45 (1:3.000) and mouse α-
TgSag1 (1:10.000) before and after permeabilization. Permeabilized cells were subjected to 
immunostaining as indicated above, while all solutions were substituted to PBS for non-
permeabilized staining (i.e. no detergent triton X-100 and BSA). To detect the exact 
membrane distribution of TgATPaseP-GC, extracellular parasites were treated with α-toxin 
from Clostridium septicum (20 nM) (List Biological Laboratories, USA) for 2 h to separate 
plasma membrane from inner membrane complex. Subsequently, samples were fixed on 
BSA-coated coverslips and exposed to standard immunostaining.  
2.6.2 SDS-PAGE and immunoblot analysis 
Both recombinant proteins of GC1 and GC2 catalytic domains of TgATPaseP-GC 
purified from E. coli M15 strains (5 µg) and probe-sonicated bacterial cell lysates (20 µl) 
were exposed to SDS-PAGE and following western blot to verify the size and expression of 
proteins, respectively. Briefly, sample suspensions were mixed with SDS sample buffer (5x) 
and boiled at 99 °C for 5 min. Samples were then loaded to each lane of 5% stacking gel and 
separated by 12% resolving gel (120 V, 2 h). Afterwards, proteins were transferred from SDS-
gel onto a nitrocellulose membrane by semi-dry blotting (85 mA/cm2, 2 h). The membrane 
was blocked with 5% skimmed milk solution prepared in 0.2% tween 20/TBS (1 h with 
shaking at room temperature or overnight at 4 °C) and then stained with mouse α-6xHis 
(1:1.000) antibody. 
 
To detect protein expression levels in T. gondii tachyzoites, standard western blot 
protocol was applied. However, dot blot analysis was performed for TgATPaseP-GC-HA3’IT 
due to its large size (477-kDa). For standard western blot, the protein samples prepared from 
extracellular parasites (2-3 x107) were separated by 8% SDS-PAGE (120 V, 2 h), followed 
by semi-dry blotting onto a nitrocellulose membrane (85 mA/cm2, 3 h). The membrane was 
blocked as described above and stained with appropriate primary antibodies diluted in 0.2% 
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tween 20/TBS/5% skimmed milk powder. For the dot blot, protein samples equivalent to 107 
parasites were spotted directly onto nitrocellulose membrane. The membrane was blocked in 
a solution containing 1% BSA and 0.05% tween 20 in TBS for 1 h, followed by 
immunostaining with rabbit α-HA (1:1.000) and/or rabbit α-TgGap45 (1:3.000) antibodies 
diluted in the same buffer. After primary antibody staining, membranes were washed three 
times with tween 20/TBS buffer in all cases. Eventually, proteins were visualized by Li-COR 
imaging after staining with IRDye® 680RD and IRDye® 800CW (1:15.000) antibodies. 
Densitometric analysis was performed using the Image J software. 
2.6.3 cGMP measurement by ELISA-based kits 
Parasite samples collected for cGMP measurement were thawed from -80 °C and 
subjected to ELISA using the commercial ‘Direct cGMP ELISA kit’ (ADI-900-014, Enzo 
Life Sciences). The acetylated (2 hours) format of the assay was run for all samples including 
the standards and controls, as described by manufacturers to increase the sensitivity of kit. 
Briefly, cGMP standard (5,000 pmol/ml) provided by kit was serially diluted in 0.1 M HCl 
to prepare standards whose cGMP concentrations range between 50 pmol/ml and 0.08 
pmol/ml. Acetylation reagent was prepared by mixing acetic anhydride with trimethylamine 
at 1:2 (v/v) ratio. As suggested in kit manual, 10 µl of acetylation reagent was added into 
each 200 µl volume of sample and standard by mixing thoroughly for 5 sec. Following 
ELISA, cGMP levels of samples were measured at 405 nm absorbance, and the data were 
analyzed using the microplate analysis tool by adjusting dilution factor to 1:3 
(www.myassays.com).  
2.6.4 cGMP measurement by High Performance Liquid Chromatography (HPLC) 
cGMP production potentials of GC1 and GC2 domains of TgATPaseP-GC, purified 
from E. coli M15 strains or by directly using bacterial lysates, were tested by in vitro cyclase 
assays prior to measurement of cGMP contents by HPLC. Frozen samples were thawed and 
filtered by 0.22-µm centrifugal filters (Corning Costar Spin-X, Sigma) at 14.000xg for 30 
min (4 °C) prior to measurement. 2 mM of GTP and 2 mM of cGMP (final concentration) 
were resuspended in 0.1 M HCl and used as standards. 200 μl of each sample including 
standards were prepared for running on HPLC device, and injection volume was adjusted to 
20 μl. Nucleotides were separated by HPLC with a C18 reversed phase column 
(SUPELCOSIL™ LC-18-T, 3 μm particle size, 15 cm × 4.6 mm, Sigma Aldrich) at a flow 
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rate of 1 ml/min in an eluent buffer containing 100 mM potassium phosphate (pH: 5.9), 4 
mM tetra-butylammonium iodide and 10% (v/v) methanol. Analyte elution was recorded via 
absorbance at 260 nm. The peak areas of GTP and cGMP in standard was detected and 
compared with sample retention times (for GTP ~5 min and for cGMP ~7.5 min, 
respectively). cGMP and GTP concentrations of samples were quantified by peak analysis in 
Geneious® 6.1 (Biomatters Ltd., New Zealand). 
2.7 Methods – Optogenetic manipulation of T. gondii 
Optogenetic parasite strains were cultured in standard D10 medium supplemented with 
appropriate selection in dark conditions by wrapping aluminium foil. Regular passaging of 
parasites was performed under red light (635 nm) using RGB-LED Strip (Paulmann) installed 
on the safety cabinet. Before setting an assay, cultures were incubated by adding 1 µM all-
trans retinal as chromophore of rhodopsin that makes photo-regulated fusion protein RhoGC 
sensitive to the light. 
2.7.1 Design of 24-well plate illumination device for optogenetic studies 
Light activation of RhoGC in T. gondii tachyzoites was performed for all functional 
assays using a 24-well plate compatible illumination device designed specifically for this 
study by Willi Weber as a bachelor thesis project (HU, Berlin) (Figure 10). Briefly, LEDs 
with Red-Green-Blue (RGB) light emitting feature (Adafruit Breadboard-friendly RGB 
Smart NeoPixel), which are in the emission wavelengths of 620-630 nm, 515-530 nm and 
465-475 nm, respectively, were placed on the printed circuit board to make a LED-plate. 
Afterwards, the control unit of LED-plate was assembled. A real time clock module which 
will ensure the accurate timing of LEDs and an infrared receiver module for the remote 
actuation of device were integrated into the breadboard. Subsequently, the breadboard with 
all circuit components was connected to an Arduino Mega 2560 as a micro controller and a 
LED-plate, which enables data transfer between micro controller and LED-plate (Figure 
10A).  
The user interface of the software to enter the information of intended illumination 
pattern and time sequence was developed as a Microsoft Excel sheet (Figure 10B), that allows 
to adjust the light intensity and exposure time of each well individually. Because information 
transfer size between software and Arduino micro controller is limited to 8 bit data, it is not 
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possible to transfer light intensity values more than 256 µW/cm². Thus, excel configuration 
file of software was constructed using assigned digital values represented in Appendix 1 
instead of real light intensity values. In order to activate RhoGC, the 24-well specific LED-
device program was set at green light (530 nm) with 197,4 µW/cm² intensity (adjusted to 250 
as digital value) for 5 min illumination as depicted in Figure 10B for all assays. The excel 
configuration file is processed by clicking “Run Script” button, which transfers the 
configuration to the micro controller. Bottom light illumination was performed by placing 
24-well plates on the LED-device. Black wall glass bottom plates (IBL Baustoff + Labor 
GmbH, Austria) were used in order to prevent neighbor wells from light scattering during all 
functional assays.  
Figure 10. 24-well plate compatible LED-device used for optogenetic assays. A) The set-up 
of 24-well illumination device including important circuit components. 1-Arduino Mega 2560 as 
micro controller; 2-LED-plate containing 24 Red-Green-Blue (RGB) Smart NeoPixel LEDs in 620-
630 nm, 515-530 nm and 465-475 nm emission wavelengths, respectively; 3-Breadboard; 4-Real time 
clock module; 5-Infrared receiver module to remote control. B) Graphical user interface. An excel 
script was used for programming illumination device with an intended light colour, intensity and 
period. During this study, green light (530 nm) exposure was performed for 5 min with 197,4 µW/cm² 
intensity by adjusting digital values to 250 as shown on the script. (designed by Willi Weber, within 
the scope of bachelor thesis, HU, Berlin) 
2.7.2 Lytic cycle assays  
Cell culture dishes were infected with optogenetic parasite strains (MOI:1.5) and 
incubated 40 h by adding 1 µM of retinal and 0.5 µM of Shield1 (if required). Cultures were 
scraped and syringe-released in 2 ml of colorless DMEM media to extrude parasites as 
described in section 2.4.2. Subsequently, functional assays were set in black wall glass 
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bottom 24-well plates. For all assays, dark samples were kept in a separate plate to secure 
their protection from light exposure. In order to set motility assay, 40 µl of parasite 
suspension (including ~8x105 parasites) was diluted in 1 ml of HBSS buffer containing 1 µM 
retinal and released immediately on two BSA-coated (0.01%) coverslips (500 µl in each) in 
separate black wall plates (for dark and light samples). Plates were then centrifuged at 420xg 
for 5 min at 37 °C to settle parasites down. Afterwards, one plate was kept in the dark by 
covering with aluminium foil, and the other was exposed to the green light (530 nm) for 5 
min. Subsequently, both plates were incubated for 15 min at 37 °C to let them glide on 
coverslips. Standard motility assay protocol was followed after sample fixation with 4% PFA 
as explained in section 2.5.3.  
For invasion assay, 2x106 parasites were diluted in 1 ml of colorless DMEM medium 
including 1 µM retinal and 0.5 µM of Shield1 (if required). 106 parasites diluted in 500 µl of 
colorless DMEM was used to infect a HFF-monolayer grown on glass coverslip in dark and 
light conditions. Both samples in two conditions were incubated for 15 min at 37 °C to let 
them invade host cells following light illumination. On the other hand, tachyzoite infected 
HFF-monolayers (5x104, 24 h) cultured on glass coverslips were either kept in the dark or 
exposed to the light (530 nm, 5 min) after medium replacement with colorless DMEM 
supplemented by 1 µM of retinal and 0.5 µM of Shield1 (if required) to examine egress 
profile of parasites in response to light. Coverslips were fixed with 4% PFA after 15 min 
incubation (37 °C, 5% CO2). The following protocol procedures both for egress and invasion 
assays were applied as stated in subtitle 2.5.4. 
2.7.3 Sample collection and cGMP measurement by ELISA-based kit 
As described in section 2.5.5, HFF monolayers grown in dishes were infected with 
optogenetic T. gondii parasite strains (MOI:1.5) and incubated for 40 hours by including 1 
µM retinal and 0.5 µM of Shield1 (if required) into the culture medium. For sample 
collection, dishes containing mature parasite vacuoles were washed twice with PBS, scraped 
in 2 ml of colorless DMEM and filter-passed (5 µm) following syringe-release (2x27G). 
Parasite numbers were adjusted to 2.5x106 in 100 µl of colorless DMEM for each sample. 
Dark samples were always kept in the dark by covering with aluminium foil. Other samples 
were exposed to the green light (530 nm, 197,4 µW/cm² intensity) for specified time periods. 
Afterwards, 100 µl of sample diluent supplemented by ‘DetectX High Sensitivity Direct 
cGMP’ kit (K020-C1, Arbor Assays) was applied (at RT for 10 min) directly onto the samples 
60 
 
to quench the reaction and lyse the parasites. Samples were then centrifuged (2000xg, 15 
min, 4 °C), and supernatants were either assayed directly following kit instructions to 
measure cGMP levels or frozen at -80 °C until measurement. Luminescence of each well was 
read in chemiluminescent mode using a 0.1 sec read time per well. The obtained data was 
subsequently analyzed by the help of online web tool (www.myassays.com). 
2.8 Structure modelling 
The membrane topology of TgATPaseP-GC and TgPKG was predicted according to the 
data obtained from TMHMM (163), SMART (164), Phobius (165), NCBI conserved domain 
search (166) and TMpred (167). To detect conserved residues of active sites in TgATPaseP-
GC, GC1 and GC2 regions were aligned with the cyclase domains of representative 
organisms using Clustal Omega program (https://www.ebi.ac.uk/Tools/msa/clustalo/) (168). 
Similarly, conserved motifs in the ATPase domain of TgATPaseP-GC were obtained by 
alignment with members of human P4-ATPases using MAFFT online alignment server (v7) 
(169). Conserved residues were color-coded by the Clustal Omega program. 
The conserved motifs and cyclase domains for the tertiary model were predicted using 
UniProt (https://www.uniprot.org/). The catalytic units of GC1 (aa 2929-3200, lacking the 
loop from aa 3038 to 3103) and GC2 (aa 3989-4195) were modeled by SWISS-MODEL 
(https://swissmodel.expasy.org/), based on a ligand-free tmAC as the structural template 
(UniProt ID: 1AZS). The Qualitative Model Energy ANalysis (QMEAN) and the Global 
Model Quality Estimation (GMQE) scores were determined as -3.44 and 0.59 respectively, 
reflecting the accuracy of the model. Subsequently, the ligand GTPαS was positioned into 
the model of pseudo-heterodimer corresponding to the location of ATPαS in tmAC (Protein 
Data Bank ID: 1CJK). 
2.9 Phylogenetic analysis 
The open reading frame sequences of TgATPaseP-GC orthologs were obtained from the 
NCBI database. Briefly, the whole sequences of 30 proteins were aligned, and a consensus 
tree was generated using the CLC Genomics Workbench v12.0 (Qiagen Bioinformatics). 
Maximum likelihood method was utilized for clustering; bootstrap analysis was performed 
with 100 iterations; neighborhood joining was used for construction; and JJT model was 
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selected for amino acid substitutions. The eventual tree was visualized as a cladogram by 
Figtree v1.4.3, followed by text annotation in the Microsoft PowerPoint. 
2.10 Data analysis and statistics 
All experiments were performed at least three independent times, unless otherwise 
specified. Figures illustrating images or transgenic strains typically show a representative of 
three biological replicates. Graphs and statistical significance were generated using 
GraphPad Prism v6.0. The error bars in graphs represent means with S.E.M. from multiple 
assays, as indicated in figure legends. The p-values were calculated by Student’s t-test (*, p 
≤0.05; **, p ≤0.01; ***, p ≤0.001; ****, p ≤0.0001). 
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3 Results 
3.1 The native cGMP signaling mediators of T. gondii 
The genome searches identified a single putative guanylate cyclase and a 
corresponding protein kinase G in the parasite database (ToxoDB) (50) as the main cGMP 
signaling mediators (Table 2). Besides, 18 cNMP-dependent phosphodiesterases were 
detected in the Toxoplasma genome; however, they were excluded from the scope of this 
study. Sequence analysis revealed that T. gondii guanylate cyclase comprises multiple P-type 
ATPase like domains at its N-terminus and two nucleotide cyclase catalytic regions (termed 
as GC1 and GC2 based on the evidence herein, see section 3.1.1.2) at the C-terminus. It was 
named as TgATPaseP-GC in this study given the predicted multi-functionality of this protein. 
The entire gene size of TgATPaseP-GC is about 38.3-kb, consisting of 53 introns and 54 
exons. On the other hand, cGMP-specific protein kinase (TgPKG) is composed of four 
ligand-binding domains at the N-terminal and a kinase domain at its C-terminal. The gene 
size is 15-kb containing 19 introns and 20 exons (Table 2). TgPKG has been characterized 
extensively in an earlier work (72). This thesis primarily focused on TgATPaseP-GC. 
Table 2. The features of cGMP signaling mediators of T. gondii worked in this study                                                           
(Resource: ToxoDB) 
ToxoDB 
accession no. 
Gene 
description 
Gene 
size 
(bp) 
Protein 
length 
(aa) 
Phenotype score 
(log2) by CRISPR 
assay 
Abbreviations 
used in this 
study 
TGGT1_254370 Guanylate 
cyclase 
38286   4367  -3.56 TgATPaseP-GC 
TGGT1_311360 Protein    
kinase G 
15055    994               -2.18 TgPKG 
3.1.1 An alveolate-specific guanylate cyclase conjugated to P-type ATPase 
A variety of in silico tools were applied to get functional insight into TgATPaseP-GC 
as described in sections 2.8 and 2.9. The open reading frame of TgATPaseP-GC encodes for 
a remarkably large protein (4367 aa, 477-kDa), including multiple P-type ATPase motifs 
(270-kDa) and nucleotide cyclase domains (207-kDa) with 22 transmembrane helices (Figure 
11A and B). The first half of this huge protein (1-2480 aa) contains 10 α-helices and 4 
conserved ATPase-like subdomains: (a) the region from Lys110 to His174 encodes a lipid-
translocating ATPase; (b) the residues from Leu207 to Gly496 are predicted to form a 
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bifunctional E1-E2 ATPase binding to both metal ions and ATP, and thus functioning like a 
cation-ATPase; (c) the amino acids from Thr1647 to Ser1748 harbor yet another metal-cation 
transporter with an ATP-binding region; (d) the subdomain from Cys2029 to Asn2480 contains 
a haloacid dehalogenase-like (HAD-like) hydrolase, or otherwise a second lipid- 
translocating ATPase (Figure 11A).  
Figure 11. The genome of T. gondii harbors an unusual guanylate cyclase conjugated to P-type 
ATPase-like structures. (A-B) The primary and secondary topology of TgATPaseP-GC were 
predicted using TMHMM, SMART, TMpred, Phobius and NCBI domain search tools. The model was 
constructed by consensus across algorithms regarding the position of domains and transmembrane 
spans. The N-terminal (1-2480 aa) containing 10 α-helices resembles P-type ATPase with at least four 
domains (color-coded). The C-terminal (2481-4367 aa) harbors two potential nucleotide cyclase 
catalytic regions, termed GC1 and GC2, each follows 6 transmembrane helices. The question-marked 
(?) helix was predicted only by Phobius tool (probability score, 752). (B) To detect conserved residues 
of the active sites and ATPases in TgATPaseP-GC, sequence alignment was performed using Clustal 
Omega program. The color-coded signs on secondary structure show the position of highly conserved 
sequences in the ATPase and cyclase domains. The key residues involved in the base binding and 
catalysis of cyclases are also depicted in bold letters (Structure model in B was drawn with the help 
of Ulrike Scheib, Humboldt University of Berlin).  
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The second half of TgATPaseP-GC (2481-4367 aa) includes a potential guanylate 
cyclase comprising GC1 and GC2 domains from Ser2942-Lys3150 and Thr4024-Glu4159 residues, 
respectively (Figure 11A). Both GC1 and GC2 follow a transmembrane region, each with six 
helices. The question-marked helix (2620-2638 aa) antecedent to GC1 has been detected with 
low probability (score, 752) (Figure 11B). An exclusion of this helix from the envisaged 
model however results in a reversal of GC1 and GC2 topology (facing outside the parasite), 
which is unlikely given the intracellular transduction of cGMP signaling via TgPKG. 
Moreover, our experimental outcomes suggest that C-terminal of TgATPaseP-GC faces 
inwards (see figure 15B). Phylogenetic study performed by entire protein sequence of 30 
different guanylate cyclases from several organisms indicated an evident clading of 
TgATPaseP-GC with homologs from parasitic (Hammondia, Eimeria, Plasmodium) and free-
living (Tetrahymena, Paramecium, Oxytricha) alveolates (Figure 12). In contrast, GCs from 
the metazoan organisms (soluble and receptor-type) and plants formed their own distinct 
clusters. Quite intriguingly, the protist clade contained two groups, one each for 
apicomplexans and ciliates, implying a phylum-specific evolution of TgATPaseP-GC 
orthologous. 
3.1.1.1 P-type ATPase domain of TgATPaseP-GC resembles to P4-ATPases 
The N-terminal of TgATPaseP-GC covering 10 transmembrane helices (TM) and 4 
conserved motifs is comparable to P4-ATPases, a subfamily of P-type ATPases involved in 
translocation of phospholipids across the membrane bilayer and vesicle trafficking in the 
secretory pathways (170,171). The human genome contains 14 different genes for P4-
ATPases clustered in 5 classes (1a, 1b, 2, 5, 6), all of which have five functionally distinct 
domains (170). A-(actuator), N-(nucleotide binding), and P-(phosphorylation) domains are 
cytoplasmic; whereas T-(transport) and S-(class-specific support) domains are membrane-
anchored. Besides, a regulatory (R-) domain usually exists either at the N- or C-terminal or 
at both ends (171). In mammalian orthologs, the region between TM1-TM6 constitutes a 
functional unit for lipid flipping, and the segment between TM7-TM10 undertakes a 
supportive role. ATPases have an intrinsic kinase activity to phosphorylate itself at the 
aspartate residue located in the P-domain while catalytic cycle is taking place, and later it 
gets dephosphorylated by A-domain when transportation is terminated (171,172). The 
phosphorylated Asp located in Asp-Lys-Thr-Gly (DKTG) sequence is highly conserved in P-
type ATPases. The consensus residue region has been formulized as 
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DKTG[T/S][L/I/V/M][T/I]. The A-domain has Asp-Gly-Glu-Thr (DGET), P4-ATPase-
specific signature residues that facilitate dephosphorylation (173). 
Figure 12. Phylogenetic analysis reveals a protozoan-specific clading of TgATPaseP-GC. The tree 
shows the evolutionary relationship of TgATPaseP-GC from T. gondii with respective orthologs from 
various organisms signifying various domains of life. The image represents a single most 
parsimonious cladogram generated by maximum likelihood method. Sequence alignment and 
construction of the tree were performed by CLC Genomics Workbench v12.0, followed by 
visualization using Figtree v1.4.3. The colored dots on branching nodes show the bootstrap values. 
NCBI accession numbers of proteins: Arabidopsis thaliana, AAM51559.1; Ascaris suum (receptor-
type), ERG86823.1; Bos taurus (retinal-type) NP_776973.2; Bos taurus (soluble α1-subunit), 
P19687.1; Bos taurus (soluble β1-subunit), P16068.1; Caenorhabditis elegans (receptor-type), 
NP_494995.2; Caenorhabditis elegans (soluble), NP_510557.3; Drosophila melanogaster (receptor-
type), AAA85858.1; Drosophila melanogaster (soluble β-subunit), NP_524603.2; Eimeria tenella 
(soluble α), XP_013229212.1; Eimeria tenella (particulate β), XP_013235760.1; Hammondia 
hammondi, XP_008885058.1; Homo sapiens (retinal-type), NP_000171.1; Homo sapiens (soluble 
α1-subunit), NP_001124157.1; Homo sapiens (soluble β1-subunit), NP_001278880.1; Musca 
domestica (receptor-type), XP_005177218.1; Musca domestica (soluble), XP_019895151.1; Mus 
musculus (retinal-type), NP_001007577.1; Mus musculus (soluble α1-subunit),  AAG17446.1; Mus 
musculus (soluble β1-subunit), AAG17447.1; Oryza sativa, ABD18448.1; Oxytricha 
trifallax, EJY85073.1; Paramecium tetraurelia, XP_001346995.1; Plasmodium falciparum (soluble 
α), AJ245435.1; Plasmodium falciparum (particulate β), AJ249165.1; Prunus persica, AGN29346.1; 
Tetrahymena pyriformis, AJ238858.1; Toxoplasma gondii, EPR59074.1; Toxocara canis (receptor-
type), KHN81453.1; Toxocara canis (soluble), KHN85312.1. 
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Besides, two other conserved sequences, Thr-Gly-Asp-Asn (TGDN) and Gly-Asp-
Gly-x-Asn-Asp (GDGxND), are located in the P-domain that bind Mg2+ and connect ATP-
binding region to the transmembrane segments (173). T-domain includes the ion-binding site, 
which has a conserved proline in Pro-Glu-Gly-Leu (PEGL) sequence located usually between 
TM4 and TM5 (170).  
The alignment of ATPase domains from TgATPaseP-GC, PfGCα and PfGCβ with five 
different members of human P4-ATPases revealed several conserved residues (Appendix 2). 
For example, the second subdomain of TgATPaseP-GC (defined as Ca2+-ATPase, yellow 
colored in Figure 11A) carries DGET signature of A-domain albeit with one altered residue 
in the region (ETSKLDGET instead of ETSNLDGET). PfGCα contains two amino acid 
mutations in the same region (ETSLLNGET) when compared to the human ATP8A1, which 
translocates phosphatidylserine as its main substrate (174). Another replacement (Ser to 
Thr781) was observed both in TgATPaseP-GC and PfGCα at the IFTDKTGTIT motif, which 
harbors the consensus phosphorylated aspartate residue (D) in P-domain. The nucleotide 
binding sequence KGAD in N-domain (third region indicated as cation-ATPase) – the most 
conserved signature among P4-ATPases – is preserved in TgATPaseP-GC but substituted by 
a point mutation in PfGCα (Ala to Ser1739, KGSD). Additional mutation (D to E) was detected 
in the DKLQEQVPETL sequence located in the last ATPase subdomain of TgATPaseP-GC 
(highlighted with blue in Figure 11A). Not least, the GDGxND signature is conserved in 
TgATPaseP-GC but degenerated in PfGCα (Appendix 2). Notably most signature residues 
could not be identified in PfGCβ, which signifies a degenerated ATPase domain. Taken 
together, in silico analysis suggests that N-terminal ATPase domain of TgATPaseP-GC 
belongs to the P4-ATPase subfamily, and thus it is likely involved in lipid translocation. 
3.1.1.2 GC1 and GC2 domains of TgATPaseP-GC form a pseudo-heterodimer 
The arrangement and architecture of GC1 and GC2 domains in TgATPaseP-GC 
correspond to mammalian transmembrane adenylate cyclase (tmAC) of the class III (89). 
tmACs are activated by G-proteins to produce cAMP following extracellular stimuli (e.g., 
hormones). The cyclase domains of tmACs, C1 and C2, form an antiparallel pseudo-
heterodimer with one active and one degenerated site at the dimer interface (89). Amino acids 
from both domains contribute to the binding site, and seven conserved residues were 
identified to play essential roles for nucleotide binding and catalysis (89,175,176). These 
include two aspartate residues which bind two divalent metal cofactors (Mg+2, Mn+2) crucial 
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for substrate placement and turnover. An arginine and asparagine stabilize the transition state, 
while another arginine binds the terminal phosphate (Pγ) of the nucleotide. A lysine/aspartate 
pair underlies the selection of ATP over GTP as the substrate. In contrast, the existence of a 
glutamate/cysteine or glutamate/alanine pair defines the substrate as GTP in guanylate 
cyclases. The nucleotide binding and transition-state stabilization are conferred by one 
domain, while the other domain directly or via bound metal ions interacts with the terminal 
phosphate of the nucleotide in tmACs (175-177).  
The sequence alignment of GC1 and GC2 domains from TgATPaseP-GC to their 
orthologous GCs/ACs (Appendix 3) showed that GC1 contains a 74-residues long loop 
insertion (3033-3107 aa) unlike other cyclases. A shorter insertion (~40 amino acids) was 
also found in PfGCα. The tertiary model structure (depleted for the loop inserted between α3 
and β4 of GC1) shows that both domains consist of a seven-stranded β-sheets surrounded by 
three helices (Appendix 3, Figure 13B). The key functional amino acid residues with some 
notable substitutions could be identified as distributed across GC1 and GC2 (Figure 13). In 
GC1 domain, one of the two metal binding (Me) aspartates is replaced by glutamate (E2991), 
while both are conserved in GC2 (D4029 and D4073) (Figure 13A-C). The transition-state 
stabilizing (Tr) asparagine (N3144) and arginine (R3148) residues are located within GC1 
domain (Figure 13A-C), however both are replaced by leucine (L4153) and methionine 
(M4157), respectively in GC2 motif (Figure 13A). Another arginine (R4125) that is 
responsible for phosphate binding (Pγ) in tmACs is conserved in the GC2 domain (Figure 
13A-C), whereas it is substituted by K3116 in GC1 (Figure 13A). 
The cyclase specificity defining residues (B) are glutamate/alanine (E2987/A3137) and 
cysteine/aspartate (C4069/D4146) pairs in GC1 and GC2, respectively (Figure 13A-C). The 
E/A identity of the nucleotide binding pair in GC1 is indicative of specificity towards GTP. 
Thus, we propose that GC1 and GC2 form a pseudo-heterodimer and function as a guanylate 
cyclase (Figure 13A). Similar to tmACs, one catalytically active and one degenerated site are 
allocated at the dimer interface to make TgATPaseP-GC functional. However, the sequence 
of GC1 and GC2 is inverted in TgATPaseP-GC, which means that, unlike tmAC, GC1 domain 
contributes to the nucleotide and transition state binding residues of the active site, whilst 
GC2 harbors two aspartates crucial for metal ion binding. Guanylate cyclase function of 
TgATPaseP-GC was also experimentally validated by showing the involvement in cGMP 
synthesis by mutagenesis studies in parasite tachyzoites (see section 3.1.4.2). 
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Figure 13. The sequence alignment of GC1 and GC2 domains from TgATPaseP-GC with other 
cyclases identifies signature residues. (A) Amino acid sequences were obtained from Uniprot and 
aligned with the Clustal Omega program. Only conserved residues containing regions were shown in 
the figure with color-codes. (See full-length sequence alignment in appendix 3). The secondary α-β 
structures depicted underneath the alignment correspond to transmembrane type III adenylate 
cyclases (tmAC) (UniProt-Protein Data Bank ID: 1AZS, Oryctolagus cuniculus for GC1, Rattus 
norvegicus for GC2; DSSP hydrogen bond estimation algorithm). In type III cyclases, 7 residues are 
involved in cofactor binding for the catalysis, which are indicated above in the alignments as ‘Me’ 
for metal, ‘B’ for base, ‘Pγ’ for phosphate, ‘R’ for ribose, and ‘Tr’ for transition state binding. Note 
that alignment of GC1 and GC2 domains from TgATPaseP-GC to their orthologous GCs/ACs showed 
that, unlike other cyclases, a 74-residues long segment (3033-3107 aa) is inserted between α3 and β4 
of GC1 (not shown). Organism abbreviations and accession numbers: TgATPaseP-GC, Toxoplasma 
gondii (Uniprot; S7VVK4); PfGCα, Plasmodium falciparum (AJ245435.1); PfGCβ, P. falciparum 
(AJ249165.1); PtGC, Paramecium tetraurelia (XP_001346995.1; TpGC, Tetrahymena pyriformis 
(AJ238858.1); soluble MmGCα, Mus musculus (AAG17446.1); soluble MmGCβ, M. musculus 
(AAG17447.1); retinal-type MmGC2, M. musculus (NP_001007577.1); type II RntmAC, Rattus 
norvegicus (P26769.1) and; type V OctmAC, Oryctolagus cuniculus (CAA82562.1). (B-C) Tertiary 
structure of GC1 and GC2 domains based on sequence alignment. The catalytic units of GC1 and 
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GC2 were modelled by SWISS-MODEL (https://swissmodel.expasy.org/) using a ligand-free tmAC 
as the structural template (UniProt ID: 1AZS). The ribbon diagrams of GC1 and GC2 suggest a 
functional activation by pseudo-heterodimerization similar to transmembrane adenylate cyclases 
(tmACs). The model shows an antiparallel arrangement of GC1 and GC2, where each domain harbors 
a 7-stranded β-sheet surrounded by 3 α-helices. The image in panel C illustrates a GC1-GC2 
heterodimer interface bound to GTPαS. The residues of GC2 labelled with asterisk (*) interact with 
the phosphate backbone of the nucleotide. 
3.1.1.3 Overexpression and purification of recombinant GC1 and GC2 domains 
With an objective to determine the functionality of TgATPaseP-GC, we expressed 
ORFs of GC1 (M2850-S3244), GC2 (M3934-Q4242) and GC1+GC2 (M2850-Q4242) in E. coli 
(Figure 14A). Transgenic bacterial strains showed expected 1185, 927 and 4176 bp ORF-
specific PCR-bands for GC1, GC2 and GC1+GC2 domains, respectively, by PCR screening 
(Figure 14B). Positive clones were further verified by sequencing of PCR amplicons. An 
overexpression of GC1 and GC2 proteins as 6xHis-tagged in the M15 strain resulted in 
inclusion bodies, which did not allow us to use native conditions in order to purify proteins. 
We nevertheless purified them through a Ni-NTA column under denaturing conditions. 
Purified GC1 and GC2 proteins exhibited an expected molecular weight of 47 and 38-kDa, 
respectively (Figure 14C). Our attempts to purify GC1+GC2 protein were futile however. To 
test the catalytic activity of purified GC1 and GC2 domains, we executed an in vitro guanylate 
cyclase assay. Neither for GC1 nor for GC2 any functionality was detected when tested 
separately or together. Further optimization of protein purification process yielded no 
detectable GC activity. By considering the possibility of obtaining misfolded or unfolded 
purified proteins, the guanylate cyclase assay was repeated with bacterial lysates expressing 
specified domains (Appendix 4A); yet, no cGMP production was observed either as judged 
by HPLC (Appendix 4B).  
Furthermore, it was examined whether GC1 and GC2 can function as adenylate 
cyclase using a bacterial complementation assay, as described by Karimova et al. (161) 
(Figure 14D). GC1, GC2 and GC1+GC2 proteins were expressed in the BTH101 strain of E. 
coli, which is deficient in the adenylate cyclase activity and so unable to utilize maltose as a 
carbon source. The BTH101 strain produced white colonies on MacConkey agar containing 
maltose, which would otherwise be red-colored upon induction of cAMP-dependent 
disaccharide catabolism. It was observed that, unlike the positive control (adenylate cyclase 
from E. coli), BTH101 strains expressing GC1, GC2 or GC1+GC2 produced only white 
colonies in each case (Figure 14D), which could either be attributed to inefficient expression 
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or a lack of adenylate cyclase activity in accordance with the presence of signature residues 
defining the specificity for GTP in indicated domains (Figure 13A).  
Figure 14. Expression of TgATPaseP-GC1 and GC2 domains in the M15 and BTH101 strains of 
Escherichia coli. (A) Scheme depicting the molecular cloning of GC1, GC2 and GC1+GC2 domains 
in the pQE60 expression vector. The open reading frames of indicated domains were amplified 
starting from the first upstream start codon (ATG) using the tachyzoite-derived RNA, and ligated into 
BglII-digested pQE60 plasmid. Proteins were fused with a C-terminal 6xHis-tag for subsequent 
detection by immunoblot and purification by virtue of the Ni-NTA column. (B) PCR screening of 
genomic DNA of transgenic M15 strains resulted in obtaining of 1185, 927 and 4176 bp ORF-specific 
PCR-amplicons, which verifies successful transformation of GC1, GC2 and GC1+GC2 domains, 
respectively. (C) Immunoblot of purified GC1-6xHis and GC2-6xHis proteins (5 µg) using the mouse 
α-His antibody. The protein bands of 47-kDa and 38-kDa correspond to GC1 and GC2 domains, 
respectively. Purification was performed under denaturing conditions from the M15 strain, as 
described in methods, section 2.3. However, GC1+GC2 protein could not be purified. (D) Functional 
testing of GC1, GC2 and GC1+GC2 domains in the BTH101 strain. Bacterial strains expressing GC1, 
GC2, GC1+GC2 were grown in LB medium (OD600,1.6; 37°C), and then plated on MacConkey agar 
containing 1% maltose (carbon source) and 200 µM IPTG (inducer) by dilutions. Bacteria strain 
expressing EcCyaA (adenylate cyclase) or harboring the empty pQE60 vector were used as positive 
and negative controls, repectively. The appearance of red colonies is indicative of cAMP-dependent 
catabolism of disaccharide following a functional expression of EcCyaA, but not others. 
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Notwithstanding technical issues with our expression model or enzyme assay, it is 
plausible that the P4-ATPase domain is required for the functionality of cyclase domains in 
TgATPaseP-GC, as also suggested by two recent studies (99,153). In similar experiments 
conducted with Plasmodium guanylate cyclases, PfGCα and PfGCβ, the guanylate cyclase 
activity could only be confirmed for PfGCβ, but not for PfGCα (151), which happens to be 
the nearest ortholog of  TgATPaseP-GC (refer to phylogeny in Figure 12). 
3.1.2 TgATPaseP-GC is expressed in the plasma membrane at the apical pole 
To gain insight into the endogenous expression and localization of TgATPaseP-GC 
protein, epitope tagging of the gene was performed in tachyzoites of T. gondii (Figure 15A). 
The parental (RHΔku80-hxgprt-) strain was transfected with a plasmid construct which 
allows 3’-insertional tagging of TgATPaseP-GC with a hemagglutinin (HA) tag by single 
homologous crossover (see the vector map in Appendix 8). The resulting transgenic strain 
(Pnative-TgATPaseP-GC-HA3’IT-TgGra1-3’UTR) encoded HA-tagged TgATPaseP-GC under 
the control of its native promoter but TgGra1-3’UTR. Notably, the fusion protein localized 
predominantly at the apex of the intracellularly growing parasites, as deduced by its co-
staining with TgGap45, a marker of the IMC (178) (Figure 15A, left). The apical location of 
TgATPaseP-GC-HA3’IT was confirmed by its co-localization with the IMC sub-compartment 
protein 1 (TgISP1) (156) (Figure 15A, right). Besides, a significant expression of TgATPaseP-
GC-HA3’IT outside the parasite periphery within the residual body (Figure 15A, marked with 
arrows) was noted, which has also been observed for several other proteins, such as Rhoptry 
Neck 4 (RON4) (179). To assess the membrane location and predicted C-terminal topology 
of the protein, extracellular parasites were stained with α-HA antibody prior to and after 
detergent permeabilization of the parasite membranes (Figure 15B). The HA-staining was 
detected only after the permeabilization, indicating that C-terminus of TgATPaseP-GC faces 
the parasite interior, as shown in the model (Figure 11B). 
Then, extracellular parasites were treated with α-toxin as described in section 2.6.1 to 
split the plasma membrane from inner membrane complex, which enabled to distinguish the 
distribution of TgATPaseP-GC-HA3’IT between both entities. By staining of tachyzoites with 
two markers, i.e. TgGap45 for the IMC and TgSag1 for the PM, the association of 
TgATPaseP-GC-HA3’IT was shown with the plasma membrane (Figure 15C). Making of a 
transgenic line encoding TgATPaseP-GC-HA3’IT also enabled to evaluate its expression 
pattern by immunoblot analysis throughout the lytic cycle, which recapitulates the successive 
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events of gliding motility, host- cell invasion, intracellular replication, and egress leading to 
host-cell lysis.      
Figure 15. TgATPaseP-GC is a constitutively expressed protein located at the apical end in the 
plasma membrane of T. gondii. (A) Scheme for the genomic tagging of TgATPaseP-GC with a 3’-
end HA epitope. The SacI-linearized plasmid for 3’-insertional tagging (p3’IT-HXGPRT-TgATPaseP-
GC-COS-HA3’IT) was transfected into the parental (RHΔku80-hxgprt
-) strain, followed by drug 
selection. Intracellular parasites of the resulting transgenic strain (Pnative-TgATPaseP-GC-HA3’IT-
TgGra1-3’UTR) were subjected to immunostaining with specified antibodies (24 h post-infection). 
Arrows indicate the location of the residual body. The host-cell and parasite nuclei were stained by 
DAPI. COS, crossover sequence; S.C., selection cassette. (B) Immunofluorescence staining of 
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extracellular parasites expressing TgATPaseP-GC-HA3’IT. The α-HA immunostaining of the free 
parasites was performed before or after membrane permeabilization either using PBS without 
additives or with BSA dissolved in detergent-supplemented PBS, respectively. The appearance of 
TgGap45 signal (located in the inner membrane complex) only after permeabilization confirms 
functionality of the assay. TgSag1 is located in the plasma membrane and thus visible under both 
conditions. (C) Immunostaining of extracellular parasites encoding TgATPaseP-GC-HA3’IT after drug-
induced splitting of the inner membrane complex (IMC) from the plasma membrane (PM). 
Tachyzoites were incubated with α-toxin (20 nM, 2 h) prior to immunostaining with α-HA antibody 
in combination with primary antibodies recognizing IMC (α-TgGap45) or PM (α-TgSag1), 
respectively. (D-E) Immunoblots of tachyzoites expressing TgATPaseP-GC-HA3’IT, and of the 
parental strain (RHΔku80-hxgprt-, negative control). The protein samples prepared from extracellular 
parasites (107) were directly loaded onto membrane blot, followed by staining with α-HA and α-
TgGap45 antibodies. Samples in panel E were collected at different time periods during the lytic cycle 
and stained with α-HA and α-TgGap45 (loading control) antibodies.  
TgATPaseP-GC is a bulky protein (477-kDa) with several transmembrane regions; 
hence it was not possible for us to successfully resolve it by gel electrophoresis and transfer 
onto nitrocellulose membrane for immunostaining. Thus, we performed the dot-blot analysis 
by loading protein samples directly onto an immunoblot membrane (Figure 15D-E). Unlike 
the parental strain (negative control), which showed only a faint (background) α-HA staining, 
we observed a strong signal in the TgATPaseP-GC-HA3’IT-expressing strain (Figure 15D). 
Samples of transgenic strains collected at various periods embracing the entire lytic cycle 
indicated a constitutive and steady expression of TgATPaseP-GC-HA3’IT in tachyzoites 
(Figure 15E). 
3.1.3 TgATPaseP-GC is essential for the parasite survival 
Having established the expression profile and location, next the physiological 
importance of TgATPaseP-GC for tachyzoites was examined. Multiple efforts to knockout 
the TgATPaseP-GC gene by double homologous recombination were unrewarding, 
suggesting its essentiality during the lytic cycle (lethal phenotype). Hence, the strain 
expressing TgATPaseP-GC-HA3’IT was utilized to monitor the effect of genetic disruption 
immediately after the transfection of the plasmid for gene disruption (Figure 16). To achieve 
this, a CRISPR/Cas9-directed cleavage were executed in TgATPaseP-GC gene, and then 
parasites were immunostained at various periods to determine a time-elapsed loss of HA-
signal (Figure 16A). Within a day of transfection, about 4% of vacuoles had lost the apical 
staining of TgATPaseP-GC-HA3’IT (Figure 16B). Parasites losing the HA-signal remained 
constant until the 1st passage (P1, 24-40 h). However, their growth reduced gradually down 
to 2% during the 2nd passage (P2, 72-88 h) and fully seized by the 3rd passage (P3, 120-136 
h).  
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 Figure 16. Genetic disruption of TgATPaseP-GC is lethal to tachyzoites of T. gondii. (A) Scheme 
for the CRISPR/Cas9-mediated disruption of the gene in parasites expressing TgATPaseP-GC-HA3’IT. 
The guide RNA was designed to target the nucleotides between 145 and 164 bp in the progenitor 
strain (Pnative-TgATPaseP-GC-HA3’IT-TgGra1-3’UTR). Image shows the loss of HA signal in some 
vacuoles after CRISPR/Cas9-cleavage. Parasites were transfected with the pU6-TgATPaseP-GCsgRNA-
Cas9 vector, and then stained with α-HA and α-TgGap45 antibodies at specified periods. (B) 
Quantitative illustration of TgATPaseP-GC-HA3’IT-disrupted mutant parasites from panel A. The HA-
negative vacuoles harboring at least 2 parasites were scored during successive passages (P1-P3) of 
culture. (C) The replication rates of the HA (+) and HA (-) tachyzoites, as evaluated by 
immunostaining (panel A). About 500-600 vacuoles were enumerated for the parasite numbers per 
vacuole (n=3 assays, means ± S.E.M.). 
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The same assay also allowed to quantify the replication rates of HA-negative parasites 
in relation to the HA-positive parasites by counting their numbers in intracellular vacuoles 
(Figure 16C). As expected, the fraction of single parasites and small vacuoles comprising 2 
parasites were much higher in the nonexpression (HA-negative) parasites. Inversely, the 
progenitor strain expressing TgATPaseP-GC-HA3’IT showed predominantly a higher 
percentage of bigger vacuoles with 16-64 parasites. By 3rd passage, only single-parasites 
without HA-signal were detected, which demonstrates an essential role of TgATPaseP-GC 
for the asexual reproduction. It must also be mentioned that the off-target activity caused by 
Cas9 toxicity is a well-documented problem of this system in a variety of cell-lines (180-
182) as well as in Toxoplasma (110) and cannot be ruled out here. However, the effect of 
Cas9 toxicity, if any, should not only be seen in the parasites without HA signal but also with 
HA-positive parasites at all of time points. As shown in Figure 16A-B, we detected about 4% 
vacuoles without HA signal with normally replicating parasites, which gradually disappeared 
in the entire population over a week period. These results are consistent with a refractory 
nature of guanylate cyclase. 
3.1.4 Genetic knockdown of TgATPaseP-GC in T. gondii tachyzoites 
Although an indispensable nature of TgATPaseP-GC for tachyzoites could be 
established, the above mentioned CRISPR/Cas9-mediated gene disruption strategy did not 
yield a clonal mutant for in-depth biochemical and phenotypic analyses due to an eventual 
mortal phenotype. Therefore, a knockdown approach was applied on the basis of Cre/LoxP-
mediated native 3’UTR deletion of TgATPaseP-GC to lower the protein expression that 
allowed to examine the physiological importance of this mega gene during the lytic cycle of 
the parasite. 
3.1.4.1 Excision of TgATPaseP-GC-3’UTR reduces cGMP synthesis 
Following successful expression of the TgATPaseP-GC-HA3’IT under the regulation 
of its native promoter and TgGra1-3’UTR (Figure 15A), an additional transgenic strain, in 
which TgGra1-3’UTR was replaced by the 3’UTR of TgATPaseP-GC, was generated to 
designate native protein expression. To achieve this, 1 kb part of the TgATPaseP-GC-3’UTR 
following stop codon was amplified from the genomic DNA of parental RHΔku80-hxgprt- 
strain, and amplicon was substituted for TgGra1-3’UTR in our expression construct by 
flanking with two loxP sites (see vector map in Appendix 8). Subsequently, transfection and 
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drug selection were performed as described (section 3.1.2). In the eventually engineered 
parasite strain, TgATPaseP-GC-HA3’IT was expressed under its natural regulatory elements; 
however, the 3’UTR of gene was loxP-flanked (floxed) (Pnative-TgATPaseP-GC-HA3’IT-
3’UTRfloxed) (Figure 17A). The transfection of this strain culture with a Cre recombinase 
expressing vector permitted the Cre/loxP-mediated excision of the 3’UTR as well as and 
HXGPRT selection cassette. Mutant parasites were selected by 6-thioxanthine treatment (80 
µg/ml) (Figure 17A).  
Genomic screening using specific primers (indicated with red arrows in Figure 17A) 
confirmed a successful generation of the mutant (Pnative-TgATPaseP-GC-HA3’IT-3’UTRexcised), 
which yielded 2.2-kb amplicons as opposed to 5.2-kb in the progenitor strain (Pnative-
TgATPaseP-GC-HA3’IT-3’UTRfloxed) (Figure 17B). The sequencing of amplicons further 
verified the accomplished 3’UTR excision. Immunoblots of a clonal mutant by α-HA 
antibody staining showed the evidence of downregulation of the TgATPaseP-GC-HA3’IT 
protein expression (Figure 17C). Densitometric analysis of TgATPaseP-GC-HA3’IT protein 
revealed about 65% reduction in the mutant when compared to the progenitor strain. 
Knockdown of the protein was also endorsed by loss of HA-staining in immunofluorescence 
assay (Figure 17D), where about 94% vacuoles lost their HA-signal, and the rest (~6%) 
displayed only a faint HA-staining (Appendix 5A). 
 Next, it was evaluated if the repression of TgATPaseP-GC translated into a declined 
cGMP synthesis by the parasite. Indeed, ~60% regression was measured in the steady-state 
levels of cGMP in the mutant (Figure 17E), equating to the decay at the protein level (Figure 
17C-D). The average cGMP level of mutant strain was detected as about 67 fmol/106 
parasites, while this value was measured as ~153 and ~216 fmol/106 parasites in progenitor 
and parental strains, respectively (Figure 17E). The progenitor strain (Pnative-TgATPaseP-GC-
HA3’IT-3’UTRfloxed) also showed a decreased cGMP level in comparison to parental strain 
likely due to epitope tagging and introduction of loxP sites between the last gene exon and 
3’UTR. Overall, these results indicate that TgATPaseP-GC functions as a guanylate cyclase 
to serve for cGMP production. 
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Figure 17. Cre recombinase-mediated downregulation of TgATPaseP-GC-HA3’IT declines cGMP 
synthesis in T. gondii. (A) Schematics for making the parasite mutant (Pnative-TgATPaseP-GC-HA3’IT-
3’UTRexcised). A vector expressing Cre recombinase was transfected into the progenitor strain (Pnative-
TgATPaseP-GC-HA3’IT-3’UTRfloxed), in which 3’UTR of the TgATPaseP-GC gene was flanked with 
two loxP sites. Parasites involving Cre recombinase expressing vector were selected for the loss of 
HXGPRT selection cassette (S.C.) using 6-thioxanthine. (B) Genomic screening of the TgATPaseP-
GC mutant confirming Cre-mediated excision of 3’UTR and HXGPRT. Primers, indicated as red 
arrows in panel A, were used to PCR-screen of the gDNA isolated from four different mutant clones 
(C1-C4) along with the progenitor strain. (C) Immunoblot showing a repression of TgATPaseP-GC-
HA3’IT in 3’UTR- excised parasites with respect to the progenitor and parental (RHΔku80-hxgprt
-) 
strains. Parasites (107) were subjected to the dot blot analysis using α-HA and α-TgGap45 (loading 
control) antibodies. (D) Immunostaining of the mutant (TgATPaseP-GC-HA3’IT-3’UTRexcised) and 
progenitor parasites revealing the loss of HA-signal in the former strain. Parental strain was used as 
a negative control for the background staining. Parasites were stained with α-HA and α-TgGap45 
antibodies 24 h post infection. (E) Changes in total steady-state cGMP level of the mutant compared 
to the parental and progenitor strains. Fresh syringe-released extracellular parasites (5x106) were 
subjected to ELISA-based cGMP measurements (n=4 assays, the means are with ±S.E.M.). **, p 
≤0.01; ***, p ≤0.001 (Student’s t-test) 
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3.1.4.2 Downregulation of cGMP synthesis impairs the parasite growth 
The growth fitness of TgATPaseP-GC-HA3’IT-3’UTRexcised mutant was examined by 
comparing it with the progenitor (Pnative-TgATPaseP-GC-HA3’IT-3’UTRfloxed) and parental 
(RHΔku80-hxgprt-) strains (Figure 18A). A significant impairment in the plaque number of 
mutant was observed in comparison to parental strain (Figure 18B). As anticipated, the 
mutant exhibited about 65% and 35% reduction in plaque area when compared to the parental 
and progenitor strains, respectively (Figure 18C), which correlated rather well with its 
residual expression of TgATPaseP-GC in the immunoblot, immunofluorescence as well as in 
cGMP assays (Figure 17C-E). However, the progenitor strain also showed lesser plaque 
formation and ~30% impairment in plaque sizes (Figure 18B-C), which corresponds again to 
the observed reduction in cGMP level when compared to the parental strain (Figure 17E). 
Next, we checked the replication rate of the mutant to determine whether observed 
growth defect in plaque assay is due to the affected replication. Parasites released on HFF-
monolayers were incubated for 24- and 40 h to replicate themselves in parasitophorous 
vacuoles, followed by counting of the parasite numbers in vacuoles across strains. The 
replication assay revealed a modestly higher fraction of smaller vacuoles with two parasites 
in early culture (24 h) of the mutant compared to the control strains; however, the effect was 
assuaged at the later culture stage (40 h) (Figure 18D). The average parasite numbers in each 
vacuole were also scored to ascertain the obtained data. Indeed, no significant difference was 
observed in the average parasite numbers of the TgATPaseP-GC mutant (33 
parasites/vacuole) with respect to the control strains (37-38 parasites/vacuole) in late stage 
cultures (40 h), although a slight delay was observed in early culture stage (6-7 
parasites/vacuole in mutant versus 10 and 8 parasites/vacuole in progenitor and parental 
strains, respectively) (Figure 18E), which suggests a nonessential function of TgATPaseP-GC 
for the cell division. All together, these results show that the knockdown of TgATPaseP-GC 
protein causes a significant decrease in cGMP synthesis of mutant parasites. The effect of 
cGMP decline was observed on the growth profile of tachyzoites, which indicates that 
TgATPaseP-GC is necessary for the lytic cycle of parasite. 
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Figure 18. A declined cGMP synthesis causes a defect in parasite growth. (A-C) Plaque assays 
using the TgATPaseP-GC mutant (Pnative-TgATPaseP-GC-HA3’IT-3’UTRexcised), progenitor (Pnative-
TgATPaseP-GC-HA3’IT-3’UTRfloxed) and parental (RHΔku80-hxgprt
-) strains. (A) The dotted white 
areas and blue staining signify plaques formed by parasites and intact host-cell monolayers, 
respectively. (B) The score of the plaque numbers revealing the comparative growth of mutant with 
respect to parental and progenitor strains (n=3 assays). (C) The area of each plaque (arbitrary units, 
a.u.) embodies the growth fitness of indicated strains. 150-200 plaques of each strain were evaluated 
from 3 independent assays. (D-E) Replication assays of mutant, progenitor and parental strains (n=4 
assays). (D) The intracellular replication rates were analyzed 24 h and 40 h post-infection by scoring 
the parasite numbers in a total of 500-600 vacuoles after staining with α-TgGap45 antibody. (E) The 
average parasite numbers per vacuole were also depicted in two time points for all strains. Statistics 
was performed by Student´s t-test; *, p ≤0.05; **, p ≤0.01; ****, p ≤0.0001 (the means with ±S.E.M). 
80 
 
3.1.4.3 TgATPaseP-GC regulates the crucial events of lytic cycle 
The availability of an effective mutant encouraged to study also the importance of 
TgATPaseP-GC for the critical steps of lytic cycle including invasion, egress and gliding 
motility, all of which contribute eventually to the parasite virulence (Figure 19). About 30% 
decline was quantified in the invasion efficiency of the 3’UTR-excised TgATPaseP-GC-
mutant down from 80% to 53% (Figure 19A). Hence, we presume that a minor replication 
defect observed at 24 h (Figure 18D-E) may be a consequence of a poor host-cell invasion 
by the mutant parasite. Besides, the effect of protein repression was more pronounced in 
egress assay, where the mutant showed 70% decline in natural egress when compared to the 
parental strain and 40% defect in relation to the progenitor strain at 40 h and 48 h post-
infections (Figure 19B). Notably though, the egress defect was compensated and not apparent 
upon prolonged (64 h) culture. Such compensation at the later stage is probably caused by 
alternative (CDPKs) signaling cascades (42). 
Figure 19. Cyclic GMP signaling governs the key events during the lytic cycle of T. gondii. (A-
C) In vitro phenotyping of the TgATPaseP-GC mutant and its progenitor compared with parental 
strain. (A) Host-cell invasion, (B) Parasite egress and (C) Gliding motility were assessed using 
standard phenotyping methods described in section 2.5. Invasion and egress rates were calculated by 
dual staining with α-TgGap45 and α-TgSag1 antibodies. In total, 1000 parasites for each strain from 
4 independent assays were examined to estimate the invasion efficiency. The natural egress of 
tachyzoites was measured after 40 h, 48 h and 64 h by scoring 500-600 vacuoles of each strain (n=3 
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assays). To estimate the gliding motility, fluorescent images stained with α-TgSag1 antibody were 
analyzed for the motile fraction (500 parasites of each strain, n=3 assays), and 100-120 trail lengths 
per strain were measured (the means with ±S.E.M; the significance with Student’s t-test, *, p ≤0.05; 
**, p ≤0.01; ***, p ≤0.001). 
Because invasion and egress are considered to be mediated by gliding motility (100), 
in vitro motility assay was performed to test the phenotype of our TgATPaseP-GC mutant 
strain. We determined that the average motile fraction was reduced by more than half in the 
mutant (from ~25-30% to ~10%), and trail lengths of moving parasites were remarkably 
shorter (~18 µm) than the control strains (~48 µm) (Figure 19C). Not least, as witnessed in 
plaque assays (Figure 18 A-C), it was also found a steady, albeit not significant, decline in 
the invasion and egress rates of the progenitor when compared to the parental strain, which 
further confirms a correlation across all phenotypic assays.  
3.1.4.4 Pharmacological modulation of cGMP signaling in the TgATPaseP-GC mutant 
A partial phenotype prompted us to pharmacologically inhibit the residual cGMP 
signaling via PKG in the 3’UTR-excised TgATPaseP-GC mutant. An inhibitor called 
compound 2 (C2), which has been shown to block mainly TgPKG but also calcium-dependent 
protein kinase 1 (CDPK1) (183), was used to assess the effect of cGMP signaling on the lytic 
cycle steps of mutant by comparison with its progenitor strain (Pnative-TgATPaseP-GC-HA3’IT-
3’UTRfloxed) (Figure 20). Conversely, TgATPaseP-GC mutant was also treated with two 
cGMP-specific PDE inhibitors, namely zaprinast and BIPPO, which are known to inhibit 
parasite enzymes along with human PDE5 and PDE9, respectively (122,184), to complement 
the depletion of TgATPaseP-GC by drug-mediated elevation of cGMP (Figure 21). 
The gliding motility of TgATPaseP-GC mutant was completely suppressed by 2 µM 
of C2 treatment. Besides, a remarkable reduction was also detected in progenitor strain 
(Figure 20A). Approximately, 6-fold decrease was observed in motile fraction of both strains. 
The length of trails in motile parasites was extremely short (in turn, ~16 and ~ 8 µm in 
progenitor and mutant strains). The impact of C2 was more accentuated on the motility of 
mutant strain, likely due to the cumulative effect of genetic repression and drug inhibition.  
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Figure 20. Inhibition of residual cGMP signaling in the TgATPaseP-GC mutant by Compound 
2 augments the defective phenotype. The effect of PKG inhibitor Compound 2 (2 µM) on the (A) 
Motility, (B) Invasion and (C) Egress of TgATPaseP-GC mutant and its progenitor. (A) The impact of 
compound 2 treatment on gliding motility was analyzed using the fluorescent images stained with α-
TgSag1 antibody following 15 min incubation to let parasites making trails on BSA-coated glass 
coverslips. For the motile fraction, 500 parasites of each strain were considered (n=3 assays). A total 
of 50 trails in the progenitor and 15 trails of the mutant (due to severe defect) were measured by 
ImageJ. (B-C) Invasion and egress rates were scored after staining with α-TgGap45 and α-TgSag1 
antibodies. For invasion, freshly extracellular parasites (106) were released on HFF-monolayers 
grown on glass coverslips with or without compound 2 treatment following 1 h incubation. 450-500 
parasites were scored (n=3 assays). For egress, parasite cultures grown to the mature vacuoles in HFF-
monolayers were treated with Compound 2 40 hpi and incubated 8 more hours to observe the effect 
of drug. 500-600 vacuoles were counted for each strain from 4 independent assays.  Mean values are 
shown with S.E.M. Statistical significance was calculated for each pair of columns individually by 
Student’s t-test. (*, p ≤0.05; **, p ≤0.01; ***, p ≤0.001; ****, p ≤0.0001.)  
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The impairment observed in motility was also detected in invasion and egress after 
C2 treatment (Figure 20B-C). Invasion efficiency dropped from ~80% to 20% and from 
~60% to 30% in the progenitor and mutant strains, respectively (Figure 20B). On the other 
hand, C2 treatment did not influence the egress phenotype of the mutant significantly, while 
egress rate of the progenitor strain declined from ~60% to ~25% (Figure 20C). The inhibitory 
potential of C2 was evidently stronger on the invasion and egress events of the progenitor 
strain than on the TgATPaseP-GC mutant, which can be attributed to the already-activated 
compensatory mechanisms in the mutant parasite after genetic attenuation of TgATPaseP-GC. 
To further validate our findings, zaprinast (500 µM) and BIPPO (55 µM) were applied 
to the cultures to check if the elevation of cGMP via drug treatment could alleviate the 
phenotypic defects in the TgATPaseP-GC knockdown mutant (Figure 21). As shown in Figure 
21A, both drugs led to a dramatic increase in the motile fraction and trail lengths of the 
progenitor (Pnative-TgATPaseP-GC-HA3’IT-3’UTRfloxed) and mutant (Pnative-TgATPaseP-GC-
HA3’IT-3’UTRexcised) strains expectedly. The latter parasites were as competent as the former 
after drug exposure. A similar restoration of phenotype in the mutant was detected in egress 
assays. The effect of BIPPO was much more pronounced than zaprinast, leading to egress of 
nearly all parasites (Figure 21B).  
In contrast to the motility and egress, a treatment of BIPPO and zaprinast resulted in 
a surprisingly divergent effect on the invasion rates of both strains (Figure 21C). Indeed, 
BIPPO exerted an opposite effect, i.e. a reduction in invasion efficiency of both progenitor 
and mutant strains. Impairment was stronger in the former strain; hence a reversal of the 
phenotype was noted when compared to the control (untreated) samples. A similar effect was 
seen on the progenitor strain after zaprinast treatment; although, it was much less potent than 
BIPPO, as implied previously (122). However, invasion rate of the mutant could be increased 
by zaprinast treatment. These observations can be ascribed to differential elevation of cGMP 
(overabundance or above certain threshold) caused by PDE-inhibitors which might inhibit 
the host-cell invasion, but promotes the parasite motility and egress.  
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Figure 21. cGMP-specific PDE inhibition can repair phenotypic defects of TgATPaseP-GC 
mutant. (A) Gliding motility of the Pnative-TgATPaseP-GC-HA3’IT-3’UTRexcised mutant and progenitor 
(Pnative-TgATPaseP-GC-HA3’IT-3’UTRfloxed) strains in the presence of two inhibitors of cGMP-specific 
phosphodiesterases, zaprinast (500 µM) and BIPPO (55 µM). Fresh syringe-released parasites were 
treated with drugs for 15 min during the assay, followed by fixation and staining with α-TgSag1 
antibody. 500-600 parasites of each strain were evaluated for the motile fraction, and 100-120 trail 
lengths were measured by ImageJ (n= 3 assays, mean with S.E.M.). (B-C) Egress and invasion rates 
of indicated parasite strains after exposure to zaprinast and BIPPO. Intracellular and extracellular 
parasites were differentially stained with α-TgGap45 and α-TgSag1 antibodies, as described in 
methods. Drug treatment during invasion assay was performed for 1 h. For egress, parasitized cells 
(MOI, 1; 40 h post-infection) were stimulated with either zaprinast (500 µM) or BIPPO (55 µM) for 
5 min 30 sec prior to fixation and staining. In total, 1000 parasites and 500-600 vacuoles were scored 
for each strain in panel B and C, respectively (n= 3 assays, mean with S.E.M.). Statistics was 
performed for individual pair of columns using Student’s t-test (*, p ≤0.05; **, p ≤0.01; ***, p 
≤0.001). 
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3.1.5 T. gondii harbors a single gene expressing two isoforms of Protein kinase G 
cGMP-dependent protein kinase of T. gondii (TgPKG) is a member of serine/threonine-
specific protein kinases which largely regulate signal transduction pathways via 
phosphorylation of target proteins to coordinate core cellular processes. In Toxoplasma, only 
a single cGMP-dependent protein kinase gene was detected in the database (ToxoDB) (50). 
The entire gene size is about 15-kb which consists of 19 introns and 20 exons. The ORF 
encodes for a 994 amino acids-long protein including a regulatory subunit at its C-terminus 
and a serine/threonine kinase catalytic domain at its N-terminus (Figure 22A). The first half 
of TgPKG (1-670 aa) constitutes the regulatory region containing four cGMP-binding 
domains positioned between the amino acids from Val198 to Gln290, from Phe308 to Ile417, from 
Leu430 to Gly539 and from Ile561 to Lys661, respectively. The second half (670-994 aa) involves 
a catalytic domain encoded from the region between Leu684 and Phe941 amino acids. As 
opposed to TgATPaseP-GC, TgPKG does not contain any transmembrane helix (Figure 22A). 
Because TgPKG is known as the main effector of cGMP signaling in T. gondii, the 
same abovementioned genomic-tagging (section 3.1.2), knockdown (section 3.1.4.1) and 
phenotyping (section 3.1.4.2 and 3.1.4.3) approaches were also implemented to TgPKG in 
order to consolidate aforesaid work on TgATPaseP-GC. Briefly, 1 kb from the 3’ end of 
TgPKG gene was amplified with C-terminal HA-tag between NcoI and EcoRI restriction 
enzyme recognition sites and introduced into the expression vector that includes 1 kb part of 
native TgPKG-3’UTR. Thereafter, a parasite strain expressing TgPKG with HA-epitope 
under the control of its endogenous regulatory elements was generated by 3’-insertional 
tagging strategy. The 3’UTR and HXGPRT selection cassette were floxed in the expression 
construct (Figure 22B-Step 1) (please see vector map in Appendix 8). The resultant 
progenitor strain (Pnative-TgPKG-HA3’IT-3’UTRfloxed) was then exposed to a Cre-mediated 
knockdown of TgPKG-HA3’IT by excising the loxP-flanked 3’UTR and selection cassette, 
which resulted in a generation of TgPKG-HA3’IT-knockdown mutant (Pnative-TgPKG-HA3’IT-
3’UTRexcised) (Figure 22B-Step 2). As intended, genomic screening with specified primers in 
Figure 22B yielded 1.9-kb amplicons in the isolated clonal mutants (Pnative-TgPKG-HA3’IT-
3’UTRexcised) as opposed to a 4.8-kb band in the progenitor strain (Pnative-TgPKG-HA3’IT-
3’UTRfloxed) (Figure 22C). The excision of 3’UTR and HXGPRT marker was further 
confirmed by DNA sequencing of PCR amplicons.  
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Figure 22. C-terminal epitope-tagging and Cre recombinase-mediated knockdown of TgPKG 
in T. gondii. (A) The primary structure of TgPKG as predicted by SMART and NCBI domain search 
online tools. The N-terminal (1-670 aa) comprises a ligand-binding domain with four subunits. C-
terminal (670-994 aa) contains a serine/threonine protein kinase domain. (B) 3’-insertional tagging 
of the TgPKG gene with an HA-epitope (step 1) and subsequent deletion of loxP-flanked (floxed) 
native 3’UTR by Cre recombinase (step 2). The construct for 3’-insertional tagging (3’IT) was 
transfected into the parental strain (RHΔku80-hxgprt-) through crossover sequence (COS) and drug-
selected for the HXGPRT selection cassette (S.C.). The eventual progenitor strain (Pnative-TgPKG-
HA3’IT-3’UTRfloxed) expressed TgPKG-HA3’IT under its own regulatory elements. In the second step, 
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the progenitor strain was transfected with a vector expressing Cre-recombinase under TgSagI 
promoter (60) to cutoff the floxed 3’UTR and HXGPRT by negative selection, which resulted in 
downregulation of TgPKG in mutant (Pnative-TgPKG-HA3’IT-3’UTRexcised). (C) Genomic screening 
PCR validating the integrity of the TgPKG mutant generated by the excision of 3’UTR. Primers 
indicated as red-color arrows in panel B were used to test gDNAs isolated from the mutant clones 
(C1-C3) and progenitor strain. The mutagenesis was further confirmed by sequencing of amplicons 
(1.9-kb). (D) Immunoblot depicting the expression of TgPKG isoforms in clonal mutants (C1 and C2) 
along with the progenitor and parental strains. Extracellular tachyzoites (2x107) of each strain were 
subjected to protein sample preparation, followed by immunoblotting with α-HA antibody. 
Expression of 112-kDa and 135-kDa isoforms in the progenitor and mutants, but not in the parental 
strain, confirms efficient 3’-HA tagging and successful knockdown of the TgPKG protein, 
respectively. TgRop2 served as loading control. (E) The fluorescence images demonstrating the 
expression of TgPKG-HA3’IT in the progenitor strain, and its downregulation in the 3’UTR-excised 
mutant. The parental strain was included as a negative control. Intracellular parasites (24 h post-
infection) were stained with α-HA and α-TgGap45 antibodies. The merged image shows DAPI-
stained host and parasite nuclei in blue. 
Besides, 3’UTR excision gave rise to the reduced TgPKG-HA3’IT expression which was 
validated by immunofluorescence and immunoblot assays (Figure 22D-E). Moreover, 
immunoblot of both TgPKG-HA3’IT progenitor and TgPKG-HA3’IT-3’UTRexcised mutant 
strains demonstrated two isoforms of TgPKG, where the expression of smaller isoform (112-
kDa/PKGII) was found stronger than the larger one (135-kDa/PKGI). Besides, excision of 
3’UTR resulted in a marked reduction of both TgPKG isoforms in the mutant. Densitometry 
analysis of immunoblots revealed a similar decline in the both isoforms of the mutant clones 
(135-kDa isoform, ~70%; 112-kDa isoform, ~85%) (Figure 22D). The expression of TgPKG-
HA3’IT was detected by immunofluorescence assay in cytoplasm and parasite membrane of 
intracellular parasites, as also reported earlier for PKGII and PKGI isoforms, respectively 
(72,107,108) (Figure 22E). Knockdown of TgPKG-HA3’IT caused a residual HA-staining in 
IFA of the mutant parasites when compared to the progenitor strain, which is also in a 
harmony with immunoblot assay. Besides, the efficiency of Cre-loxP recombination was 
observed at about 93%, as judged by scoring HA+ and HA− vacuoles (Appendix 5B). 
3.1.6 Knockdown of TgPKG phenocopies the TgATPaseP-GC mutant 
The TgPKG knockdown mutant was examined during the lytic cycle of T. gondii 
tachyzoites for any phenotypic consequences (Figure 23 and 24). Cre recombinase-mediated 
3’UTR excision of TgPKG protein led to an analogous inhibition of the parasite growth in 
plaque assays of Pnative-TgPKG-HA3’IT-3’UTRexcised mutant (Figure 23A-C). The mutant 
formed smaller plaques (35% growth defect) when compared with the parental (RHΔku80-
hxgprt-) and progenitor (Pnative-TgPKG-HA3’IT-3’UTRfloxed) strains (Figure 23C), whereas 
plaque numbers did not show any significant difference (Figure 23B). Yet again, comparable 
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to the TgATPaseP-GC mutant (Figure 18D), cell division of the TgPKG mutant was only 
moderately affected, as judged by a smaller fraction of bigger vacuoles containing 16, 32 or 
64 parasites both in early (24 h) and in late (40 h) cultures in comparison to its progenitor 
strain (Figure 23D). When considered together with the results obtained from TgATPaseP-
GC mutant, the data indicates that cGMP signaling is not required for the parasite replication. 
Figure 23. TgPKG mutant showed an analogous growth inhibition phenotype with TgATPaseP-
GC mutant. The progenitor (Pnative-TgPKG-HA3’IT-3’UTRfloxed) and the mutant (Pnative-TgPKG-
HA3’IT-3’UTRexcised) strains were generated as illustrated in the Figure 22B. (A-C) Plaque assay 
revealing comparative growth of the mutant, progenitor and parental (RHΔku80-hxgprt-) strains 
(n=3). (A) HFF monolayers grown in 6-well plates were infected with 150 fresh extracellular parasites 
following 7 days incubation, methanol fixation and crystal violet staining as described in methods. 
(B) The number of plaques of each strain was calculated. (C) The plaque area is shown in arbitrary 
units (a.u.). A total of 140-170 plaques for each strain were scored by ImageJ. Statistics was done by 
Student’s t-test (*, p ≤0.05; ****, p ≤0.0001). (D) Replication rates of indicated strains during early 
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(24 h) and late (40 h) cultures. Intracellular tachyzoites proliferating in their vacuoles were stained 
with α-TgGap45 antibody. The numbers of tachyzoites per vacuole were counted from 400-500 
vacuoles for each strain (n=3 assays). The means are shown with ±S.E.M. 
 
Next, the significance of TgPKG for the key points of lytic cycle; i.e. motility-
dependent invasion and egress processes was investigated. A noteworthy invasion defect 
(~45%) was observed in the TgPKG mutant (Figure 24A). In accord, the mutant exhibited a 
significant decrease in egress, which is noticeable at all tested time points (40-, 48- and 64- 
h) when compared to the parental and its progenitor strains. The defective egress of mutant 
was scored at least 50% in the early incubation times (40- and 48- h), which was more 
outstanding in 48 hpi, though this value was assuaged to 20% in 64 hpi (Figure 24B). It is 
also worth mentioning here that the progenitor TgPKG-HA3’IT itself revealed about 42% 
egress delay (from ~85% to ~50%) in 48 h time point, as observed in the egress profile of the 
TgATPaseP-GC mutant. However, the delay was compensated at the later time (64 hpi) as 
opposed to TgATPaseP-GC mutant. Similarly, the motile fraction dropped by almost 50% in 
the TgPKG knockdown mutant, and trail lengths were accordingly shorter (~24 µm) 
compared to the control strains (~55 µm) (Figure 24C). 
 
Not least, the treatment with C2 (2 µM) further blocked the lytic cycle assays 
(Appendix 6), as expected. The motile fraction went down to ~4% both in the progenitor and 
in the mutant strains. Concordantly, the trail lengths were measured as the average of ~5 and 
~10 µm for the mutant and its progenitor, respectively (Appendix 6A). The impact of C2 on 
the invasion and egress was somewhat stronger in the mutant (Appendix 6B-C), but none of 
the two strains exhibited a complete inhibition, which resonates again with the results of 
TgATPaseP-GC mutant (Figure 20). Collectively, the results clearly show that individual 
repression of TgATPaseP-GC and TgPKG using a 3’UTR excision approach for the protein 
knockdown imposes nearly identical phenotypic defects on the lytic cycle.  
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Figure 24. Mutagenesis of TgPKG recapitulates the phenotype of the TgATPaseP-GC mutant. 
Progenitor (Pnative-TgPKG-HA3’IT-3’UTRfloxed) and mutant (Pnative-TgPKG-HA3’IT-3’UTRexcised) strains 
were generated as illustrated in the Figure 22B. (A-B) Invasion and egress profiles of the TgPKG 
mutant along with the parental and progenitor parasites, as judged by dual-color staining. Intracellular 
tachyzoites were immunostained red using α-TgGap45 antibody, while extracellular ones appeared 
two-colored (red and green) stained with both α-TgGap45 and α-TgSag1 antibodies. (A) In total, 
1000-1200 parasites were evaluated to score the invasion rate of each strain (n= 5 assays). (B) The 
percentage of ruptured vacuoles at indicated periods was determined by observing 400-500 vacuoles 
for each strain from 3 experiments. (C) The motile fraction and trail lengths of the indicated parasite 
strains. About 600 parasites were analyzed for the motile fraction, and 100 trail lengths were measured 
using ImageJ software, following immunostaining with α-TgSag1 (n= 3 assays). Numerical values in 
all graphs show the means with S.E.M. Statistical significance in individual assays was measured by 
comparing the mutant against the parental and progenitor strains (*, p ≤0.05; **, p ≤0.01; ***, p 
≤0.001). 
3.2 Optogenetic modulation of cGMP signaling in T. gondii  
So far, cyclic nucleotide signaling research has been performed utilizing chemical 
modulators (i.e. activators and inhibitors) in combination with reverse genetics, as also 
applied in this study.  Although it is a universal way to examine nucleotide signaling 
pathways, the aforesaid commercial drug usage is not the best method in two-organism 
systems, since it does not allow to selectively modulate the parasite-specific signaling. 
Furthermore, phenotypic consequences of genetic knockouts might be due to the non-specific 
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“knock-on effect” on downstream mediators and do not necessarily reflect the actual 
importance of the target protein, given the very rapid and transient nature of signaling. 
Notwithstanding the existing knowledge of cGMP signaling in the parasite, the affirmative 
evidence demonstrating a direct relationship between the specific induction of signaling 
within the parasite and subsequent activation of downstream molecular and phenotypic 
events is still lacking, because of the inadequacy of routine methods.  
In this thesis, the application of optogenetics was integrated in T. gondii research with 
intent to (i) modulate and/or monitor cGMP signaling in real-time and adjustable manner in 
intracellular parasites without perturbing its host cells, (ii) determine the correlation between 
the activation of cGMP cascade and the onset of phenotypic events (motility-driven egress 
or invasion), (iii) evaluate the downstream impact of cGMP induction on calcium 
homeostasis. In accordance with these purposes, a photo-activated guanylate cyclase 
(RhoGC) from an aquatic fungus Blastocladiella emersonii (135,136) was stably expressed 
in T. gondii tachyzoites which permitted a fast, efficient and spatiotemporal control of cGMP 
signaling by green light (530 nm) exposure in a time-dependent manner during the lytic cycle 
of parasite.  
3.2.1 Stable expression of light-activated RhoGC in tachyzoites 
The RHΔku80-hxgprt- strain of T. gondii was transfected with various plasmid 
constructs carrying RhoGC-ORF (please see the primer sequences in Table 1 and vector maps 
in the appendix 8) to examine whether RhoGC can be functionally expressed in the parasite. 
Four transgenic strains expressing RhoGC under different conditions were generated by 
following strategies (Figure 25):  
1. The full length of RhoGC was tagged with HA-epitope from its C-terminal end. The 
RhoGC-HA fusion was then cloned into the pTKO-DHFR/TS vector whose transfection 
allowed random integration of expression cassette driven by TgGra1 promoter in T. 
gondii genome. Transgenic parasites were selected for the DHFR/TS expression using 
pyrimethamine (1 µM) (56). The resulting strain following limiting dilution from the 
stable pool was named as “RhoGC-HA” in this thesis (Figure 25A). 
 
2. The HA-tagged RhoGC-ORF was firstly cloned into the above-mentioned pTKO-
DHFR/TS plasmid as described in point 1. In the second step of cloning, a ligand-
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controlled ddFKBP destabilization domain (DD) was inserted to the N-terminal of 
RhoGC, which enabled conditional expression of protein. The fusion of DD domain 
caused degradation of RhoGC protein in the absence of its ligand, Shield1, during 
regular culturing of transfected parasites (67). The transgenic strain termed as “DD-
RhoGC-HA” in this study was supplemented with Shield1 (0.5 µM) 24 h prior to 
setting experiment to ensure protein expression (Figure 25B).  
 
3. The ORF of RhoGC was fused with 3xHA-epitope at the C-terminus and cloned into 
pDHFR-UPKO plasmid, which permitted a weak to moderate expression of RhoGC 
flanked by TgDHFR/TS regulatory elements (5’- and 3’- UTR). The transfection of this 
vector into tachyzoites enabled a single copy insertion of RhoGC-3xHA expression 
cassette to the UPRT locus. The transgenic strains named as “RhoGC-3xHA” were 
selected for the loss of UPRT using 5-fluorodeoxyuridine (FudR) (5 µM) (58) (Figure 
25C).    
 
4. To monitor the relationship between cGMP signaling and Ca+2 homeostasis within the 
parasite, a genetically-encoded calcium sensor GCaMP6s (146) was co-expressed with 
RhoGC-3xHA, both targeted at the UPRT locus. To achieve this, GCaMP6s-ORF was 
first cloned into pGRA1-UPKO vector to express it under strong TgGra1 promoter since 
it is  known from a former study conducted in our group that the high expression of 
GECI does not affect the parasite growth (147). Thereafter, the whole GCaMP6s 
expression cassette was amplified and inserted into the constructed pDHFR-UPKO-
RhoGC-3xHA plasmid described in point 3 from the end of RhoGC-3xHA expression 
cassette within the UPRT locus (Figure 25D). The orientation of GCaMP6s cassette 
was confirmed by DNA sequencing. The eventual vector was introduced into the 
RHΔku80-hxgprt- strain to generate an optogenetic parasite termed “RhoGC-3xHA-
GCaMP6s” in this study (Figure 25D). 
The successful insertion and transcription of full length ORF of RhoGC and/or 
GCaMP6s were confirmed by PCR screening using cDNAs of clonal optogenetic strains 
(Appendix 7). Positive clones were further verified by the sequencing of PCR amplicons 
whose size were detected as 1900 and 1354 bp for RhoGC and GCaMP6s, respectively 
(Appendix 7).  
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Figure 25. Different strategies for expression of photo-activated guanylate cyclase (RhoGC) in 
T. gondii tachyzoites. (A-B) Schematic illustrations for random integration of HA-tagged RhoGC 
(RhoGC-HA) driven by TgGra1 promoter and TgGra2-3’UTR. The NaeI-linearized plasmids were 
transfected into the parental strain (RHΔku80-hxgprt-) to express RhoGC-HA either constitutively 
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(A), or conditionally (B) by introducing destabilization domain (ddFKBP) at the N-terminus of 
RhoGC, which enables RhoGC expression in the presence of Shield1. The optogenetic strains were 
selected by pyrimethamine (1 µM) for DHFR/TS selection cassette (S.C). (C) Scheme for a single 
copy insertion of 3xHA-tagged RhoGC (RhoGC-3xHA) by double homologous recombination 
targeting the TgUPRT locus. The transgenic strain expressed RhoGC-3xHA under a weaker 
TgDHFR/TS promotor, following drug-selection by FudR (5 µM) (The strain was generated by 
Claudia Ufermann in the scope of her project module studies under my lab supervision). (A-C) The 
resulting transgenic lines were immunostained by α-HA antibody for RhoGC co-localization. α-
TgGap45 antibody was used as a control to stain IMC (24 h post infection). The merged images 
include DAPI-stained host and parasite nuclei in blue. Immunoblots using α-HA antibody exhibit the 
successful expression of RhoGC in all transgenic lines. DD-RhoGC-HA strain showed Shield1-
dependent RhoGC expression both in IFA and immunoblot assays. Shield1 (0.5 µM) treatment was 
performed for 24 h prior to assays. Protein samples of the parental strain (RHΔku80-hxgprt-) were 
used as a negative control, and α-TgHSP90 antibody served as a loading control. (D) Scheme 
depicting tail-to-tail expression strategy of RhoGC-3xHA flanked by TgDHFR/TS regulatory 
elements and GCaMP6s-ORF expressed under the TgGra1-5’UTR and TgGra2-3’UTR, both targeted 
at the TgUPRT locus. Positive strains were subjected to IFA and immunoblot with α-HA (for RhoGC) 
and α-GFP (for GCaMP6s) antibodies. α-TgHSP90 and α-TgSagI antibodies were used as loading 
controls (The transgenic strain was made by Elena Pies during her master studies under my lab 
supervision).  
Subsequently, all aforesaid optogenetic strains were subjected to immunostaining assay 
with the IMC marker TgGap45 antibody, resulted in cytosolic as well as perinuclear 
localization of HA-tagged RhoGC in intracellular parasites (Figure 25A-D). The intensity of 
HA-staining explicitly differed between the strains generated by random integration under 
strong promoter (RhoGC-HA and DD-RhoGC-HA) and a single gene copy insertion under 
weaker promoter (RhoGC-3xHA and RhoGC-3xHA-GCaMP6s) strategies. The perinuclear 
staining of RhoGC was more obvious in RhoGC-3xHA and RhoGC-3xHA-GCaMP6s 
strains.  On the other hand, co-staining of EGFP domain of GCaMP6s sensor with RhoGC-
3xHA revealed the distribution of GCaMP6s in the parasite cytosol of RhoGC-3xHA-
GCaMP6s strain (Figure 25D), as reported earlier (147). 
The successful expression of RhoGC was also demonstrated by an immunoblot 
analysis using α-HA antibody (Figure 25A-D). An apparent protein band of approximately 
76-kDa was detected for RhoGC expression in all optogenetic strains apart from DD-RhoGC-
HA, in which an expected band size of ~88-kDa was determined due to the fusion of DD-
tag. Besides, DD-RhoGC-HA strain showed a Shield1-dependent expression of RhoGC both 
in immunofluorescence and immunoblot assays as a proof of concept for conditional 
regulation of protein, although a weak background of HA-staining could still be observed in 
the absence of Shield1 (Figure 25B). The number of parasites used to prepare protein samples 
for western blot analysis varied between the strains. While 107 parasites were enough to show 
the RhoGC expression in RhoGC-HA and DD-RhoGC-HA strains (Figure 25A-B), this 
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number was increased to 2x107 for RhoGC-3xHA and RhoGC-3xHA-GCaMP6s strains due 
to relatively weaker RhoGC expression under TgDHFR/TS promoter (Figure 25C-D). 
Similarly, the immunoblot of GCaMP6s using α-GFP antibody resulted in a ~55-kDa protein 
band on the membrane blot from 107 parasites of RhoGC-3xHA-GCaMP6s co-expressing 
culture (Figure 25D).  
Taken together, these data confirmed the integrity of RhoGC and/or GCaMP6s 
constructs in newly engineered transgenic strains of T. gondii, which was essential to 
establish an optogenetic system in the parasite tachyzoites. Having multiple optogenetic 
strains provided the flexibility of different target-oriented applications.   
3.2.2 Expression of RhoGC is not detrimental to tachyzoites 
The overall growth fitness of the aforementioned transgenic parasite strains expressing 
light-activated RhoGC were examined by plaque assays which comprise 3-4 consecutive 
lytic cycles of parasite cultures. The parental strain (RHΔku80-hxgprt-) was also included 
into the assays as a control (Figure 26). 150 parasites were counted from each cultures and 
released into a 6-well plate seeded with confluent host cells without any supplement, i.e. 
retinal, drug-selection or Shield1, which allowed to compare all strains under the standard 
culturing conditions. Cultures were incubated for 7 days without perturbation to let parasites 
producing plaques. Methanol-fixed and crystal violet-stained wells were evaluated by 
relative plaque numbers and plaque area (Figure 26A). The average plaque numbers of all 
strains including parental strain ranged from 75 to 85 without any significant difference 
(Figure 26B). Importantly, the expression of RhoGC did not cause any negative impact on 
the plaque size produced by optogenetic strains in comparison to the parental strain (Figure 
26C). Considering these data, it can be said that the expression of RhoGC or co-expression 
of RhoGC with GCaMP6s does not have any toxic effect on the parasite growth, which 
permitted further comparison and testing of subsequent optogenetic assays.  
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Figure 26. Expression of light-activated RhoGC does not affect the growth of tachyzoites. (A) 
Images illustrating a representative plaque assay of RhoGC-expressing optogenetic strains in 
comparison to the parental (RHΔku80-hxgprt-) strain. 6-well plates with confluent HFF monolayers 
were infected with freshly syringe-released parasites (150) and then incubated for 7 days in a standard 
culture medium without intervention. Following incubation, cultures were fixed with methanol and 
stained with crystal violet. Blank areas represent plaques formed by each infective parasite, and purple 
staining denotes host cell monolayers. (B) The average plaque numbers were scored for all parasite 
strains from three independent assays. (C) The area of each plaque (arbitrary units, a.u.) was measured 
by ImageJ software. About 200-250 plaques for each strain (n=3) were evaluated for the growth 
phenotype. Statistical analysis was performed by Student’s t test (mean with ±S.E.M). (Assays were 
performed by Elena Pies and counted by Anika Freitag within the scope of their master theses under 
my lab supervision).  
3.2.3 Kinetics of GMP induction in RhoGC-expressing tachyzoites  
To test whether RhoGC is functional in T. gondii tachyzoites, the optogenetic strains 
were investigated for induction of cGMP by green light (530 nm, 197,4 µW/cm2) (Figure 
27). Among four optogenetic strains (section 3.2.1), two strains were selected for functional 
testing: (i) DD-RhoGC-HA strain expressing RhoGC conditionally under a strong TgGra1 
promoter, (ii) RhoGC-3xHA parasite strain expressing a single RhoGC copy driven by 
weaker TgDHFR/TS regulatory elements. The effect of green light-exposure was evaluated 
in fresh syringe-released extracellular parasites supplemented with retinal (1 µM) and 
Shield1 (0.5 µM, if required) prior to experiment. Seven samples, each containing 2.5x106 
parasites in 100 µl of colorless DMEM aliquot, were prepared from optogenetic cultures. In 
principle, one sample aliquot was always kept in the dark to determine the steady-state cGMP 
level of parasites. Each of the remaining samples was then released in a well of a black-wall 
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24 well-plate, followed by a light illumination from the bottom using the LED device 
described elsewhere (section 2.7.1).  Parasite samples were stimulated by the light pulses at 
530 nm in 197,4 µW/cm2 intensity, but with different durations (varies from 30 sec to 5 min). 
The assay was immediately quenched following light illumination, and cGMP levels of 
parasites were measured by commercial “DetectX High Sensitivity Direct cGMP kit” (Figure 
27A).  
As seen in Figure 27A, optogenetic strains (DD-RhoGC-HA and RhoGC-3xHA) 
responded disparately to the green light exposure as reflected by cGMP levels of the parasites 
over the illumination time. cGMP amount in dark sample was about 220 fmol/106 parasites 
in DD-RhoGC-HA strain (Figure 27A-B). The RhoGC expressed in DD-RhoGC-HA strain 
was activated within 1 min of light exposure, thus 2-fold increase (~450 fmol/106 parasites) 
in cGMP level was observed when compared to the basal state (dark) measurement (Figure 
27A). The longer photo-stimulation gradually elevated cGMP amount in the DD-RhoGC-HA 
strain, which was measured as ~1.48 pmol/106 parasites after 3 min illumination (Figure 
27A). A 5 min green light exposure to the optogenetic strain caused ~16.5-fold increase in 
the cGMP level (~3.45 pmol/106 parasites) (Figure 27A-B). A nearly linear increase in cGMP 
induction (as a result of light illumination from 1 min to 5 min) suggests that the level of 
cGMP is not saturated yet in the DD-RhoGC-HA strain. Besides, GTP as a cellular resource 
is not a limiting factor to restrict cGMP induction in extracellular parasites.  
On the other hand, cGMP level in dark sample of RhoGC-3xHA strain was slightly less 
(~180 fmol//106 parasites) than the measured in the DD-RhoGC-HA (Figure 27A). A 1 min 
green light exposure was not enough to activate RhoGC expressed under the weaker 
TgDHFR/TS promoter in the RhoGC-3xHA strain. However, cGMP level increased slightly 
in culture after 2 min illumination (~235 fmol//106 parasites). A 3 min exposure caused to 
double the amount of cGMP (~398 fmol//106 parasites) in comparison to dark sample. After 
4 min light illumination, ~1055 fmol of cGMP per a million extracellular parasites was 
quantified (Figure 27A). Additional light exposure did not show any significant influence in 
cGMP level, indicating a maximal catalytic activity of RhoGC in the RhoGC-3xHA strain. A 
5 min green light exposure of RhoGC-3xHA strain revealed about 6.3-fold induction of the 
basal cGMP level in the extracellular parasites (Figure 27B).  
These data confirm that the light-activated RhoGC was functional in T. gondii 
tachyzoites, which allowed an optogenetic control of cGMP in time-dependent manner. 
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Working with extracellular parasites enabled to evaluate the intrinsic cGMP levels in T. 
gondii without an involvement of host-cell originated cGMP. The effect of light illumination 
was stronger in DD-RhoGC-HA when compared to the RhoGC-3xHA strain, which is also 
consistent with the level of RhoGC expression. Besides, the cGMP profile of RhoGC-3xHA 
permitted to select the optimal duration of light illumination (5 min) for downstream assays. 
Figure 27. Expression of RhoGC in tachyzoites allows cGMP induction by green light. HFFs 
grown in Petri dishes were infected (MOI:1.5) with RhoGC-expressing transgenic lines (DD-RhoGC-
HA, RhoGC-3xHA) and incubated for 38-40 h in D10 medium supplemented by 1 µM of retinal and 
0.5 µM of Shield1 (if required). Mature parasite cultures were scraped, syringe-released (2x27G) to 
set parasites free and filter-passed (5 µm) to eliminate host-cell debris. (A) Fresh extracellular 
parasites (2.5x106) were exposed to green light (530 nm, 197,4 µW/cm2 intensity) in colorless DMEM 
medium for indicated durations, followed by cell lysis immediately by sample diluent provided by 
commercial “DetectX High Sensitivity Direct cGMP kit” (K020-C1, Arbor Assays). cGMP amounts 
were measured following kit instructions, and the data was normalized per 106 parasites (n=2). (B) 
Induction of cGMP in two different RhoGC-expressing transgenic parasite strains following 5 min 
green light exposure (n=2). The bars show the mean with ± S.E.M. 
3.2.4 Photo-stimulation of RhoGC induces motility, invasion and egress 
The importance of native cGMP signaling for the successful lytic cycle of T. gondii has 
been already described by experimental evidences in the first part of this thesis (section 3.1). 
Having functional optogenetic strains enabled to investigate the direct effect of increased 
subcellular cGMP levels on distinct steps of lytic cycle. Prior to setting up experiments, 
intracellular tachyzoites were incubated for 38-40 h with 1 µM of retinal. DD-RhoGC-HA 
strain was also supplemented with 0.5 µM of Shield1 to stabilize the expression of RhoGC. 
Fresh syringe-released parasites were subjected to motility, invasion and egress assays. A 5 
min light illumination (530 nm) with defined intensity (197,4 µW/cm2) was performed on 
the RhoGC-HA, DD-RhoGC-3xHA, RhoGC-3xHA and RhoGC-3xHA-GCaMP6s strains. 
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Besides the dark samples of optogenetic strains, the parental strain (RHΔku80-hxgprt-) was 
also included in all assays as a negative control (Figure 28).  
Figure 28A shows the representative gliding motility images of all strains in dark and 
light conditions. The fraction of motile parasites in the parental culture was not affected by 
light, as expected. Besides, the average motile fraction of dark samples of all transgenic 
strains was also similar to the parental strain, which indicates the absence of dark activity in 
RhoGC-expressing strains (Figure 28B). The excitation of RhoGC by light stimulated the 
gliding motility of optogenetic strains leading at least 2-fold increase (from ~30% to ~60%) 
in the motile fraction of all four optogenetic parasite strains when compared to their 
respective dark cultures (Figure 28B). Likewise, the average trail lengths of moving parasites 
in dark samples of all strains including the parental line ranged from 22 to 25 μm without 
any significant difference. The light exposure resulted in making three times longer trails 
(~60-63 μm) in all RhoGC-expressing parasite strains (Figure 28C). 
Next, the invasion and egress efficiencies of RhoGC-expressing strain were tested 
(Figure 28D-E) in response to the green light because these events are dependent on the 
gliding motiliy (42,100,106). The invasion rate of dark samples of optogenetic strains was 
scored quite similar to the invasion efficiency of the parental strain, exhibiting approximately 
36-42% invading parasites (Figure 28D). This rate was enhanced to ~60% (as the observed 
highest level) in RhoGC-HA strain after light exposure, corresponding to 1.5-fold increase, 
when compared to dark samples of all strains. On the other hand, DD-RhoGC-HA, RhoGC-
3xHA and RhoGC-3xHA-GCaMP6s strains behaved similarly to the green light illumination 
showing an enhanced invasion (~55-57%) in comparison to their respective dark samples 
(Figure 28D).  
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Figure 28. Activation of RhoGC stimulates motility-dependent invasion and egress. Tachyzoites 
of the indicated strains were used to examine the impact of RhoGC activation in (A-C) motility, (D) 
invasion and (E) egress as described in section 2.7.2. Optogenetic strains were induced by the green 
light (197.4 μW/cm² intensity, 530 nm wavelength) or kept in the dark for the assays. Parental 
(RHΔku80-hxgprt-) strain was included as a negative control. (A) Representative images of the 
gliding motility on the BSA-coated glass coverslips. Parasites and their trails were immunostained 
with α-TgSag1 antibody. The scale bars represent 10 µm. (B-C) To evaluate gliding motility, around 
1000 parasites were analyzed for motile fraction, and a total of 500-600 trail lengths for each strain 
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was measured by ImageJ under each condition. (D-E) Invasion and egress rates were scored by 
counting of parasites and vacuoles, respectively, after the dual staining with α-TgGap45 and α-TgSag1 
antibodies as explained in methods section. At least 800 parasites or vacuoles per each strain were 
examined for invasion and egress efficiency, respectively. The data were evaluated from three 
independent experiments, each with two replicates, for the motility, invasion and egress assays. (Lytic 
cycle assays were set by Elena Pies and Anika Freitag followed by evaluation of results individually 
from one replicate within the context of their master thesis under my supervision. The obtained data 
were pooled in this thesis). Statistical comparing light and dark samples was performed by Student’s 
t test. The significance was measured of each individual strain (*, p ≤0.05; **, p ≤0.01; ***, p ≤0.001; 
****, p ≤0.0001; the means with ±S.E.M). 
Although invasion profiles of optogenetic strains conform with the motility data by 
showing almost the same proportion of increase in response to light, the egress phenotypes 
of strains differed from each other (Figure 28E). All dark samples of studied parasite strains 
including the parental exhibited an about 8-13% natural egress 24 h post infection. The light-
exposed transgenic parasite samples demonstrated an explicitly higher but different rates of 
egress in comparison to their dark samples. Almost all parasites were egressed in DD-
RhoGC-HA strain after 5 min illumination. However, the percentage of egressed vacuoles in 
light-stimulated RhoGC-HA strain was only counted as ~40%, although it shares features 
(i.e. promoter strength, random insertion) with DD-RhoGC-HA line except for ddFKBP-
tagging. On the other hand, RhoGC-3xHA and RhoGC-3xHA-GCaMP6s lines were 
consistent in their light-illuminated egress profile, both revealing ~2.5-fold increase with 25-
27% egressed vacuole (Figure 28E).  
Collectively, these results reveal that the photo-activation of RhoGC in tachyzoites 
augments the motility, invasion and egress events. Besides, the data are consistent with the 
genetic knockdown studies of TgATPaseP-GC and TgPKG, which indicates the importance 
of cGMP regulation for the lytic cycle of parasite. 
3.2.5 Co-expression of RhoGC and GCaMP6s in tachyzoites to study the impact of 
cGMP on Ca2+  
cGMP and Ca2+ signaling pathways are essential for the asexual reproduction of 
T. gondii. They are tightly coordinated with each other to assure the successful lytic cycle 
(42,115,185). The optogenetic strain co-expressing RhoGC-3xHA and GCaMP6s was used 
to measure the cytosolic Ca2+ in response to light activation of RhoGC in tachyzoites. In this 
regard, intracellular parasites of RhoGC-3xHA-GCaMP6s strain were tested whether the 
induction of cGMP by light also leads to an increase in calcium level. Binding of calcium to 
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GCaMP6s causes an enhancement in EGFP fluorescence, which allows dynamic monitoring 
of cytosolic calcium in the parasite (Figure 29).  
HFF-monolayers grown on the glass coverslips were infected with RhoGC-3xHA-
GCaMP6s strain (MOI:1.5) and incubated for 40 h. Intracellular parasites within mature 
vacuoles were illuminated by light (530 nm, 197,4 µW/cm² intensity) from the bottom with 
different durations (1 min, 2 min or 5 min) using the LED device described in section 2.7.1 
or kept in dark, followed by immediate fixation of samples. The GFP fluorescence of 
vacuoles was analyzed under the microscope empirically (low-medium-high) to examine 
whether cGMP induction can promote Ca2+ increase in tachyzoites (Figure 29A). 
As shown in Figure 29B, ~60% of the vacuoles in RhoGC-3xHA-GCaMP6s strain 
exhibited the background GFP signal in the dark (standard culture) condition. The fraction of 
vacuoles with high signal intensity was only about 8%. Exposure to light for 1 min had a 
minor influence on cGMP induction (Figure 27A), which also correspondingly monitored on 
calcium levels (Figure 29B). The percentage of the vacuoles with low, medium and high GFP 
fluorescence was scored as about 40%, 44% and 16%, respectively in response to 1 min light 
exposure. The fluorescence profile did not change much after 2 min illumination (Figure 
29B), as also similarly observed in cGMP levels (Figure 27A). However, 5 min exposure 
caused a significant 5-fold increase (up to 40%) in the fraction of vacuoles with high GFP 
signal when compared to the dark sample, which is yet again compatible with the cGMP 
measurement assay (Figure 27). Accordingly, the rate of vacuoles with low GFP intensity 
decreased from ~60% to ~18% after 5 min illumination (Figure 29B).  
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Figure 29. Light induction of RhoGC leads to increased cytosolic calcium. An optogenetic strain 
co-expressing the light-activated RhoGC and calcium sensor GCaMP6s was generated as described 
in section 3.2.1. (A) Representative pictures of mature vacuoles (36-42 hpi) of RhoGC-3xHA-
GCaMP6s strain exhibiting EGFP-derived fluorescence of GCaMP6s in response to the green light 
(530 nm, 197,4 µW/cm²). The samples of transgenic strain were exposed to the green light for 1 min, 
2 min, or 5 min or kept in the dark, followed by gently fixation. The images were created at 250 msec 
exposure time. The scale bars represent 20 µm. (B) In total, 500 vacuoles from 3 assays were scored 
empirically for GFP fluorescence intensity as low, medium or high. Statistical analysis was performed 
using the Student’s t-test. Significance refers to the dark samples; *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 
0.001, the means with ±S.E.M. (The assay was performed by Elena Pies in the scope of master thesis 
under my supervision). 
These data indicate a direct linkage between cGMP and Ca2+ signaling and support to 
the notion that calcium is released from the storage organelles to the cytosol, once 
intracellular cGMP level is increased in the parasites. It also seems that a threshold induction 
of cGMP is required to stimulate calcium release in the parasite. The successful application 
of optogenetic approach provides an opportunity to discern the effect of cGMP on calcium 
homeostasis during the lytic cycle. 
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4 Discussion 
4.1 Evolutionary characteristics and possible multi-functionality of TgATPaseP-GC  
The first part of this study (186) characterized an alveolate-specific protein, termed 
TgATPaseP-GC herein, which imparts a central piece of cGMP signaling conundrum in T. 
gondii. The research conducted within this thesis provides a comprehensive functional and 
structural insight into the initiation of cGMP signaling in T. gondii in conjunction with three 
recently published independent studies while this work has been performed (99,153,154). 
The parasite encodes an unusual and multifunctional protein (TgATPaseP-GC) primarily 
localized in the plasma membrane at the apical pole of the tachyzoite stage. Previous reports 
have concluded a surface localization of TgATPaseP-GC by inference, which we reveal to be 
the plasma membrane as opposed to the inner membrane complex (Figure 15C).  
Interestingly, a confined localization of GCβ in a unique spot of the ookinete membrane 
was recently reported to be critical for the protein function in P. yoelii (152). Similar work in 
T. gondii (99) demonstrated that deletion or mutation of ATPase domain in TgATPaseP-GC 
mislocalized the protein to the ER and cytosol, whereas deletion or mutation of GC domains 
did not affect the apical localization. An impaired secretion of micronemes was observed in 
both cases, suggesting the importance of ATPase domain both for localization and function. 
Earlier, it was reported that the long isoform of TgPKG (TgPKGI) associated with the plasma 
membrane is essential and sufficient for PKG-dependent events during the lytic cycle, 
however the shorter cytosolic isoform (TgPKGII) is inadequate and dispensable (72). It was 
illustrated in this thesis that C-terminal of TgATPaseP-GC faces inside the plasmalemma 
bilayer (Figure 15B), where it should be in spatial proximity with TgPKGI to allow efficient 
induction of cGMP signaling. Moreover, it was also shown that TgATPaseP-GC is expressed 
throughout the lytic cycle of tachyzoites but required only for their entry or exit from host 
cells, which implies a post-translational activation of cGMP signaling.  
This work along with others (99,153,154) reveals that TgATPaseP-GC is essential for a 
successful lytic cycle. Its knockdown by 3’UTR excision using Cre/loxP method confirmed 
a physiological role of cGMP for the invasion and egress. The effect however was reflected 
at most in motility of parasite. The treatment of cGMP agonists, BIPPO and zaprinast, 
resulted in a fast rescue of motility defect; while inhibition of TgPKG by compound 2 further 
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blocked the gliding motility in TgATPaseP-GC mutant, which indicates once more the 
regulatory effect of cGMP signaling on the infectivity of tachyzoites. On the contrary, the 
knockdown of TgATPaseP-GC revealed that the protein is not required for parasite 
replication, as also confirmed by two recent studies (99,154). In further work, the depletion 
of TgPKG by using the same knockdown approach phenocopied the TgATPaseP-GC 
knockdown mutant, which resonates again with a previous work (72).  
The predicted topology of TgATPaseP-GC harboring 22 transmembrane helices within 
this thesis differs from the work of Yang et al. (154) suggesting the occurrence of 19 helices, 
but echoes with the two other reports (99,153). The similar organization of the 
transmembrane helices was also reported previously for GCα and GCβ of P. falciparum as 
well as GC of Paramecium (97,150). Besides, in silico analysis of TgATPaseP-GC offers 
valuable insights into bifunctional arrangement as well as regulatory and catalytic functions 
of ATPase and GC domains in TgATPaseP-GC, respectively. GC1 and GC2 of TgATPaseP-
GC dimerize to form only one pseudo-symmetric catalytic center in contrast to the 
homodimer formation in mammalian pGCs (89,176,177). GC1 and GC2 have probably 
evolved by gene duplication causing degeneration of the unused second regulatory binding 
site in protists, as reported in tmACs (176,177,187). Contrary to tmACs, the conserved 
residues that are involved in heterodimerization are found as inverted in GC1 and GC2 of 
TgATPaseP-GC, which is consistent with the previous report of PfGCα and PfGCβ (150). The 
function of TgATPaseP-GC as a guanylate cyclase aligns rather well with its predicted 
substrate specificity for GTP, though its contribution for cAMP synthesis (if any) remains to 
be tested. Several attempts to functionally complement maltose metabolism of an adenylate 
cyclase-deficient E. coli mutant (161) by expressing only guanylate cyclase domain of 
TgATPaseP-GC were not fruitful in this study; however it could still be demonstrated that the 
repression of TgATPaseP-GC leads to a comparable reduction in cGMP level of parasite 
(Figure 17E), which indicates its guanylate cyclase function.  
Unlike the C-terminal guanylate cyclase of TgATPaseP-GC, the exact function of N-
terminal ATPase domain remains rather obscure. The latter resembles P4-ATPases similar to 
other alveolate GCs (97,98,151). Lipids and cation homeostasis have been shown to influence 
the gliding motility and associated protein secretion, which in turn drives the egress and 
invasion events (100,102,104,188,189). There is a little evidence though, how lipid and 
cation-dependent pathways embrace each other. It thus tempts to propose a nodal role of 
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TgATPaseP-GC in asymmetric distribution of phospholipids in the lipid bilayer, and cation 
flux (e.g., Ca2+, K+, Na+) across the plasma membrane. The recent studies (99,153) also entail 
a regulatory role of P4-ATPase domain on the functioning of GC domain. Conversely, the 
GC domain of GCβ was found sufficient to produce cGMP independently of the ATPase 
domain in P. yoelii (152). This may be due to degenerated conserved sequences in the ATPase 
domain of PfGCβ, as shown in the sequence alignment (Appendix 2). Equally, the expression 
of PfGCα and PfGCβ resulted in the functional protein only for PfGCβ, but not for PfGCα 
(151). Likewise, the heterologous expression of GC catalytic domains of TgATPaseP-GC in 
E. coli and subsequent GC assays did not yield to cGMP production in this study. As shown 
by phylogeny (Figure 12), TgATPaseP-GC is more homologous to PfGCα (Identity, 43%; E 
value, 3E-140), which may explain the differences in the PfGCβ and TgATPaseP-GC mutants.  
Two additional components, cell division component 50 (CDC50.1) and unique GC 
organizer (UGO), were suggested to secure the functionality of TgATPaseP-GC by interacting 
with ATPase and GC domains, respectively (153). It was already known that most of the 
mammalian P4-ATPases require CDC50 proteins as accessory subunits which are 
transmembrane glycoproteins ensuring formation of active P4-ATPase complex (170,190). A 
similar interaction between GCβ and CDC50A protein was also shown in P. yoelii (152). The 
CDC50.1 expressed in T. gondii was also found in connection with the P4-ATPase domain 
of TgATPaseP-GC to facilitate the recognition of phosphatidic acid, and thereby regulating 
the activation of GC domain. The second interacting partner UGO on the other hand was 
proposed to be essential for the activation of GC domain after phosphatidic acid binding 
(153). Additionally, the study of Yang et al. (154) showed that the depletion of TgATPaseP-
GC impairs the production of phosphatidic acid, which is consistent with our postulated lipid 
flipping function of P4-ATPase domain in TgATPaseP-GC. However, a systematic 
experimental analysis is still required to understand the intramolecular coordination of 
ATPase and guanylate cyclase domains. 
The topology, subcellular localization, modelled structure as well as depicted multi-
functionality of TgATPaseP-GC strikingly differ from the particulate GCs of mammals. Other 
distinguished features of mammalian pGCs, such as extracellular ligand binding and 
regulatory kinase-homology domains, are also absent in TgATPaseP-GC, which exhibits an 
evolutionary specialization of cGMP signaling in T. gondii. Likewise, other PKG-
independent effectors of cGMP, i.e. nucleotide-gated ion channels as reported in mammalian 
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cells (80,85,191), could not be identified in the genome of T. gondii, which suggests a rather 
linear transduction of cGMP pathways through PKG. Notably, the topology of TgATPaseP-
GC is shared by the members of another alveolate phylum Ciliophora (e.g., Paramecium, 
Tetrahymena) (97) which exhibits an entirely different lifestyle. Also, a guanylate cyclase 
with 2 catalytic domains but lacking ATPase-like region is present in Dictyostelium (member 
of amoebozoa) (192). Such a conservation of cGMP signaling architecture in several 
alveolates with diverse lifestyles signifies a convoluted repurposing of signaling within the 
protozoan kingdom. A divergent origin and essential requirement of cGMP cascade can be 
exploited to selectively inhibit the asexual reproduction of the parasitic protists. 
4.2 Optogenetic control of cGMP in T. gondii tachyzoites 
 The previous work performed by Hartmann et al. (149) has successfully produced 
optogenetic T. gondii strains to modulate cAMP signaling using a photo-activated adenylate 
cyclase (bPAC) (130). It was the first study pioneering the application of optogenetics in 
infection research. Though several applications have been proposed meanwhile (127), there 
has not been any study conducted in this direction. The attempts were made in earlier work 
to express mutagenized version of bPAC (bPGC), which produces cGMP in response to light 
exposure (131), to regulate cGMP signaling in T. gondii. The expression of bPGC however 
resulted in the cAMP production alongside cGMP, which is not optimal when specifically 
targeting to control of cGMP signaling. After a while, a light-activated guanylate cyclase 
(RhoGC) (135) was discovered from an aquatic fungus. The electrophysiological 
characterization of RhoGC in different heterologous expression systems revealed its cyclase 
specificity for cGMP production (136). In this regard, we believed that RhoGC should prove 
particularly useful to study cGMP signaling in T. gondii tachyzoites.  
 Within the scope of this thesis, four different transgenic Toxoplasma strains expressing 
RhoGC under different conditions were generated. The expression of RhoGC showed a 
cytosolic as well as perinuclear, presumably ER, localization in tachyzoite stage of parasite 
(Figure 25), due to the presence of multiple transmembrane helices in the protein structure 
(136). The insertion of RhoGC did not exert any detrimental effect on the parasite growth. 
The functional expression enabled the induction of cGMP simply by light within the parasite 
without affecting the sheltering host cells. Shining green light on extracellular parasites of 
two different transgenic strains (DD-RhoGC-HA and RhoGC-3xHA) showed a differential 
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and dynamic regulation of cGMP in the parasite (Figure 27). Having multiple optogenetic 
strains enabled to make some inferences and optimize several parameters during this work. 
Some of them are summarized below:  
1) The expression level of RhoGC influences the induction of cGMP in proportion. 
For instance, a single copy of RhoGC under a relatively weak TgDHFR/TS regulatory 
elements in RhoGC-3xHA strain delivered a moderate expression when compared to its 
expression under stronger TgGra1 promoter in DD-RhoGC-HA strain (Figure 25). Although 
the basal (dark) levels of cGMP were almost the same in these aforesaid strains, light 
exposure resulted in differential induction of cGMP (6.3-fold increase versus 16.5-fold-
increase) after 5 min illumination (530 nm, 197.4 μW/cm2 intensity). These strains can 
therefore serve for a flexible and goal-oriented modulation of cGMP in diverse experimental 
setups. Besides, DD-RhoGC-HA allows to regulate the expression of RhoGC by chemical 
treatment in ligand-dependent manner, which prevents an unintended expression in regular 
cultures. The conditional expression of RhoGC also exhibited much stronger cGMP 
induction in DD-RhoGC-HA in comparison to the RhoGC-3xHA strain.    
2) Light intensity-dependent control of RhoGC does not seem so critical for the 
performance of RhoGC. Previous studies have shown that cGMP production by RhoGC 
remained the same in Xenopus oocytes (136) and in vitro activity assays (128) even when the 
light was gradually increased after reaching the half-maximal light intensity value in a given 
expression model. After some optimization steps, the light intensity was fixed to 
197.4 μW/cm2 throughout this study.  
3) The duration of illumination is another important determinant in the assays. 
Variable exposure times were utilized from 0.5 to 5 min for the cGMP assay performed with 
extracellular parasites of optogenetic T. gondii strains (Figure 27). The assay results revealed 
that RhoGC differentially responds to light exposure in different strains, accordingly the 
exposure time to reach the maximal cGMP induction varies between strains. 30 sec light 
pulse was not enough to stimulate cGMP production in neither DD-RhoGC-HA nor RhoGC-
3xHA strains, although flashing light for few seconds was sufficient to induce cGMP levels 
in other heterologous systems; such as in Xenopus oocytes, HEK293T or Chinese hamster 
ovary cells (128,136). Both DD-RhoGC-HA and RhoGC-3xHA strains exhibited a moderate 
cGMP induction until reaching 0.4-0.45 pmol (per 106 parasites) cGMP levels after 1 min 
and 3 min exposure, respectively. The subsequent illumination (from 1 min to 5 min) showed 
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almost a linear increase of cGMP in DD-RhoGC-HA strain. In addition, this strain had still a 
tendency to increase cGMP level, which suggests that the amount of cGMP is not saturated 
yet in DD-RhoGC-HA strain after 5 min illumination. However, the maximal induction of 
cGMP in RhoGC-3xHA was limited with 1 pmol/106 parasite after 4 min illumination. An 
additional exposure did not increase cGMP level in RhoGC-3xHA strain. Consequently, at 
least 3 min light pulse is required to reach a minimum threshold to assure an exponential 
cGMP induction in our optogenetic strains. Based on the cGMP profile of RhoGC-3xHA 
strain, 5 min light illumination was applied to test the functional effect of RhoGC in all 
optogenetic strains during lytic cycle assays.  
Designing an optogenetic device offered an easy control of illumination parameters. 
A 24-well plate compatible LED-device built specifically for this study (section 2.1.7) 
facilitated the application of optogenetics in T. gondii research. It enabled to minimize the 
variations between independent assays by stabilizing the assay conditions, such as excitation 
wavelengths, light intensity and durations via a designed graphical user interface. Such low-
cost devices also allow to standardize the research parameters between laboratories. Although 
some optogenetic setups are available specifically for Neurobiology researches (193-195), 
development of new target-oriented devices compatible to different systems is an emergent 
requirement nowadays to integrate the application of optogenetics in wider fields.  
Application of optogenetics in T. gondii showed a direct link between induction of 
cGMP signaling in the parasite and regulation of lytic cycle events. The percentage of 
motility, invasion and egress in dark samples of different optogenetic strains were quite 
similar with the parental strain, which confirms functional stability and robust light-
dependent cyclase activity of RhoGC in T. gondii. Expression of RhoGC in different models 
also did not display any dark activity (128,136,137). Furthermore, light-induced phenotypes 
were consistent across all optogenetic strains. The comparison of cGMP induction assay and 
phenotype data of DD-RhoGC-HA and RhoGC-3xHA strains also reveals a relationship 
between cGMP thresholds and phenotypic consequences. cGMP levels were measured as 
~1.1 pmol and ~3.45 pmol per 106 parasites in RhoGC-3xHA and DD-RhoGC-HA strains, 
respectively, after 5 min illumination. These cGMP levels were clearly sufficient to induce 
the motility, invasion and egress phenotypes in the tachyzoites. The impact of induced cGMP 
was also observed as an enhanced motility in proportion, which was also reflected in invasion 
rates of different strains. Likewise, all optogenetic strains showed an escalated egress in 
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response to light; however, the efficiency of egress differed across the strains. The egress 
event was complete in DD-RhoGC-HA strain, which indicates above the threshold cGMP 
induction in this strain. These results together suggest that different threshold levels of cGMP 
might be required to regulate individual events of the lytic cycle. It must be noted that the 
phenotypes observed with optogenetic assays are quite consistent with the genetic 
knockdown studies of TgATPaseP-GC and TgPKG, which endorses the utility of an 
optogenetic strain in T. gondii. 
Based on the existing literature (42,115,123,154), cGMP signaling and Ca2+ signaling 
most likely interact with each other to regulate the lytic cycle of parasite. To investigate the 
relationship of both pathways, a T. gondii strain co-expressing RhoGC (to modulate the 
cGMP levels) and calcium sensor GCaMP6s (to monitor the dynamics of Ca2+) was 
engineered in this study. Our initial proof of concept work confirms the hypothesis that cGMP 
signaling leads to an increase in cytosolic calcium, which also seems to require a minimum 
threshold of cGMP level as observed for lytic cycle assays. We proposed a model system 
within the parasite, which illustrates an optogenetic induction of cGMP by activation of 
RhoGC and synchronously monitoring of Ca2+ by GCaMP6s in T. gondii (Figure 30). The 
system shall enable to monitor calcium changes in individual steps of lytic cycle in further 
assays. It should now be possible to create mutants of intermediate signaling mediators to 
dissect the pathways leading to the release of calcium. In this regard, PI-PLC-mediated IP3/ 
DAG-signaling pathway which connects cGMP and calcium signaling requires a special 
attention.  
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Figure 30. Proposed model for optogenetic induction of cGMP and sensing Ca2+ in T. gondii. 
Light-activated RhoGC converts GTP into cGMP when activated by the green light (530 nm) within 
the parasite. TgATPaseP-GC initiates native cGMP signaling. A rise in cGMP level either via 
TgATPaseP-GC or RhoGC activates TgPKG, which stimulates the calcium signaling via an 
intermediate lipid signaling. Active TgPKG provides the substrates for phosphoinositide 
phospholipase C (PLC) which in turn produces inositol trisphosphate (IP3) 
and diacylglycerol (DAG). IP3 formation leads to release calcium from the storage organelles, like 
ER, to the cytosol. It is still an open question whether TgPKG directly or by another pathway can also 
induce calcium release to the cytosol.  Free cytosolic calcium can be detected by genetically-encoded 
calcium sensor GCaMP6s. An increase in cytosolic calcium induces Ca2+-dependent protein kinases 
(CDPKs) which regulate microneme secretion. The conversion of DAG to phosphatidic acid (PA) is 
another way for parasite to promote microneme secretion. The cascade can be regulated by RhoGC 
in a reversible manner, once the parasite is kept in the dark. The inhibition of TgPKG by compound 
2 totally impairs the cascade. However, BIPPO treatment blocking phosphodiesterases (PDEs), can 
stimulate the pathway again. Straight lines represent known pathways, while hypothetical ones are 
shown by dashed lines. Ca2+: calcium; cGMP: cyclic guanosine monophosphate; eGFP: enhanced 
green fluorescent protein; ER: endoplasmic reticulum; GCaMP6s: circularly permuted GFP-
calmodulin-M13 peptide 6; GC: guanylate cyclase; GTP: guanosine triphosphate; M13: myosin light-
chain kinase; PDE: phosphodiesterase; PKG: protein kinase G. 
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5 Conclusions and Outlook 
This work demonstrates the importance of cGMP signaling on the lytic cycle of obligate 
intracellular parasite T. gondii. An atypical guanylate cyclase fused to a P4-ATPase, 
TgATPaseP-GC, was characterized in the parasite as an upstream mediator of native cyclic 
GMP signaling. Genetic knockdown and pharmacological inhibition studies revealed the 
essentiality of this protein for the successful lytic cycle of parasite. In silico analysis provided 
valuable insights into its membrane topology, complex architecture and possible 
multifunctioning, however many questions are still awaiting to be answered: 
(1) Intermolecular coordination of P4-ATPase and GC domains in TgATPaseP-GC, 
(2) The role of P4-ATPase domain on GC function, 
(3) Mechanism of lipid-sensing by P4-ATPase domain. 
Besides, the integration of an optogenetic approach into the T. gondii research by 
expressing a light-activated guanylate cyclase, RhoGC, enabled to induce cGMP simply by 
light in fast, spatial and reversible manner. The proof of concept work exhibited a direct 
linkage between the induction of cGMP in the parasite and its impact on the motility, invasion 
and egress events. The optogenetic strain co-expressing RhoGC with a calcium sensor, 
GCaMP6s, sounds promising to selectively modulate and monitor cGMP and calcium levels 
within the parasite.  Having multiple optogenetic strains permits now an objective-oriented 
usage of them to address following signaling-related researches in the future:  
(1) Kinetics of cGMP and Ca2+ in intracellular parasites during the lytic cycle, 
(2) Real-time monitoring of phenotypes in response to light during the lytic cycle, 
(3) Phosphoproteomic analysis of C2-sensitive and C2-resistant optogenetic strains, 
(4) Genetic knockouts/knockdowns of PKG-dependent phosphorylated proteins in the 
optogenetic strains to dissect hierarchical nature of signaling. 
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7 Appendices 
Appendix 1: Assigned digital values and corresponding light intensities depending on the 
wavelengths to control constructed 24-well plate compatible illumination device for 
optogenetic study.   
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Appendix 2. The alignment of P-type ATPase-like domains of TgATPaseP-GC, PfGCα and 
PfGCβ with the members of human P4-ATPases. The human P4-ATPases were aligned by 
MAFFT alignment server (v7) (169), and then merged with the aligned ATPase domains of 
TgATPaseP-GC, PfGCα and PfGCβ using MAFFT merge. The alignment was trimmed, as 
indicated by horizontal lines, and signature residues were color-coded with the Clustal 
Omega program (>30% sequence conservation). Selected amino acids that are essential for 
ATP binding and phosphorylation, as well as transmembrane helices are boxed in black. 
Transmembrane topology of ATP8A1 retrieved from TMHMM Server (v2) (163) was used 
as a reference. Organism abbreviations and accession numbers: P-type ATPase-like domain 
of TgATPaseP-GC, Toxoplasma gondii (EPR59074.1); PfGCα, Plasmodium falciparum 
(AJ245435.1); PfGCβ, Plasmodium falciparum (AJ249165.1); and P4-ATPases of Homo 
sapiens: ATP8A1 (Q9Y2Q0.1), ATP8B4 (Q8TF62.3), ATP9A (O75110.3), ATP10A 
(O60312.2), ATP11C (Q8NB49.3). 
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Appendix 3: Protein sequence alignment of GC1 and GC2 domains of TgATPaseP-GC with 
orthologous GCs/ACs showing a 74- and 40-residues long loop insertions in the GC1 of 
TgATPaseP-GC and PfGCα, respectively. Both GC1 and GC2 domains are structured with 
seven-stranded β-sheets surrounded by four α-helices, and conserved residues that are 
important for the functionality were annotated. 
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Appendix 4: (A) Expression profiles of GC1 and GC2 domains of TgATPaseP-GC in E. coli 
M15 strain before- and after- IPTG induction as well as in induced bacterial lysates. (B) 
cGMP measurements via HPLC following in vitro guanylate cyclase assay that was set by 
bacterial lysates expressing GC1 and GC2 domains as described in methods resulted in no 
cGMP detection.  
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Appendix 5: Efficiency of Cre recombinase-mediated 3’UTR excision in TgATPaseP-GC 
and TgPKG mutants. Efficiency of 3’UTR excision was quantified by scoring the loss of HA 
signal (A) in the TgATPaseP-GC-HA3’IT-3’UTRexcised mutant, which was generated as 
described in Figure 16A (B) in the TgPKG mutant, which was generated as described in 
Figure 21B.  Both mutants were immunostained with α-HA and α-TgGap45 antibodies. 300 
vacuoles containing parasites with or without HA signal were counted from three 
independent immunofluorescence assays (mean with S.E.M.). 
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Appendix 6: Inhibition of residual activity in the TgPKG-HA3’IT mutant by compound 2 
enhances the defect of motility, invasion and egress. (A) Motile fraction and trail lengths of 
the Pnative-TgPKG-HA3’IT-3’UTRexcised mutant and Pnative-TgPKG-HA3’IT-3’UTRfloxed 
progenitor strains, generated according to Figure 21B, were measured by staining with α-
TgSag1 antibody after Compound 2 treatment (2 µM, 15 min). A total of 500 parasites for 
each strain were analyzed to calculate the motile fraction. In total, 100 trails were measured 
for the progenitor strain, whereas only 30 trails could be evaluated for the mutant due to 
severe defect (n = 3 assays). (B-C) Comparative invasion and egress of strains were 
calculated following α-TgGap45 and α-TgSag1 antibody staining. (B) Fresh extracellular 
parasites (106) were let to invade to HFF-monolayers for 1 h with or without compound 2 (2 
µM) addition. 450-500 parasites were evaluated from 3 independent assays. (C) Early 
parasite cultures (40 hpi) were treated with Compound 2 (2 µM) and incubated 8 hours to 
follow their attitude against the drug. 500-600 vacuoles were counted for each strain (n=4). 
(mean with S.E.M., significance with Student’s t-test. (*, p ≤0.05; **, p ≤0.01; ***, p ≤0.001; 
****, p ≤0.0001). 
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Appendix 7: Transcript screening of RhoGC and/or GCaMP6s expressing-optogenetic 
strains following transfection into T. gondii tachyzoites of RHΔku80-hxgprt- strain. RNAs of 
transgenic strains were isolated from transgenic strains followed by cDNA synthesis. cDNAs 
were screened for positive expression of the ORFs using specific primers given in Table 1, 
resulted in 1900 and 1354 bp amplicons for RhoGC and GCaMP6s, respectively.  
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Appendix 8: Maps and sequences of vector constructs used in this study 
A) Plasmid of pQE60-TgATPasep-GC1 
 
 
CTCGAGAAATCATAAAAAATTTATTTGCTTTGTGAGCGGATAACAATTATAATAGATTCAATTGTGAGCGGATAACAATTTCACACAGAATT
CATTAAAGAGGAGAAATTAACCATGGGAGGATCCAGATCTATGCTCGATAAGAAGTACTTGCCCCCACTAAATTTCGTCCACTACATTCCAC
TGTTCATTGGCATAGACGTCTTTGTCGCCTTTGTCGGTTATCGCCTGGAGTACAACCAGCGCAAGTCGTTCTTGCTGGACTACTCAGTGGAC
GCGTCTCGCAGGAAGCAACGAGAAATTCTCAACACGATGCTTCCCTCCTTCGTCGTCGACCAGATGATTAACTCGGAACTCAACGAAGAAGG
GATTCCGACGTCCCTCAAGGCCGAAGACAGAGGAACTGTGTCAGTCATTTTCTGCGATGTCTACGAATTCCAGCATGTCGTCGCATCCATCG
AACCGACGCGTCTCGTCGAGGTCTTGGATTCTCTTTTTCTCTGCTTCGACCGCAGTGCCGAACAGTTTGGTTGCACAAAAATCGAGACCGTC
TTCGAAACCTACCTGGCAGCCGCCGGCCTCCAGCCTGGTCGCGAAGCATCACCGGCATCGTACCAGCAAGACGCATGCGACGCCCTCGACAT
GGCACTGGCGATGCTGGAAGTCGCTGCACAGATTCGCTACGAAGTGAAAAGCAATCAGGGAGTTTTATCGGGGTCTGCTGTCGGCTCGAGCT
CAGCCGTCGGCCCCGCGGTGTCTGCCTCCAATCTTGAGGCTTCGGGCAACCACATGGAGCCTCGGCTTTCTCTCCATGGTCACAACTCTGGT
GTCGCCATGGGCAGTCGCATGAACAGCAGCCGGTTCCACCGACAGAAAACAGGCAGTGTCGTGCGCACTGTCCTCCAGTCTCGTCCGCAAAG
AATTCGCGTAAAGATTGGAATTCACTCAGGTCGTGTCATCAGTGGAGTCGTCGGGGCCAAGAAGCCCCAATACGCGCTTTTCGGAGACACTG
TCAACACAGCAAGTCGTATGAAGACCACCGGACAGCCGGGCTACATTCACATTTCGGAGGATTCCTACGAGCTTGTCAAGGGAGACGACACT
CTGGAATATGAATCACGACACACAGAAGTCAAAGGCAAAGGTCTGATGAACACCTATCTTCTCGTCAGAGTCAAAGGTTCGCCTTACCCTCA
CTTCGACGATCAAGAAGCAGACGAGGGAGACGTAATCTCGGAAACAGGAGGCCAAAACGGCGAGTCGCGGCGGTCGACCGCTTCCCTGCCCA
GGCAGCTGGAGACTGCGGGTGCGTCGTCGAGATCTCATCACCATCACCATCACTAAGCTTAATTAGCTGAGCTTGGACTCCTGTTGATAGAT
CCAGTAATGACCTCAGAACTCCATCTGGATTTGTTCAGAACGCTCGGTTGCCGCCGGGCGTTTTTTATTGGTGAGAATCCAAGCTAGCTTGG
CGAGATTTTCAGGAGCTAAGGAAGCTAAAATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACAT
TTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAA
GCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTTCGTATGGCAATGAAAGACGGTGAGCTGG
TGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTC
CGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTT
CGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGCATG
GGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTCTGTGATGGCTTCCATGTCGGCAGAAT
GCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAATTTTTTTAAGGCAGTTATTGGTGCCCTTAAACGCCTGGGGTAA
TGACTCTCTAGCTTGAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCT
CCTGAGTAGGACAAATCCGCCGCTCTAGAGCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGG
TCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACC
CAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATA
CCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCG
AGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAA
AGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAG
AGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTAC
CGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCT
CCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACAC
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GACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAA
CTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCA
AACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTT
TCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT
AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCT
CAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGT
GCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCC
TGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTG
CCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCC
CCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGC
AGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTA
TGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGT
TCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTT
TACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCA
TACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAA
ATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTAT
CACGAGGCCCTTTCGTCTTCAC 
 
 
 
T5 promoter                   Ampicillin                    rrnB_T1_Terminator              TgATPasep-GC1 
BglII                               CAT/CamR                  6xHis-tag 
 
 
B) Plasmid of pQE60-TgATPasep-GC2 
 
CTCGAGAAATCATAAAAAATTTATTTGCTTTGTGAGCGGATAACAATTATAATAGATTCAATTGTGAGCGGATAACAATTTCACACAGAATT
CATTAAAGAGGAGAAATTAACCATGGGAGGATCCAGATCTATGACGATGAGCTTAACGTTCATCATCACCACAGCCAGGGAAACCGCGTCGA
CAGTCAGCACGATTGCCACCTTCCCCTGCTACGTCTTCTTCAACTTGGTCAGTGCATACTGCAAAGAGTACATCGATCGTCTGACTTTCTAC
GTGAACGAGCATGCCAAGACGACAGAAAGCCGTGCGACGCAGCTTCTCAACGATATGCTTCCGAAGCAGGTTCTGGAGGAGTTTCAGCAGGA
CAAGCTGAAGCTCGCGTACCTCCACGAGAACGTGACTTTCCTTTTCGCAGATATTTGTGGGTTTACAAGTTGGGCAAAGGGTGTCGACGCTT
GCGAGGTCGTAACAATGCTGCAGAAACTCTTTGCGAAGTTCGACAAAGACAGTACCAAGTTCGGCCTGTACAAACTCTGCACCATCGGAGAC
GCTTACGTCGCTGTCTCCGAACCGGTCACAGCAGAGAATGCTCAAGACACAGACCCCCGAGAGGGCATGTGGCTTGTCTACGAGATGGCCAA
GGCGATGATCGGAAACATCACAGAAGTTCGAGAGCGTTTGTGCATTCCCAATCTGAACATGCGCATAGGTCTGCACTACGGAAGCTGCGTAG
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GAGGCGTTATCGGGAGTGGACGCCTTCGTTACGATTTGTGGGGAATGGATGTCTTGACGGGGAACATGATGGAGAGCAACGGAGTTCCTGGA
AAAATCAATGTCTCGGAAATCCTGAAAAACGAAATGGAAAAAGGCTTTCCAGGAGAATTCGTTTTCAAGTTCAACAAGACAGTAGCGGTCTT
GCAAAGCACCGTCGACTCGTACCTCATTCGCCCTGCGAAGGATTTCGACGAAGACGAAGAACTTGCGGCAGCGGCGGCGACGATGGCTGTTG
CAGGTCCCTCTGCCTCTCTTCAGCAGGGCGGCGGTGCGATCCCTCAAAGATCTCATCACCATCACCATCACTAAGCTTAATTAGCTGAGCTT
GGACTCCTGTTGATAGATCCAGTAATGACCTCAGAACTCCATCTGGATTTGTTCAGAACGCTCGGTTGCCGCCGGGCGTTTTTTATTGGTGA
GAATCCAAGCTAGCTTGGCGAGATTTTCAGGAGCTAAGGAAGCTAAAATGGAGAAAAAAATCACTGGATATACCACCGTTGATATATCCCAA
TGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTTAAA
GACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTTCGTATGGCAA
TGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGT
GAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTT
TATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCC
CCGTTTTCACCATGCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTCTGTGATGG
CTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGGGGCGTAATTTTTTTAAGGCAGTTATTGGTGCC
CTTAAACGCCTGGGGTAATGACTCTCTAGCTTGAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTG
TTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCCGCCGCTCTAGAGCTGCCTCGCGCGTTTCGGTGATGACGGTGAAAACCTCTGACACA
TGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGT
CGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGAGTGCAC
CATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTC
GGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGATAACGCAGGAAAGAACATGT
GAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAA
AATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGT
TCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTT
CGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAG
TCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTT
CTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTG
GTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAA
GAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGAT
CTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAA
TCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGC
TTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGC
CGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATA
GTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCA
AGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTT
ATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGT
CATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTG
CTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAA
CTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACAC
GGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGT
ATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAAC
CTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAC 
 
T5 promoter                   Ampicillin                    rrnB_T1_Terminator         TgATPasep-GC2 
BglII                               CAT/CamR                  6xHis-tag 
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C) Plasmid of pQE60-TgATPasep-GC1+GC2 
 
 
 
CTCGAGAAATCATAAAAAATTTATTTGCTTTGTGAGCGGATAACAATTATAATAGATTCAATTGTGAGCGGATAACAATTTCACACAGAATT
CATTAAAGAGGAGAAATTAACCATGGGAGGATCCAGATCTATGCTCGATAAGAAGTACTTGCCCCCACTAAATTTCGTCCACTACATTCCAC
TGTTCATTGGCATAGACGTCTTTGTCGCCTTTGTCGGTTATCGCCTGGAGTACAACCAGCGCAAGTCGTTCTTGCTGGACTACTCAGTGGAC
GCGTCTCGCAGGAAGCAACGAGAAATTCTCAACACGATGCTTCCCTCCTTCGTCGTCGACCAGATGATTAACTCGGAACTCAACGAAGAAGG
GATTCCGACGTCCCTCAAGGCCGAAGACAGAGGAACTGTGTCAGTCATTTTCTGCGATGTCTACGAATTCCAGCATGTCGTCGCATCCATCG
AACCGACGCGTCTCGTCGAGGTCTTGGATTCTCTTTTTCTCTGCTTCGACCGCAGTGCCGAACAGTTTGGTTGCACAAAAATCGAGACCGTC
TTCGAAACCTACCTGGCAGCCGCCGGCCTCCAGCCTGGTCGCGAAGCATCACCGGCATCGTACCAGCAAGACGCATGCGACGCCCTCGACAT
GGCACTGGCGATGCTGGAAGTCGCTGCACAGATTCGCTACGAAGTGAAAAGCAATCAGGGAGTTTTATCGGGGTCTGCTGTCGGCTCGAGCT
CAGCCGTCGGCCCCGCGGTGTCTGCCTCCAATCTTGAGGCTTCGGGCAACCACATGGAGCCTCGGCTTTCTCTCCATGGTCACAACTCTGGT
GTCGCCATGGGCAGTCGCATGAACAGCAGCCGGTTCCACCGACAGAAAACAGGCAGTGTCGTGCGCACTGTCCTCCAGTCTCGTCCGCAAAG
AATTCGCGTAAAGATTGGAATTCACTCAGGTCGTGTCATCAGTGGAGTCGTCGGGGCCAAGAAGCCCCAATACGCGCTTTTCGGAGACACTG
TCAACACAGCAAGTCGTATGAAGACCACCGGACAGCCGGGCTACATTCACATTTCGGAGGATTCCTACGAGCTTGTCAAGGGAGACGACACT
CTGGAATATGAATCACGACACACAGAAGTCAAAGGCAAAGGTCTGATGAACACCTATCTTCTCGTCAGAGTCAAAGGTTCGCCTTACCCTCA
CTTCGACGATCAAGAAGCAGACGAGGGAGACGTAATCTCGGAAACAGGAGGCCAAAACGGCGAGTCGCGGCGGTCGACCGCTTCCCTGCCCA
GGCAGCTGGAGACTGCGGGTGCGTCGTCGGGTGTACATACGGGCGAGGCGATGGGCTGTTTCGCATCTGTGGGGTCTCGGGGAGAGAGTCAG
ACAGCGGCAGATGCGGCGGCGGCCGAGGCCATCGAAGAGGACATCCAAGTGGAGATCGACGAGGAAGGCGTCGTGGAAGACACCGTCGAAAA
GGCAGTGGAAGATGTGCGACGTCTCAGGAACGAAGGGTCGCACGCAGTCGCGAGCGACGACTTCCCAGTCTCTCAGGCCGGTGCAGCGCAGC
CGCGACGCTGCTCCCGCTTCCTCTTCCAAAATGCGGAGGAGCATGGAGCTGCAGAGCCTCAACGAGGAGAGGGCGCGCGCTTGATTCTCTCC
CCTGGACAGACAGAGGGAACGCGTCAAAGCGAGAAAGAGGGATCGGCTCTCGGCAGCAACATCGCTGCGAGTGCACGCGCAGATCGCAGGCC
TGCCGGGCGGCGAGAGGATTCGAGAGGAGACAGCCGCTTCGACTACGAGTCCATGACAACACAGCAGCTTCTGCGAATCTACAGGAGACAAC
AGAAGGTCGCCAAGGTTCTCCAGTGGATCGACGAAGAACTGAGAGGGCAGCGCGATACAGCGCACAGACACGCAAGGACAGCGGACATCGTC
GCGAAGCTCCTCGCTTCGTCGGGAGACGAGCAGGCAGCTGGAGAGAGTTCGGAGGCAGACCACGACGAAGTGCCTCTGGACGAGATCAAGGA
GGAACTGCGGCGACAAGCTCGGGAGGCGAACGAGCAGGAATCCGCGAAGAGGTCCGGGGGAGACGCTCCACCCCACACACCCACACGCAAGG
CCCTTCTCAAGGCCTTTCGCAGCGAAATCGTGCATGGATGCGCGGCTCCCACGGAAGAAGAGAAGACTGCAAAGGAAGGCAGAGAGTCTGAA
GTGGCTCTCGCCTCTCCAGAAACCGAATCTCGAGACGCCAATGGCCAGCGAGTTTCCGAAAGGGATGCGTCAGATGCCCGAGAGGGCAGCGC
GTCTCCGCAACCGGACCACGCGGCGCCTCCGTCAGGGCTACCGCAGGGATTGAAAGGACAAGAGACAGAGAAGCAGCAAGGCTGGAAACTGT
TTCGTTCTGCGAGTCTTGTGCGCGCCGCCGGCCAGTCGTTTGCTTCTCTCTTCAGGCGGCGCAAACCGGCCGCTCCTTCTGAAGCTGCGAGC
CCCTCAAGTGCGGACACACCCATGGATAGCCGCGTCTCGCCGACGTCGGTCGATGACGAAGACCTGGAGCAAAACAGAGTGACGCGAATCGG
CGTATCGAGTGAGTGGCTGCTTCTCAAATTCAAAGACAAGAATCTCGAGGCGCGCTATCGAACGCACTTTTACAACAACAAGTCCAACATTA
ACACAATTGAACAAGCCCTCATCATCTTTCTTGTGACCTTTTGCGTTCAAACGCTGACACGGCTGGCGCTGCCGCGCTTCTACGTTGTTTGC
TCTCATCACACGATCAACCTCCACGTCTGCACAGGCCTTTACTGGGCGGTTCGCGCGACGTACACCTTAGCCGCGTTCGTCCTCTGGATGTT
GTTCCACTACCGAAACCGAAAGGAGGTGGCGACATGTTTGGAGCTTCGCTGGATGGTTTTCCTTCTGAATTTGCTGTTTATTTCTGCGTCGT
GTGTCTTCGCACTCTCGAACTCCTGGGGTGTCTGCGGACAGCAGCAGGAAGACCATGGGGCGTCCGAGACCGCCGTGGAGAACACCCTGGTC
GCTCTCTCGCATCTTGCGAAAGACGGCAGCTTCCCGGCCGACGACGCAGAAGTGAACAGCGTCGCCGGCTCGCCTCTCGCTCAGGCCATGCA
CTCTCCCTTCACCACGGCAGGCGTCTCACGAGCCTCCCGAATGCTGAGGAGTGGAGGCGTCAGTGTCTCCGGAGGAACGGATTGCACGGGTG
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TCGGCACCTCGGGTGAAGAGGGATCCGACCTCGTGACTGCCAACGGGAGGGCCTACACCTACTGGCTTCTCAGCGACACGATTGAGCTCTTC
TTCTACATCGTCATTCTCCACCACAACACCGGTCTCTTGTTCCAAAACTGCATCCTCGTCGATGTCCTGCTGATGACGATGAGCTTAACGTT
CATCATCACCACAGCCAGGGAAACCGCGTCGACAGTCAGCACGATTGCCACCTTCCCCTGCTACGTCTTCTTCAACTTGGTCAGTGCATACT
GCAAAGAGTACATCGATCGTCTGACTTTCTACGTGAACGAGCATGCCAAGACGACAGAAAGCCGTGCGACGCAGCTTCTCAACGATATGCTT
CCGAAGCAGGTTCTGGAGGAGTTTCAGCAGGACAAGCTGAAGCTCGCGTACCTCCACGAGAACGTGACTTTCCTTTTCGCAGATATTTGTGG
GTTTACAAGTTGGGCAAAGGGTGTCGACGCTTGCGAGGTCGTAACAATGCTGCAGAAACTCTTTGCGAAGTTCGACAAAGACAGTACCAAGT
TCGGCCTGTACAAACTCTGCACCATCGGAGACGCTTACGTCGCTGTCTCCGAACCGGTCACAGCAGAGAATGCTCAAGACACAGACCCCCGA
GAGGGCATGTGGCTTGTCTACGAGATGGCCAAGGCGATGATCGGAAACATCACAGAAGTTCGAGAGCGTTTGTGCATTCCCAATCTGAACAT
GCGCATAGGTCTGCACTACGGAAGCTGCGTAGGAGGCGTTATCGGGAGTGGACGCCTTCGTTACGATTTGTGGGGAATGGATGTCTTGACGG
GGAACATGATGGAGAGCAACGGAGTTCCTGGAAAAATCAATGTCTCGGAAATCCTGAAAAACGAAATGGAAAAAGGCTTTCCAGGAGAATTC
GTTTTCAAGTTCAACAAGACAGTAGCGGTCTTGCAAAGCACCGTCGACTCGTACCTCATTCGCCCTGCGAAGGATTTCGACGAAGACGAAGA
ACTTGCGGCAGCGGCGGCGACGATGGCTGTTGCAGGTCCCTCTGCCTCTCTTCAGCAGGGCGGCGGTGCGATCCCTCAAAGATCTCATCACC
ATCACCATCACTAAGCTTAATTAGCTGAGCTTGGACTCCTGTTGATAGATCCAGTAATGACCTCAGAACTCCATCTGGATTTGTTCAGAACG
CTCGGTTGCCGCCGGGCGTTTTTTATTGGTGAGAATCCAAGCTAGCTTGGCGAGATTTTCAGGAGCTAAGGAAGCTAAAATGGAGAAAAAAA
TCACTGGATATACCACCGTTGATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAG
ACCGTTCAGCTGGATATTACGGCCTTTTTAAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCT
GATGAATGCTCATCCGGAATTTCGTATGGCAATGAAAGACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATG
AGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGATTTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTAC
GGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTCAGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTT
AAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGCATGGGCAAATATTATACGCAAGGCGACAAGGTGCTGATGCCGCTG
GCGATTCAGGTTCATCATGCCGTCTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGATGAGTGGCAGGGCGG
GGCGTAATTTTTTTAAGGCAGTTATTGGTGCCCTTAAACGCCTGGGGTAATGACTCTCTAGCTTGAGGCATCAAATAAAACGAAAGGCTCAG
TCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCCGCCGCTCTAGAGCTGCCTCGCGCG
TTTCGGTGATGACGGTGAAAACCTCTGACACATGCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGCCC
GTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCGCAGCCATGACCCAGTCACGTAGCGATAGCGGAGTGTATACTGGCTTAACTATG
CGGCATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCATCAGGCGCTCT
TCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCAC
AGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCC
ATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTT
CCCCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCT
TTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACC
GCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGC
AGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCT
GCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGC
AGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAA
GGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGA
GTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCC
CCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGAT
TTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCG
GGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTA
TGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCG
ATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATG
CTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATA
ATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGA
TCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCA
AAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTT
ATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGAC
GTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCCCTTTCGTCTTCAC 
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BglII                               CAT/CamR                  6xHis-tag 
 
144 
 
D) Plasmid of p3’IT-HXGPRT-TgATPaseP-GC-HA3’IT-TgGra1-3’UTR 
 
 
 
 
 
 
 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTG
CCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTC
CGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCAT
AGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAG
AGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGG
GATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGT
AAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTT
ATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGG
AAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATG
GCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGAT
CGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCT
TTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAAT
ACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATC
CAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAA
ATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTAT
TGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGC
GCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCG
CTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTA
CGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGA
GTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGC
CGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGC
CATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGA
TTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATT
GGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGATTCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCC
CACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGGCATGAGTGTGGCGGAGTCGCGCTGTGAGTTTTTGCTCTTTTCCTCGCCC
TGTGTGTTCTTCTTTTGCGCAGCATTCGAGGAAATTACCGCAGGAGATTCACCATTCTTGGCAGTGCGCCGCGCGTTCTGGGACGCCGACAG
TCTCTCAGGGGTCACCAGTTCAGTGCACTCGCTCTCGCGTCACACGTAAGTTCAGATGCATGCGCACCGAATTGAGAAAAGGCGCTCCGGAC
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GCAAATTGAGACAAACATGCAACAAAACCTACCGAGTCTGCTTTTCTCCTGTGTCGGCAGGGACTTCCCGCTACACAGACGTCGTCACAGAT
CCGTTTCACGAGCTCTCTACTTGGATACTGAACATATATATTTATACATATATCGATTGCTATTTGGATTTGGATGTCTGTATGTTCTCAAA
CGTACAGACAAGTTGATCACTCTTGTTCGATAAATCGGTATATGTGTGGGTGTGCGTATATGGATGTTTGTGTCTTCAACGAGGCAATACTT
GGTGGATAGGTGATTTTTTCGAGATGTCGGCACCTGTGCAGAGCTGTGGTGAGATGTTTGGCGCGTATCCTTGCGCGTTGTTTGTGTTTTTT
TCTCGCAGGGCGATTCTGGACCCAGCGACGAACCGCGCCACCTGGGAGACGAAGGGCAAGCAGCTGGCTCTGTCACTTCGCATGATGGACCA
CTGCGTGAGGAGGTTGAGGACGATGAGATCGACGGCCTCAAGCAACTGAGGAAGGAAATCGAGCGTGCTGGAGGTAGGTTCGAAAGACTAAA
GTCTTCGTAAATTTTTTTCCACACTTTTGGCGTGCATCTCGGCATCGCAGATCCTCGTTTCCAGTCGCAGCATCGGTCCTCACAAAGACACC
TTCGCTGTCGATTGTGTTGAGTCTTCTCACTCCTATTGTTCATACTTGTACATATGCATCTACGTATATATACAGATGTTCATGTTTGTATA
TATATATATATATAGATATAGATATAGATATACGTACGCGGTTTGATATTCTGCGTCGACTTGAGTCGTCTACGTGCATCGCGCCGAGAAGA
TTCTTCTCCACAGTTAAATGTATATATGTATGCATAAAAACATATATATACATATATATGTATATATGTGCATCTATATACATTTACGCATG
CCTAAATGTTTTTTTGTATTTTCATGGGATTCCGAGAGATATTGGTATGTGAGACAACGGCTGTGGTTTTCTCGTAGGTCTCGGTTTGGACG
CGTCGCCTTCGGATATAGGGTCGACACCTGGCTCTGCACTCGGGTCGTACCCGTACGACGTCCCGGACTACGCGTAGGAATTCATAACTTCG
TATAGCATACATTATACGAAGTTATGACTACGACGAAAGTGATGCGCAGGCTGGAAAGCCGCTGAAGGGAGAAGTCTACAAAGCCGATCAGT
GAAAAATGTGTGGGGAGGTGGTCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGTGTTCGAATGCAGTGCGTGTATCAGTTGTGCGCGGAA
GGACACTGCTTCAATGTTAAGAACCTGTTTTCTCCGTAGAGAGGACCAAAAGACGATTGCAAAACTGGTATGTACGCAATAGCCCAATGCCG
GACGTCAGTTGGTTGTATGTGACGCTCCCAGATGTCATATGCCTTGTGAGTGTGTCTGGGATGCAAGTTTTTGGTGTGCGTTGATTTCGCCA
GCTTATGACAGTGGCAGACGAATTATTGACATGATACAAGGACGCAGAAAGGAACAAACACCGTAGTTCCAGTCGACGGATCCACTAGTGGA
TCCCCCTCCACCGCGGTGTCACTGTAGCCTGCCAGAACACTTGTCAACCGACTGTGTCCACATTTTTATGCGCACTGACTGGCATGAATGGC
CAGAGGCAGGCATCAGCAAGTCACGTAGGCCAACGCGTGCGCAGAAACGCTCAAGGCTCGATTGTGGGTGGGGGTTGGTAGCATTTTATCGA
CCTAAACAAGGTTTACACTTAGGTGGTGCGGTTTTACTGATCTGGACGGATTCAGCGGTCGCAGATTATCGATCTGCAAATGGTGTACACTT
AGGTGTCGCGGCTTATTTAGTTAAGGGAGCTTCGTGGTCGGAGCCTAACAAGTCAACAGAGACGTATCGCCAATCGTTCGCGGTGAAGAGTC
GAAACTGACAGCACATCGTAGGGAAACTGAGAGGGTGCTCCTTTCTCTCCGTCGTTTGCGCTGCACCATCCTGCAAGTGCATAGAAGGAAAG
TTGTCTGCTGTCGTGGGCAGACAGCAACAGTCCAGCACTCTAGCGGCATACAGAACGATAACGCATTCACGAGTGGATACACGCACATCTGC
GTCACCCGCAACTCGCTTTCGTTCTGATTGACAAAAAGAAAACAAGGCGAGGTGAGACTGTGTGAAATGCCACATGAAGAGTCATCCCTTTT
CTTCGATAAAGGACACAGGGGTCTCTGGCACCCCCTCGTCAGCTCTCTCCGACCCGAGGCACTCTCCCTGATCCCTCCGAAAAGAGAGGAAA
ACGAGAGACGGGCAGCTTCTGTAGGGCTATGCAGGGTTTACTTCTCGAACTTTTTGCGAGCGGCGTCGCTCAGGACGGCGACGTGGTCGAAG
TCGCGGAACATCTCGTTGAAGTCGTAGCAGCAACCAACGATCCAGACGTCTTCAATGCTGAAGCCGACGAAGTCGCCCTTCAAGCTGTTGGA
GCGATCTGTGCGCTTCTCGACGAGGGTGGCGATTCTCATCGACTTGGGACCGACGGCTTTCAGGCGCTCACCGAACTCGGTGAGGGTGAAAC
CGGTGTCGACGATGTCCTCAACAATCAGAACGTGCTTGTCGCGAAAGATTGACAAGTCGTCGCTCAAGACGGTGAGCTGGCCTGTGCTGTTG
TCGTTCTGGTAGGACTTCAGGCGGACATAGTGCTCGAAGAAGGGGGGCACGCTGGACTCACGACCACTGTACTTCTGTATGGTGGCAAGGTA
GTCGATCAGAAGGTTGAAGAAGCCGCGAGAGCCTTTCAGGATGCAAATGATGTGCAACTCCTCGCCGAAGTAAGTTCTGTGGATGTCATACG
CCAACTTCTCAACTCTGTCCTTGACCAATCCACCAGGGAGGAGGATTTTGTCAATGTAGGGCTTGCAGTGGGGGGGCACAAGAAAGTCATCA
GCGTTGTAGAAGGTGTTGTCGGGGATATACATGGGCTCAATACGGCCCTTGCCCTTGCCGTAGTCTTCAATGGGTTTGGACGCCATTTTGGA
TCTGACAACGCCCCGTAGAGCAGAAACGCACTACTAAAGCGAAACTTCACCCGTCCCTGCTGCACTCAGAGCAGTGCTCCGCACTGCCGTGT
GGTAAAATGAAAAGGTTCTACGAGACACGCGTCTCCGGATCGACAAGCGAAGGATCTGCACACCTGGTCTCGATGTCGAACAAAGCACGGAG
GAGAGACGGAAAGTGCTTACATCGAACACGGTTATCAAACCCGAGAAAAAGAAACGAACAGAAGAAAAAGGAAACCTCCGCATACTTTTAAA
GAATGAAGTTCCCCGATTTTCCCAAAAATGGCGTCATTTTCGCGCACGGCAGTCAGATAACAGGTGTAGCGGCTGCCCACCAACAGAGACGG
CGCGGCCGACAGGACGCTACTGGGACTGCGAACAGCAGCAAGATCGGATCTTCCGCGGGCGGGTTTGAATGCAAGGTTTCGTGCTGATCATA
ACTTCGTATAGCATACATTATACGAAGTTATAAGCTTGCTAGCGTTAACGGGCCCCGTACC 
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E) Plasmid of p3’IT-HXGPRT-TgATPaseP-GC-HA3’IT-3’UTRfloxed  
 
 
 
 
 
 
 
 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTG
CCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTC
CGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCAT
AGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAG
AGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGG
GATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGT
AAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTT
ATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGG
AAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATG
GCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGAT
CGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCT
TTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAAT
ACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATC
CAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAA
ATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTAT
TGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGC
GCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCG
CTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTA
CGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGA
GTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGC
CGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGC
CATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGA
TTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATT
GGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGATTCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCC
CACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGGCATGAGTGTGGCGGAGTCGCGCTGTGAGTTTTTGCTCTTTTCCTCGCCC
147 
 
TGTGTGTTCTTCTTTTGCGCAGCATTCGAGGAAATTACCGCAGGAGATTCACCATTCTTGGCAGTGCGCCGCGCGTTCTGGGACGCCGACAG
TCTCTCAGGGGTCACCAGTTCAGTGCACTCGCTCTCGCGTCACACGTAAGTTCAGATGCATGCGCACCGAATTGAGAAAAGGCGCTCCGGAC
GCAAATTGAGACAAACATGCAACAAAACCTACCGAGTCTGCTTTTCTCCTGTGTCGGCAGGGACTTCCCGCTACACAGACGTCGTCACAGAT
CCGTTTCACGAGCTCTCTACTTGGATACTGAACATATATATTTATACATATATCGATTGCTATTTGGATTTGGATGTCTGTATGTTCTCAAA
CGTACAGACAAGTTGATCACTCTTGTTCGATAAATCGGTATATGTGTGGGTGTGCGTATATGGATGTTTGTGTCTTCAACGAGGCAATACTT
GGTGGATAGGTGATTTTTTCGAGATGTCGGCACCTGTGCAGAGCTGTGGTGAGATGTTTGGCGCGTATCCTTGCGCGTTGTTTGTGTTTTTT
TCTCGCAGGGCGATTCTGGACCCAGCGACGAACCGCGCCACCTGGGAGACGAAGGGCAAGCAGCTGGCTCTGTCACTTCGCATGATGGACCA
CTGCGTGAGGAGGTTGAGGACGATGAGATCGACGGCCTCAAGCAACTGAGGAAGGAAATCGAGCGTGCTGGAGGTAGGTTCGAAAGACTAAA
GTCTTCGTAAATTTTTTTCCACACTTTTGGCGTGCATCTCGGCATCGCAGATCCTCGTTTCCAGTCGCAGCATCGGTCCTCACAAAGACACC
TTCGCTGTCGATTGTGTTGAGTCTTCTCACTCCTATTGTTCATACTTGTACATATGCATCTACGTATATATACAGATGTTCATGTTTGTATA
TATATATATATATAGATATAGATATAGATATACGTACGCGGTTTGATATTCTGCGTCGACTTGAGTCGTCTACGTGCATCGCGCCGAGAAGA
TTCTTCTCCACAGTTAAATGTATATATGTATGCATAAAAACATATATATACATATATATGTATATATGTGCATCTATATACATTTACGCATG
CCTAAATGTTTTTTTGTATTTTCATGGGATTCCGAGAGATATTGGTATGTGAGACAACGGCTGTGGTTTTCTCGTAGGTCTCGGTTTGGACG
CGTCGCCTTCGGATATAGGGTCGACACCTGGCTCTGCACTCGGGTCGTACCCGTACGACGTCCCGGACTACGCGTAGGAATTCATAACTTCG
TATAGCATACATTATACGAAGTTATAACGCAGCTTTTGTCAGCGTTTCTTTTTTCATTTCATTCTCCACTTCTTCGCGAAAAGCCGTCTTCC
TTCGACAGGGCGACTGCTCCAAGGTTCTGCGTTGCTCCAGAGGCGGGTCTGTGTCCTGCCGCTTCGGGCAGTCGAGACAGACAGAGGCGGCA
GGTGTCTCGTCACGGCCGGAGGAACCAGAAGAGGAAAGGAGAAAAGGAACAGGACTGTGCGCACCCGGGAGAGAGAAGAGCGCTGCCAGCTT
CGTCAACGCAAAAGGCAAAAGGAAGGCAGAAGCAGGGAGGTGGAGAGACTGCGGATGTGCCGAATTACCTGTTGTGCCATGTTTTCCTGTTT
CCAAACACGGTTGCTGTGTGCATTGACCGCAGCGGCGAGTCGCCCCTAGCAGGTTCCAGTATCCTGCCTCCACGGTAGCGCTCGCTGGCTCG
CATTCGGTCGTTTTTCCGATTTTATTTTGCTTTCATTCTGCGCCTTTTTCCTTCCGTGTGGCATCATCTCTTCTGATGAGTCAGCGTCCTTC
GATGTTCCGCTTGCTCTCGTCGTCTTCTGGCTAGGGAAACCTCTCGCACTTGTCGTATGGCCCTCTTGATTCCTGTCGTCGCTCGCGATGCG
CCCCGCGTGACCGTGCGCGCTGTATGTACACCTCAGACGCGCTTGCGTAGTCTTGTGCCACTGAACAGGGTCAAGGCGAATGCGCTTCTGTC
AGTAAACGTCCATAAATGCATTTGCAGAGAGAACGTGTGCAAACGCATGTTGTCGCTTCCTGAACATTCCTCAAAAAAAATCCGTTTTCTCG
AATTGGGTCAGGAAGACCCCACACCTCTCGTCTTGTTCCCCACCTCTCACACTGGAGAAAACGCCGACTTCCTAAAATATGGCGGAGTCCGC
TCTTCGTACCAAAACGTTCGATGCCAAACTGTCACATGCACGCAGTTTACACACGCACGTACAGACGTTCACACATACATGTGCGTATATAC
GTACATAAACTAGTGGATCCCCCTCCACCGCGGTGTCACTGTAGCCTGCCAGAACACTTGTCAACCGACTGTGTCCACATTTTTATGCGCAC
TGACTGGCATGAATGGCCAGAGGCAGGCATCAGCAAGTCACGTAGGCCAACGCGTGCGCAGAAACGCTCAAGGCTCGATTGTGGGTGGGGGT
TGGTAGCATTTTATCGACCTAAACAAGGTTTACACTTAGGTGGTGCGGTTTTACTGATCTGGACGGATTCAGCGGTCGCAGATTATCGATCT
GCAAATGGTGTACACTTAGGTGTCGCGGCTTATTTAGTTAAGGGAGCTTCGTGGTCGGAGCCTAACAAGTCAACAGAGACGTATCGCCAATC
GTTCGCGGTGAAGAGTCGAAACTGACAGCACATCGTAGGGAAACTGAGAGGGTGCTCCTTTCTCTCCGTCGTTTGCGCTGCACCATCCTGCA
AGTGCATAGAAGGAAAGTTGTCTGCTGTCGTGGGCAGACAGCAACAGTCCAGCACTCTAGCGGCATACAGAACGATAACGCATTCACGAGTG
GATACACGCACATCTGCGTCACCCGCAACTCGCTTTCGTTCTGATTGACAAAAAGAAAACAAGGCGAGGTGAGACTGTGTGAAATGCCACAT
GAAGAGTCATCCCTTTTCTTCGATAAAGGACACAGGGGTCTCTGGCACCCCCTCGTCAGCTCTCTCCGACCCGAGGCACTCTCCCTGATCCC
TCCGAAAAGAGAGGAAAACGAGAGACGGGCAGCTTCTGTAGGGCTATGCAGGGTTTACTTCTCGAACTTTTTGCGAGCGGCGTCGCTCAGGA
CGGCGACGTGGTCGAAGTCGCGGAACATCTCGTTGAAGTCGTAGCAGCAACCAACGATCCAGACGTCTTCAATGCTGAAGCCGACGAAGTCG
CCCTTCAAGCTGTTGGAGCGATCTGTGCGCTTCTCGACGAGGGTGGCGATTCTCATCGACTTGGGACCGACGGCTTTCAGGCGCTCACCGAA
CTCGGTGAGGGTGAAACCGGTGTCGACGATGTCCTCAACAATCAGAACGTGCTTGTCGCGAAAGATTGACAAGTCGTCGCTCAAGACGGTGA
GCTGGCCTGTGCTGTTGTCGTTCTGGTAGGACTTCAGGCGGACATAGTGCTCGAAGAAGGGGGGCACGCTGGACTCACGACCACTGTACTTC
TGTATGGTGGCAAGGTAGTCGATCAGAAGGTTGAAGAAGCCGCGAGAGCCTTTCAGGATGCAAATGATGTGCAACTCCTCGCCGAAGTAAGT
TCTGTGGATGTCATACGCCAACTTCTCAACTCTGTCCTTGACCAATCCACCAGGGAGGAGGATTTTGTCAATGTAGGGCTTGCAGTGGGGGG
GCACAAGAAAGTCATCAGCGTTGTAGAAGGTGTTGTCGGGGATATACATGGGCTCAATACGGCCCTTGCCCTTGCCGTAGTCTTCAATGGGT
TTGGACGCCATTTTGGATCTGACAACGCCCCGTAGAGCAGAAACGCACTACTAAAGCGAAACTTCACCCGTCCCTGCTGCACTCAGAGCAGT
GCTCCGCACTGCCGTGTGGTAAAATGAAAAGGTTCTACGAGACACGCGTCTCCGGATCGACAAGCGAAGGATCTGCACACCTGGTCTCGATG
TCGAACAAAGCACGGAGGAGAGACGGAAAGTGCTTACATCGAACACGGTTATCAAACCCGAGAAAAAGAAACGAACAGAAGAAAAAGGAAAC
CTCCGCATACTTTTAAAGAATGAAGTTCCCCGATTTTCCCAAAAATGGCGTCATTTTCGCGCACGGCAGTCAGATAACAGGTGTAGCGGCTG
CCCACCAACAGAGACGGCGCGGCCGACAGGACGCTACTGGGACTGCGAACAGCAGCAAGATCGGATCTTCCGCGGGCGGGTTTGAATGCAAG
GTTTCGTGCTGATCATAACTTCGTATAGCATACATTATACGAAGTTATAAGCTTGCTAGCGTTAACGGGCCCCGTACC 
 
 
XcmI                                                         EcoRI 
 
TgATPaseP-GC-3’UTR TgATPaseP-GC-3`end 
HXGPRT ORF HA-epitope tag 
5`and 3`UTRs of TgDHFR/TS 
 
SpeI 
 
loxP sites 
 
 
 
148 
 
F) Plasmid of p3’IT-HXGPRT-TgPKG-HA3’IT-3’UTRfloxed  
 
 
 
 
 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTG
CCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTC
CGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCAT
AGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAG
AGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGG
GATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGT
AAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTT
ATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGG
AAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATG
GCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGAT
CGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCT
TTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAAT
ACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATC
CAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAA
ATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTAT
TGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGC
GCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCG
CTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTA
CGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGA
GTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGC
CGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGC
CATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGA
TTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATT
GGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGATTCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCC
CACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGCGTCTCAGCTGCGCGAGGCACCCCTCTCATAGCGTGGTACTCGTCACGAA
TACCAATCGCTGGGGTCGCGGCGGGAGGAATATGCTGTTTGTTGACCATACGATCACGCTGAACGAAAACATGGTATGAGACGCCGTAAGCG
149 
 
GGCACAGGTTGTTTGCCCTCGTCTCATTGCGGACCAATTCCCGGTCCACCGCTGCGTCTCGACTCGACGGTTGTGACCACCCCACTTCGCAT
TGGGCAGTCGGTAAAGCCACAACATTACTTTGCAATTTTATCGGTTGAAACTGCCGAGCGAGCTTGCGTTTTTGGGTGCTATCTTCTCCCAC
CTTTTATCAGTTAAGTTGTACAGTGAGTGTCAGCTTGTTTCGACACGTCTGTATAGACGCAACTCGGTTTGCTTGTGTTGGTTGGTGGCTGG
CCAAATCAAAGGCTATTCATTTTTCACTTGCTGTGTTCTTTGAAGAAATCAAGCAAGATGCATAAAGGAGAAGAACTTTTCACTGGAGTTGT
CCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTA
CCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGGAAAACTCGTTTTCCCGCACTATGTCACCGACCAAGATGCGATCAACC
TGATGAAGAGGCTTTTGTGTCGTCTCCCTGAGGTCCGAATCGGATGCTCCATCAACGGCTACAAGGTGGGTGAAGATTCGCCGTTCTGCCGG
GCTACACAGACTCCGGGGAACTCTGTATGCACGCTGTTTGCCGCGGAATCTGTGTAAAGAATGTGTTTCCCGTTCCTCAAAGCGAAGCTTCC
ACACCGCTTTTGGTGCACGTCAATCTTCTCCCGCTGCCTTTCTCTCTGTTTCTCTCTCGATATATATACATACATGTGTATGTATATGTATA
ATACGTATGTGCATGTGTGTGTAGATGTGTGTGTGTGTATATGCAGGGCGGTGCCTGTGCCTACGGTGTGTGTTTGTATCTTGGCATGCTTC
GCCTTACATAAGGAGGGGCGCGGGCAGACTTACGTTCCGTTTTGGTGAGGACTGTTCTGGCTTTTTAGGACATCAAGGAGCACGCATTTTTC
GGAGACTTCGACTGGGACAAACTGGCAGGTCGTGGCTTGCCGCCACCCCTCGCACCGAAAGGCGAAACCTACGCAGAAGATACTGAACAAGT
GAGAAAAATTCCATCTCTCTCCTCATTCACAGGAGTCTCCCACACACACTCTTTGTATGTACAAATAGATATGCATATATATAAATAGATAG
ATATGGACATGCATTTAGCCGCATACACACGTAGATGCATCGTATACATCGACGTACATATATGTATGTATGCATGTACGTGTGTGTATAAG
TTGTGGTCAGTGTTTTTAACGGAGATGCCCTATTCAAGGATATCTGTTCCTATATACGTGCATAGGATGACTTGATTTTTTGACAGCAGGTT
GTTCAGAAGAGATGCAAGGGGGAGGTTGTCGGATTTTTACAGTTAAGATAGAAATGCGTTTGCGTTTTTGTGTGCGTTCCGGTGTGTATGGC
GTTCAGTCCTCTTTCGAGCTGGACGAGGATGACACGATCGTTTTGGAAGACGAGTATGACTGGGACAAGGATTTCTACCCGTACGACGTCCC
GGACTACGCGTAGGAATTCATAACTTCGTATAGCATACATTATACGAAGTTATTTTTTCAGCTTAGGTGTTTGTTCCCCGTCAGTGCTGAAA
GTGCCGCTCCTTCTCTCTTCTGACTCTTCTGTGGACCTGCAACTTCCTGCATGACGAAACGATCCGTGCATAAGCATGAGCGCGATGTTCCT
CGCCCGAAATCCTTCGGCGAGGCCGGAGCCGGTGTCGGGACCGGACAGACGCAGGCAGAACATGAGAGACACACAGCAAACGACCGAAGGGG
GAGTCCGTTCGTCCGCGTGTGCGTGAATTAAAACGAGAAAGGAAAGAGACGGCGCTCTGTGCAACCTAAGGAGTCTCGTTCTTTAGCTTTAT
TCGAGGAAATAGCGAATGATTCCTCTCTCGTGAGAGAAAGTGTGAGAGCACAACGTAGACGTACGTGAGGTTTTGCGTTGCTCCACAATCTA
GCGGGAGAGAACATCGGGCATGAGATAGGTGTACGTTTCTCGAAGTCACCGTTTCACGCCATGTTCCCTCTCGCTCTGTTTTCGTGAAAGCG
GGCGTGGTCTGGGGAGCATAAAATTGGAGTCGAAGTCTGATTCGATCTGGAAGGACTTTGCTTACCGGACTCAAGTACTGCTTTCTGTAGAT
ACTCATTTCAAAGTTCGTTCCTACTCGTTTCCTCAGTTCAAGTCAACAAATCCTTTGTTCACAGTTTGCGCCGTTACCTTCAGAGGAGCGTA
CTGACAAGCATCTCTGCGTATTTAGCGGTGCATAACGCACGCACAATAAGCATGATAGGGAGATACGTGTGTGTATAGTATGGGTGACACAT
GTTTTTATACAGATTTATATTTATGTATTTGAGTTTGTGGCCACGGTGCACTGCACTACACCAAAATAGCGATGCTGCGCGCGTAAAAGACG
TCGCTTTTCTCTACGATGGGAGAGTTCAGGAGTGCTTGGGAGGGGCAACTTCGAGGCGAAATCGGATTTTCGGGGTGTGGAAGGCCAAGTTG
AATGTGTCGTTTTTCTACAAGGAGCAGAGTCGCAGAAAAGCACTAGTGGATCCCCCTCCACCGCGGTGTCACTGTAGCCTGCCAGAACACTT
GTCAACCGACTGTGTCCACATTTTTATGCGCACTGACTGGCATGAATGGCCAGAGGCAGGCATCAGCAAGTCACGTAGGCCAACGCGTGCGC
AGAAACGCTCAAGGCTCGATTGTGGGTGGGGGTTGGTAGCATTTTATCGACCTAAACAAGGTTTACACTTAGGTGGTGCGGTTTTACTGATC
TGGACGGATTCAGCGGTCGCAGATTATCGATCTGCAAATGGTGTACACTTAGGTGTCGCGGCTTATTTAGTTAAGGGAGCTTCGTGGTCGGA
GCCTAACAAGTCAACAGAGACGTATCGCCAATCGTTCGCGGTGAAGAGTCGAAACTGACAGCACATCGTAGGGAAACTGAGAGGGTGCTCCT
TTCTCTCCGTCGTTTGCGCTGCACCATCCTGCAAGTGCATAGAAGGAAAGTTGTCTGCTGTCGTGGGCAGACAGCAACAGTCCAGCACTCTA
GCGGCATACAGAACGATAACGCATTCACGAGTGGATACACGCACATCTGCGTCACCCGCAACTCGCTTTCGTTCTGATTGACAAAAAGAAAA
CAAGGCGAGGTGAGACTGTGTGAAATGCCACATGAAGAGTCATCCCTTTTCTTCGATAAAGGACACAGGGGTCTCTGGCACCCCCTCGTCAG
CTCTCTCCGACCCGAGGCACTCTCCCTGATCCCTCCGAAAAGAGAGGAAAACGAGAGACGGGCAGCTTCTGTAGGGCTATGCAGGGTTTACT
TCTCGAACTTTTTGCGAGCGGCGTCGCTCAGGACGGCGACGTGGTCGAAGTCGCGGAACATCTCGTTGAAGTCGTAGCAGCAACCAACGATC
CAGACGTCTTCAATGCTGAAGCCGACGAAGTCGCCCTTCAAGCTGTTGGAGCGATCTGTGCGCTTCTCGACGAGGGTGGCGATTCTCATCGA
CTTGGGACCGACGGCTTTCAGGCGCTCACCGAACTCGGTGAGGGTGAAACCGGTGTCGACGATGTCCTCAACAATCAGAACGTGCTTGTCGC
GAAAGATTGACAAGTCGTCGCTCAAGACGGTGAGCTGGCCTGTGCTGTTGTCGTTCTGGTAGGACTTCAGGCGGACATAGTGCTCGAAGAAG
GGGGGCACGCTGGACTCACGACCACTGTACTTCTGTATGGTGGCAAGGTAGTCGATCAGAAGGTTGAAGAAGCCGCGAGAGCCTTTCAGGAT
GCAAATGATGTGCAACTCCTCGCCGAAGTAAGTTCTGTGGATGTCATACGCCAACTTCTCAACTCTGTCCTTGACCAATCCACCAGGGAGGA
GGATTTTGTCAATGTAGGGCTTGCAGTGGGGGGGCACAAGAAAGTCATCAGCGTTGTAGAAGGTGTTGTCGGGGATATACATGGGCTCAATA
CGGCCCTTGCCCTTGCCGTAGTCTTCAATGGGTTTGGACGCCATTTTGGATCTGACAACGCCCCGTAGAGCAGAAACGCACTACTAAAGCGA
AACTTCACCCGTCCCTGCTGCACTCAGAGCAGTGCTCCGCACTGCCGTGTGGTAAAATGAAAAGGTTCTACGAGACACGCGTCTCCGGATCG
ACAAGCGAAGGATCTGCACACCTGGTCTCGATGTCGAACAAAGCACGGAGGAGAGACGGAAAGTGCTTACATCGAACACGGTTATCAAACCC
GAGAAAAAGAAACGAACAGAAGAAAAAGGAAACCTCCGCATACTTTTAAAGAATGAAGTTCCCCGATTTTCCCAAAAATGGCGTCATTTTCG
CGCACGGCAGTCAGATAACAGGTGTAGCGGCTGCCCACCAACAGAGACGGCGCGGCCGACAGGACGCTACTGGGACTGCGAACAGCAGCAAG
ATCGGATCTTCCGCGGGCGGGTTTGAATGCAAGGTTTCGTGCTGATCATAACTTCGTATAGCATACATTATACGAAGTTATAAGCTTGCTAG
CGTTAACGGGCCCCGTACC 
 
 
 
NcoI                                                         EcoRI 
 
TgPKG-3’UTR TgPKG-3`end 
HXGPRT ORF HA-epitope tag 
5`and 3`UTRs of TgDHFR/TS 
 
SpeI 
loxP sites 
 
150 
 
G) Plasmid of pTKO-DHFR/TS-RhoGC-HA  
 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTG
CCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTC
CGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCAT
AGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAG
AGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGG
GATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGT
AAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTT
ATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGG
AAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATG
GCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGAT
CGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCT
TTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAAT
ACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATC
CAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAA
ATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTAT
TGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGC
GCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCG
CTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTA
CGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGA
GTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGC
CGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGC
CATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGA
TTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATT
GGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGATTCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCC
CACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGCGTCTCAGCTGCGCGAGGCACCCCTCTCATAGCGTGGTACTCGTCACGAA
TACCAATCGCTGGGGTCGCGGCGGGAGGAATATGCTGTTTGTTGACCATACGATCACGCTGAACGAAAACATGGTATGAGACGCCGTAAGCG
GGCACAGGTTGTTTGCCCTCGTCTCATTGCGGACCAATTCCCGGTCCACCGCTGCGTCTCGACTCGACGGTTGTGACCACCCCACTTCGCAT
TGGGCAGTCGGTAAAGCCACAACATTACTTTGCAATTTTATCGGTTGAAACTGCCGAGCGAGCTTGCGTTTTTGGGTGCTATCTTCTCCCAC
151 
 
CTTTTATCAGTTAAGTTGTACAGTGAGTGTCAGCTTGTTTCGACACGTCTGTATAGACGCAACTCGGTTTGCTTGTGTTGGTTGGTGGCTGG
CCAAATCAAAGGCTATTCATTTTTCACTTGCTGTGTTCTTTGAAGAAATCAAGCAAGATGCATATGAAAGATAAGGATAATAACCTGAGAGG
AGCTTGTTCTAGCTGTAACTGCCCTGAATACTGTTTTAGCCCAACTTCCACCCTGTGCGACGATTGCAAGTGTTCCGTGACCAAACACCCAA
TCGTCGAACAGCCCCTGTCCCGAAACGGATCTTTCCGGAGCTCCGGAGCAAGTCTGCTGCCATCACCTTCTAGTCCCAATGTGAAGATTACC
TCTACAGTCGGCCTGCGGAGTAGAAAAAGCGAGTCCCAGGCAAACGTGCGCGGGTCTATGATCTCTAACAGTAATTCAGGAAGCCGATCCAA
CAATAGTGGAGGAGCAGGAGGAGGGTCAGGAGGCTCAAGCTCCTCTAAGGGGGGCAGCGCCCTGGCTAACTACCAGTCCGCTATGTCTGAGC
TGTGGTCTTGGAATATGATGCTGAGTACTCCTTCACTGAAATTCCTGACCGTGCAGTTTACCACATGGATTGTGCTGACTACCGTCGGCGCC
ATCTACACTCTGTTCTTTCATGAAAGACAGGCTTATAATAGGGGGTGGGCAGACATCTGGTACGGCTATGGGGCTTTCGGATTTGGCCTGGG
GCTGAGCTTCGCATATATGGGCTTCACCGGCGCCAGAAACCCAGAGAAGAAAGCTCTGAGCCTGTGCCTGCTGGGGGTGAATTTCATTAGCT
TTATGTCCTACATCATCATCATGCTGCGGCTGACTCCCACCATCGAAGGCACCATGGCCAACCCAGTGGAGCCCGCTAGATATCTGGAATGG
ATCGCCACTTGCCCTGTCCTGATCCTGCTGATTAGCGAGATCACCCAGTACCCTCACGACCCATATAAAGTGATCGTCAATGATTACGCCCT
GTGCCTGGCAGGATTCGTGGGAGCAATCAGCGCCCAGCAGCCATGGGGCGACCTGGCACATTTCGTGAGCTGCCTGTGCTTTTCCTACGTGG
TCTATTCTCTGTGGAGTTGCTTCACAGGGGCTATCGATGGAGAGACTCAGTGTAACGTGGAAAAAAGCGGCCTGAGGTGGATTCGCTTTTCA
ACAATCACAACTTGGAGCCTGTTCCCCATTACCTGGTTTTCATATACAAGCGGCCTGATCTCTTTCACTGTGGCAGAGGCCGGGTTTAGTAT
GATTGACATCGGAGCCAAGGTCTTCCTGACCCTGGTGCTGGTCAACAGCACAGTGGAACAGGCACAGAATCAGAAAGTCGACGCCATTACCG
CTATCGCAGAGGAACTGGAGAACCAGATTAACAATTGTGATGCCATCCTGCAGAAGATGATGCCCGAGGGCGTGCTGGAACAGCTGAAGAAT
GGGCAGGCTACTGAGGCAAAAGAGTACGAATCCGTGACCGTCTTCTTTTCTGATATTACTAACTTTACCGTGATCAGTTCAAGGACATCCAC
TAAGGACATGATGGCCACCCTGAACAAGCTGTGGCTGGAATATGATGCCATTGCTAAGCGGTGGGGAGTGTATAAAGTCGAGACAATCGGCG
ACGCTTATCTGGGAGTGACTGGAGCACCAGACGTGGTCCCTGATCACGCAGAGCGAGCTTGCAACTTCGCCGTGGATATCATCGAAATGATT
AAGAGCTTTAAAACCATCACAGGCGAGTCCATTAACATCCGCATTGGCCTGAATAGCGGACCTGTGACCGCAGGAGTCCTGGGCGACCTGAA
CCCACACTGGTGTCTGGTGGGAGATACAGTCAATACTGCCTCCCGGATGGAATCTACAAGTAAAGCTGGCCACATCCATATTTCAGAGAGCA
CCTACCATTTCATCAAGTCTAAATTTGTGACACAGCCTCTGGATGTGATGGAGGTGAAAGGCAAAGGCAAAATGCAGACTTATTGGGTGCTG
GGCAGAAAATACCCGTACGACGTCCCGGACTACGCGTAGTTAATTAAGACTACGACGAAAGTGATGCGCAGGCTGGAAAGCCGCTGAAGGGA
GAAGTCTACAAAGCCGATCAGTGAAAAATGTGTGGGGAGGTGGTCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGTGTTCGAATGCAGTG
CGTGTATCAGTTGTGCGCGGAAGGACACTGCTTCAATGTTAAGAACCTGTTTTCTCCGTAGAGAGGACCAAAAGACGATTGCAAAACTGGTA
TGTACGCAATAGCCCAATGCCGGACGTCAGTTGGTTGTATGTGACGCTCCCAGATGTCATATGCCTTGTGAGTGTGTCTGGGATGCAAGTTT
TTGGTGTGCGTTGATTTCGCCAGCTTATGACAGTGGCAGACGAATTATTGACATGATACAAGGACGCAGAAAGGAACAAACACCGTAGTTCC
AGTCGACGGATCCCACCGCGGTGGCGGCCGCACTGCAGGGTACCCTCGAGGATATCGAATTCATAACTTCGTATAGCATACATTATACGAAG
TTATGACTACGACGAAAGTGATGCGCAGGCTGGAAAGCCGCTGAAGGGAGAAGTCTACAAAGCCGATCAGTGAAAAATGTGTGGGGAGGTGG
TCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGTGTTCGAATGCAGTGCGTGTATCAGTTGTGCGCGGAAGGACACTGCTTCAATGTTAAG
AACCTGTTTTCTCCGTAGAGAGGACCAAAAGACGATTGCAAAACTGGTATGTACGCAATAGCCCAATGCCGGACGTCAGTTGGTTGTATGTG
ACGCTCCCAGATGTCATATGCCTTGTGAGTGTGTCTGGGATGCAAGTTTTTGGTGTGCGTTGATTTCGCCAGCTTATGACAGTGGCAGACGA
ATTATTGACATGATACAAGGACGCAGAAAGGAACAAACACCGTAGTTCCAGTCGACGGATCCACTAGTGGATCGATCCCCCGGGCTGCAGGA
ATTCATCCTGCAAGTGCATAGAAGGAAAGTTGTCTGCTGTCGTGGGCAGACAGCAACAGTCCAGCACTCTAGCGGCATACAGAACGATAACG
CATTCACGAGTGGATACACGCACATCTGCGTCACCCGCAACTCGCTTTCGTTCTGATTGACAAAAAGAAAACAAGGCGAGGTGAGACTGTGT
GAAATGCCACATGAAGAGTCATCCCTTTTCTTCGATAAAGGACACAGGGGTCTCTGGCACCCCCTCGTCAGCTCTCTCCGACCCGAGGCACT
CTCCCTGATCCCTCCGAAAAGAGAGGAAAACGAGAGACGGGCAGCTTCTGTATTTCCGCTAGACAGCCATCTCCATCTGGATTCGTCCGTGC
GGGACGTAGCCCACGACCTCAAAATCCTCGGCGGTGAAATCGTCGATTTCCTTGATGCGTTCCTTGTTGAGGATGTTCACAATGGGGAACGG
TCTCGGTTCTCTCCGCAGCTGCTCTTTTAAAGCCTCGACATGGTTCGTGTAGACATGCGTGTTCCCCATGAAGTGAATGAACTCCTTAGGTT
TTAGGTTGCAGACGTGTGCAACCATGAGCGTCAAAAGCGAATAGGAAGCGATGTTGAAGGGGACGCCGAGGCCGACATCGCACGACCGCTGA
TACATGATGCACGACAGCTCCTTCTGGTCGTTCACGTAGAACTGGCACAACAAGTGACAAGGCGGCAGCGCCATTTCGTCCAGCGCTGCAGG
ATTCCAGGCAGTCATGAGCATGCGACGATCTGTTGGATTCGTTCTCAGCATCTGGATCACATTCTTCAGCTGGTCGACGCCCTGCCCTGTGT
AGTCTGTGTGCATGTCTTTGTATGCCGCGCCGAAGTGTCTCCACTGGAAGCCGTAGCCCGGGCCGATGTCTCCGACCTCTCGGTGGGGGAGA
TTGCGCGAATCGAGGAACTCGCGTGTCACATTCTTGTCCCAGATCTTCACGCCCTTCTCAGAAAGATGGTTTGCGTTCGTGTCGCCGCGAAT
GAACCACAGCAACTCTTCGAGGACCCCTTTCCAGAACACACGCTTTGTGGTGAGAAGTGGAAAGGCCTGATCCAGCGAGTAGCGCATAGTGC
AGCCGAATTTGGAGATGACACCAACGCCCGTTCGGTCATCCATTGTCCTTCCATTGTTAATAATGTCGGCAATGAGATCAAGGTACTGGAAT
TCTTCATGGCCTCTAAAGTGAACATGCGGAACGGCCCGAATCAGTTCCTTTTGCTCGCGTTTTTTCCGGTCTTCTTCGTCCATCCACGCCAA
CACCGGGGCAATGGCTGCGGCCGAAGAAGGAGCCTGCAACCCGTGCACGGGAGTTGTCTCCCTCGTGGACGTCAAGGAGCTCATTGCGTTGC
TCGGTTCCGCAGTGGCTGCGTCGTCAGTCTTCCTTCTCTTCTCGAGAACCACAAAGTCGTAGGGTACCCCGTTGTCTGAGAAGGTCTTGGAA
ATGAAGATGGGTCGATACGTCGCTTCATTGTCCTTCTCTCTTCCGAGCTCCGGACAAAAGGGAACGAACACAGACTCGGCAGGAGCTGCAGC
CTGCGCAGCAGTTGATTTGTTTGAAAGAATGTCATCTCCGGGGAACGCAGGGAAGAAAACGTCGCACGGAAACTCGCGGGCTACACGCGTGA
TGTACAGGTGAGAGGCAACGCCCAGAGACAGCGCTGCCTCGTACAGTCCCGCTCCTCCCACGACAAAAATCTGGTCGACAGAATCCTTGTAC
TCTTCCTCCAGAAGGCTGAGAGCTGCTGGGAGTGAAGCACAGACTCGGACGCGCTGCTGGCCTTCAGCTTGAGGCTTCTCCGCCGCAATGTC
TTCTTCTTTGAGGGAAGAGGAAACGACGATGTTCAATCTGTCCACGAGGGGTCTAAACTTTCGAGGCATGCTTTCCCAGGTTTTCCGTCCCA
TGACAACGGCGTTGAATCTCTTGCCGACTGATGGAGAGGGAAGTCCAGAGTCGCCCGTCTTTGCAAATTTCCTGGGAAGCCACCCGTTCAGG
CGACTGGCTTCTTCGGGCGTCGTTTTTGTCACACGAGAAAAGTGTTTGAAATCTGTGGTCAAGTGGGGCCACGGGAGGCCGTTGTTGATGCC
GATGCCCCTCTTGGGGGTCATCGCGACGACCAGACACACCGGTTTCTGCATCTTCCCAGACACGACAACGCCCCGTAGAGCAGAAACGCACT
ACTAAAGCGAAACTTCACCCGTCCCTGCTGCACTCAGAGCAGTGCTCCGCACTGCCGTGTGGTAAAATGAAAAGGTTCTACGAGACACGCGT
CTCCGGATCGACAAGCGAAGGATCTGCACACCTGGTCTCGATGTCGAACAAAGCACGGAGGAGAGACGGAAAGTGCTTACATCGAACACGGT
TATCAAACCCGAGAAAAAGAAACGAACAGAAGAAAAAGGAAACCTCCGCATACTTTTAAAGAATGAAGTTCCCCGATTTTCCCAAAAATGGC
GTCATTTTCGCGCACGGCAGTCAGATAACAGGTGTAGCGGCTGCCCACCAACAGAGACGGCGCGGCCGACAGGACGCTACTGGGACTGCGAA
CAGCAGCAAGATCGGATCTTCCGCGGGCGGGTTTGAATGCAAGGTTTCGTGCTGTCGAAAAAGAGAATGGAACTTAATGTCCACGTAGTTCG
CGCATGAAAAGCGTCCTACCACTCAAAAAAGACAAAAACCGCACTCGCGGCGTTGAATGTGCGGGGGAACGGATGGCTCTCTTTTTTGGAAA
GCGAATGCAAAAAGACAAGACGCAGACGCATACAACGTTAGTCCCCTGGCACGAGAGATAGAGGTGCTGGGGGCCATTGCGGTGTCGTGGAT
TTACCAGTCATGGACGAGATCGTTCCGGAGCCTGTCTTTCCTGAAAGTCTGAAAAAATTGCGGGAAAGTCACGCATATGGAACAGCACCGGG
GCGGGACAGAGTTGTCTCGACAACGAATGACACACAGGAACTACGCGGGGGGTGAAAATCGAATGACATGCTAGCGTTCAACTTCTGGAAAG
GTGGTGGCTTCTCGATCAGGAAACTCCGTTTTCTAGTGTTGAACAGGTGCGCTCCGAGAAATCGCACGCGGGCTAATACGTGGTAAGACAAA
152 
 
AGACCAGCCTGTCGCCGGATTTAGAAGTCGTGGCACTACATACGGACCTCTGTACGAGACATGCCGATGCCAAGGGCGTTATCTGGTGCCTG
TGACCGCCAGTTTCAGACAGTACGCGTCTACTAAGTTTGAAAACGCATATGAACGCGTTTGTCGGTTACCATTCATTCTGCAACTGTCTCAG
GCATTGCGTGAGCAAAGCGAGCGCCTCGCTGGTAGTCCCAACTGAATATTATCGAGTAAGCACACTACTCCACGGACATCCCTAGCGCTCTT
ACCTGTTCGTAGGGCTAGAGAAATGATTCGGATATGGTTACACGTGACCACGCCAAAGTAGAAAGGAATTAGCATAACTCAGTCAGGCAGTC
TCCCTGAGGACACCTGCTTGATGATTTGTGAGGACGACTCACGGGATTTACAGCCTGGCGAAGCTTGCTAGCGTTAACGGGCCCCGTACC
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CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTG
CCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTC
CGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCAT
AGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAG
AGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGG
GATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGT
AAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
153 
 
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTT
ATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGG
AAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATG
GCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGAT
CGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCT
TTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAAT
ACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATC
CAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAA
ATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTAT
TGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGC
GCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCG
CTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTA
CGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGA
GTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGC
CGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGC
CATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGA
TTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATT
GGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGATTCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCC
CACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGCGTCTCAGCTGCGCGAGGCACCCCTCTCATAGCGTGGTACTCGTCACGAA
TACCAATCGCTGGGGTCGCGGCGGGAGGAATATGCTGTTTGTTGACCATACGATCACGCTGAACGAAAACATGGTATGAGACGCCGTAAGCG
GGCACAGGTTGTTTGCCCTCGTCTCATTGCGGACCAATTCCCGGTCCACCGCTGCGTCTCGACTCGACGGTTGTGACCACCCCACTTCGCAT
TGGGCAGTCGGTAAAGCCACAACATTACTTTGCAATTTTATCGGTTGAAACTGCCGAGCGAGCTTGCGTTTTTGGGTGCTATCTTCTCCCAC
CTTTTATCAGTTAAGTTGTACAGTGAGTGTCAGCTTGTTTCGACACGTCTGTATAGACGCAACTCGGTTTGCTTGTGTTGGTTGGTGGCTGG
CCAAATCAAAGGCTATTCATTTTTCACTTGCTGTGTTCTTTGAAGAAATCAAGCAAGATGCATATGGGAGTGCAGGTGGAAACCATCTCCCC
AGGAGACGGGCGCACCTTCCCCAAGCGCGGCCAGACCTGTGTGGTGCACTACACCGGGATGCTTGAAGATGGAAAGAAAGTCGATTCCTCCC
GGGACAGAAACAAGCCCTTTAAGTTTATGCTAGGCAAGCAGGAGGTGATCCGAGGCTGGGAAGAAGGGGTTGCCCAGATGAGTGTGGGTCAG
AGAGCCAAACTGACTATATCTCCAGATTATGCCTATGGTGCCACTGGGCACCCAGGCATCATCCCACCACATGCCACTCTCGTCTTCGATGT
GGAGCTTCTAAAACCGGAACCTCTGCAGATGAAAGATAAGGATAATAACCTGAGAGGAGCTTGTTCTAGCTGTAACTGCCCTGAATACTGTT
TTAGCCCAACTTCCACCCTGTGCGACGATTGCAAGTGTTCCGTGACCAAACACCCAATCGTCGAACAGCCCCTGTCCCGAAACGGATCTTTC
CGGAGCTCCGGAGCAAGTCTGCTGCCATCACCTTCTAGTCCCAATGTGAAGATTACCTCTACAGTCGGCCTGCGGAGTAGAAAAAGCGAGTC
CCAGGCAAACGTGCGCGGGTCTATGATCTCTAACAGTAATTCAGGAAGCCGATCCAACAATAGTGGAGGAGCAGGAGGAGGGTCAGGAGGCT
CAAGCTCCTCTAAGGGGGGCAGCGCCCTGGCTAACTACCAGTCCGCTATGTCTGAGCTGTGGTCTTGGAATATGATGCTGAGTACTCCTTCA
CTGAAATTCCTGACCGTGCAGTTTACCACATGGATTGTGCTGACTACCGTCGGCGCCATCTACACTCTGTTCTTTCATGAAAGACAGGCTTA
TAATAGGGGGTGGGCAGACATCTGGTACGGCTATGGGGCTTTCGGATTTGGCCTGGGGCTGAGCTTCGCATATATGGGCTTCACCGGCGCCA
GAAACCCAGAGAAGAAAGCTCTGAGCCTGTGCCTGCTGGGGGTGAATTTCATTAGCTTTATGTCCTACATCATCATCATGCTGCGGCTGACT
CCCACCATCGAAGGCACCATGGCCAACCCAGTGGAGCCCGCTAGATATCTGGAATGGATCGCCACTTGCCCTGTCCTGATCCTGCTGATTAG
CGAGATCACCCAGTACCCTCACGACCCATATAAAGTGATCGTCAATGATTACGCCCTGTGCCTGGCAGGATTCGTGGGAGCAATCAGCGCCC
AGCAGCCATGGGGCGACCTGGCACATTTCGTGAGCTGCCTGTGCTTTTCCTACGTGGTCTATTCTCTGTGGAGTTGCTTCACAGGGGCTATC
GATGGAGAGACTCAGTGTAACGTGGAAAAAAGCGGCCTGAGGTGGATTCGCTTTTCAACAATCACAACTTGGAGCCTGTTCCCCATTACCTG
GTTTTCATATACAAGCGGCCTGATCTCTTTCACTGTGGCAGAGGCCGGGTTTAGTATGATTGACATCGGAGCCAAGGTCTTCCTGACCCTGG
TGCTGGTCAACAGCACAGTGGAACAGGCACAGAATCAGAAAGTCGACGCCATTACCGCTATCGCAGAGGAACTGGAGAACCAGATTAACAAT
TGTGATGCCATCCTGCAGAAGATGATGCCCGAGGGCGTGCTGGAACAGCTGAAGAATGGGCAGGCTACTGAGGCAAAAGAGTACGAATCCGT
GACCGTCTTCTTTTCTGATATTACTAACTTTACCGTGATCAGTTCAAGGACATCCACTAAGGACATGATGGCCACCCTGAACAAGCTGTGGC
TGGAATATGATGCCATTGCTAAGCGGTGGGGAGTGTATAAAGTCGAGACAATCGGCGACGCTTATCTGGGAGTGACTGGAGCACCAGACGTG
GTCCCTGATCACGCAGAGCGAGCTTGCAACTTCGCCGTGGATATCATCGAAATGATTAAGAGCTTTAAAACCATCACAGGCGAGTCCATTAA
CATCCGCATTGGCCTGAATAGCGGACCTGTGACCGCAGGAGTCCTGGGCGACCTGAACCCACACTGGTGTCTGGTGGGAGATACAGTCAATA
CTGCCTCCCGGATGGAATCTACAAGTAAAGCTGGCCACATCCATATTTCAGAGAGCACCTACCATTTCATCAAGTCTAAATTTGTGACACAG
CCTCTGGATGTGATGGAGGTGAAAGGCAAAGGCAAAATGCAGACTTATTGGGTGCTGGGCAGAAAATACCCGTACGACGTCCCGGACTACGC
GTAGTTAATTAAGACTACGACGAAAGTGATGCGCAGGCTGGAAAGCCGCTGAAGGGAGAAGTCTACAAAGCCGATCAGTGAAAAATGTGTGG
GGAGGTGGTCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGTGTTCGAATGCAGTGCGTGTATCAGTTGTGCGCGGAAGGACACTGCTTCA
ATGTTAAGAACCTGTTTTCTCCGTAGAGAGGACCAAAAGACGATTGCAAAACTGGTATGTACGCAATAGCCCAATGCCGGACGTCAGTTGGT
TGTATGTGACGCTCCCAGATGTCATATGCCTTGTGAGTGTGTCTGGGATGCAAGTTTTTGGTGTGCGTTGATTTCGCCAGCTTATGACAGTG
GCAGACGAATTATTGACATGATACAAGGACGCAGAAAGGAACAAACACCGTAGTTCCAGTCGACGGATCCCACCGCGGTGGCGGCCGCACTG
CAGGGTACCCTCGAGGATATCGAATTCATAACTTCGTATAGCATACATTATACGAAGTTATGACTACGACGAAAGTGATGCGCAGGCTGGAA
AGCCGCTGAAGGGAGAAGTCTACAAAGCCGATCAGTGAAAAATGTGTGGGGAGGTGGTCTTGTTGCAGGAATGCAATGGTGTTAAGCATCGT
GTTCGAATGCAGTGCGTGTATCAGTTGTGCGCGGAAGGACACTGCTTCAATGTTAAGAACCTGTTTTCTCCGTAGAGAGGACCAAAAGACGA
TTGCAAAACTGGTATGTACGCAATAGCCCAATGCCGGACGTCAGTTGGTTGTATGTGACGCTCCCAGATGTCATATGCCTTGTGAGTGTGTC
TGGGATGCAAGTTTTTGGTGTGCGTTGATTTCGCCAGCTTATGACAGTGGCAGACGAATTATTGACATGATACAAGGACGCAGAAAGGAACA
AACACCGTAGTTCCAGTCGACGGATCCACTAGTGGATCGATCCCCCGGGCTGCAGGAATTCATCCTGCAAGTGCATAGAAGGAAAGTTGTCT
GCTGTCGTGGGCAGACAGCAACAGTCCAGCACTCTAGCGGCATACAGAACGATAACGCATTCACGAGTGGATACACGCACATCTGCGTCACC
CGCAACTCGCTTTCGTTCTGATTGACAAAAAGAAAACAAGGCGAGGTGAGACTGTGTGAAATGCCACATGAAGAGTCATCCCTTTTCTTCGA
TAAAGGACACAGGGGTCTCTGGCACCCCCTCGTCAGCTCTCTCCGACCCGAGGCACTCTCCCTGATCCCTCCGAAAAGAGAGGAAAACGAGA
GACGGGCAGCTTCTGTATTTCCGCTAGACAGCCATCTCCATCTGGATTCGTCCGTGCGGGACGTAGCCCACGACCTCAAAATCCTCGGCGGT
GAAATCGTCGATTTCCTTGATGCGTTCCTTGTTGAGGATGTTCACAATGGGGAACGGTCTCGGTTCTCTCCGCAGCTGCTCTTTTAAAGCCT
CGACATGGTTCGTGTAGACATGCGTGTTCCCCATGAAGTGAATGAACTCCTTAGGTTTTAGGTTGCAGACGTGTGCAACCATGAGCGTCAAA
AGCGAATAGGAAGCGATGTTGAAGGGGACGCCGAGGCCGACATCGCACGACCGCTGATACATGATGCACGACAGCTCCTTCTGGTCGTTCAC
GTAGAACTGGCACAACAAGTGACAAGGCGGCAGCGCCATTTCGTCCAGCGCTGCAGGATTCCAGGCAGTCATGAGCATGCGACGATCTGTTG
154 
 
GATTCGTTCTCAGCATCTGGATCACATTCTTCAGCTGGTCGACGCCCTGCCCTGTGTAGTCTGTGTGCATGTCTTTGTATGCCGCGCCGAAG
TGTCTCCACTGGAAGCCGTAGCCCGGGCCGATGTCTCCGACCTCTCGGTGGGGGAGATTGCGCGAATCGAGGAACTCGCGTGTCACATTCTT
GTCCCAGATCTTCACGCCCTTCTCAGAAAGATGGTTTGCGTTCGTGTCGCCGCGAATGAACCACAGCAACTCTTCGAGGACCCCTTTCCAGA
ACACACGCTTTGTGGTGAGAAGTGGAAAGGCCTGATCCAGCGAGTAGCGCATAGTGCAGCCGAATTTGGAGATGACACCAACGCCCGTTCGG
TCATCCATTGTCCTTCCATTGTTAATAATGTCGGCAATGAGATCAAGGTACTGGAATTCTTCATGGCCTCTAAAGTGAACATGCGGAACGGC
CCGAATCAGTTCCTTTTGCTCGCGTTTTTTCCGGTCTTCTTCGTCCATCCACGCCAACACCGGGGCAATGGCTGCGGCCGAAGAAGGAGCCT
GCAACCCGTGCACGGGAGTTGTCTCCCTCGTGGACGTCAAGGAGCTCATTGCGTTGCTCGGTTCCGCAGTGGCTGCGTCGTCAGTCTTCCTT
CTCTTCTCGAGAACCACAAAGTCGTAGGGTACCCCGTTGTCTGAGAAGGTCTTGGAAATGAAGATGGGTCGATACGTCGCTTCATTGTCCTT
CTCTCTTCCGAGCTCCGGACAAAAGGGAACGAACACAGACTCGGCAGGAGCTGCAGCCTGCGCAGCAGTTGATTTGTTTGAAAGAATGTCAT
CTCCGGGGAACGCAGGGAAGAAAACGTCGCACGGAAACTCGCGGGCTACACGCGTGATGTACAGGTGAGAGGCAACGCCCAGAGACAGCGCT
GCCTCGTACAGTCCCGCTCCTCCCACGACAAAAATCTGGTCGACAGAATCCTTGTACTCTTCCTCCAGAAGGCTGAGAGCTGCTGGGAGTGA
AGCACAGACTCGGACGCGCTGCTGGCCTTCAGCTTGAGGCTTCTCCGCCGCAATGTCTTCTTCTTTGAGGGAAGAGGAAACGACGATGTTCA
ATCTGTCCACGAGGGGTCTAAACTTTCGAGGCATGCTTTCCCAGGTTTTCCGTCCCATGACAACGGCGTTGAATCTCTTGCCGACTGATGGA
GAGGGAAGTCCAGAGTCGCCCGTCTTTGCAAATTTCCTGGGAAGCCACCCGTTCAGGCGACTGGCTTCTTCGGGCGTCGTTTTTGTCACACG
AGAAAAGTGTTTGAAATCTGTGGTCAAGTGGGGCCACGGGAGGCCGTTGTTGATGCCGATGCCCCTCTTGGGGGTCATCGCGACGACCAGAC
ACACCGGTTTCTGCATCTTCCCAGACACGACAACGCCCCGTAGAGCAGAAACGCACTACTAAAGCGAAACTTCACCCGTCCCTGCTGCACTC
AGAGCAGTGCTCCGCACTGCCGTGTGGTAAAATGAAAAGGTTCTACGAGACACGCGTCTCCGGATCGACAAGCGAAGGATCTGCACACCTGG
TCTCGATGTCGAACAAAGCACGGAGGAGAGACGGAAAGTGCTTACATCGAACACGGTTATCAAACCCGAGAAAAAGAAACGAACAGAAGAAA
AAGGAAACCTCCGCATACTTTTAAAGAATGAAGTTCCCCGATTTTCCCAAAAATGGCGTCATTTTCGCGCACGGCAGTCAGATAACAGGTGT
AGCGGCTGCCCACCAACAGAGACGGCGCGGCCGACAGGACGCTACTGGGACTGCGAACAGCAGCAAGATCGGATCTTCCGCGGGCGGGTTTG
AATGCAAGGTTTCGTGCTGTCGAAAAAGAGAATGGAACTTAATGTCCACGTAGTTCGCGCATGAAAAGCGTCCTACCACTCAAAAAAGACAA
AAACCGCACTCGCGGCGTTGAATGTGCGGGGGAACGGATGGCTCTCTTTTTTGGAAAGCGAATGCAAAAAGACAAGACGCAGACGCATACAA
CGTTAGTCCCCTGGCACGAGAGATAGAGGTGCTGGGGGCCATTGCGGTGTCGTGGATTTACCAGTCATGGACGAGATCGTTCCGGAGCCTGT
CTTTCCTGAAAGTCTGAAAAAATTGCGGGAAAGTCACGCATATGGAACAGCACCGGGGCGGGACAGAGTTGTCTCGACAACGAATGACACAC
AGGAACTACGCGGGGGGTGAAAATCGAATGACATGCTAGCGTTCAACTTCTGGAAAGGTGGTGGCTTCTCGATCAGGAAACTCCGTTTTCTA
GTGTTGAACAGGTGCGCTCCGAGAAATCGCACGCGGGCTAATACGTGGTAAGACAAAAGACCAGCCTGTCGCCGGATTTAGAAGTCGTGGCA
CTACATACGGACCTCTGTACGAGACATGCCGATGCCAAGGGCGTTATCTGGTGCCTGTGACCGCCAGTTTCAGACAGTACGCGTCTACTAAG
TTTGAAAACGCATATGAACGCGTTTGTCGGTTACCATTCATTCTGCAACTGTCTCAGGCATTGCGTGAGCAAAGCGAGCGCCTCGCTGGTAG
TCCCAACTGAATATTATCGAGTAAGCACACTACTCCACGGACATCCCTAGCGCTCTTACCTGTTCGTAGGGCTAGAGAAATGATTCGGATAT
GGTTACACGTGACCACGCCAAAGTAGAAAGGAATTAGCATAACTCAGTCAGGCAGTCTCCCTGAGGACACCTGCTTGATGATTTGTGAGGAC
GACTCACGGGATTTACAGCCTGGCGAAGCTTGCTAGCGTTAACGGGCCCCGTACC 
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I) Plasmid of pDHFR-UPKO-RhoGC-3xHA  (generated by Claudia Ufermann) 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTG
CCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTC
CGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCAT
AGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAG
AGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGG
GATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGT
AAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTT
ATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGG
AAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATG
GCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGAT
CGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCT
TTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAAT
ACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATC
CAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAA
ATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTAT
TGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGC
GCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCG
CTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTA
CGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGA
GTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGC
CGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGC
CATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGA
TTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATT
GGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGATTCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCC
CACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGTTGTAAGCGGCAAAAGGACGCGAAAATGGTGGGAGCAGCAAAGACAGCTA
AAACGCCACAGCATTAATATTCTCCATTAAGACTCATATGCCGAAGAAAGATGCAGTGTGTAGAAACCTGTGAAGTCCGTATTCTCATCTGT
AACAGAGAGACTAGCTTTAGTTGTTTTCCGACACGTCCTGGATCACCCGCGTTACTTTGTCTTCTAACCGTTCTGTCACTACTGGCTCTCTC
CCTGAGCTGCACGTGAGCTCATGCTGGAGCTTCGTATGGATAGGGTTACCCTGGTACACTCGGAAATGTTCTTTGAACGCGGCTGGTGTGGC
TTCTTGTCCCTGGGTGTTTCCTCTCCTCCTTCGACACGTGTTTTTTTCTGCTTTTTCCTGCGCCATCCGCTGTGCCTAGTATCGAAAGCTGT
AGAGTTGCCACCCTGATCTTCTCCCTTCCAACTCTCCGCTTCGACACACCCCCCAACGACTTGTTGTGAAGCTCTGGCCCCCCTGTTTCGGT
TGTGACAGGCTCTCCAGGTGCTCTTGCACTCTCCAGTCCAGCTGGTGTCATAGAACCGTTATCTCTAGAGTGCCCCGAAAGAGCCCCCTCCT
156 
 
TTTATTCGTTGTTTCCCCTGGGTACGAGCTATCTTGTGGCTTTCTTTGCTTGGGGATGACCCTTGTCGTGACCTTCTATGCGTTCTCGATGA
GAAACCGTCGAGTCTTCGTTGCATGCAGGGGTTTCTGCGCGAAGATACTCTCCCACAGAGCCACAGAAAGTGGTAGCCGCTGTTTTCCAACG
CAGCGTACGTACCTATGCAAAGCTTCGCCAGGCTGTAAATCCCGTGAGTCGTCCTCACAAATCATCAAGCAGGTGTCCTCAGGGAGACTGCC
TGACTGAGTTATGCTAATTCCTTTCTACTTTGGCGTGGTCACGTGTAACCATATCCGAATCATTTCTCTAGCCCTACGAACAGGTAAGAGCG
CTAGGGATGTCCGTGGAGTAGTGTGCTTACTCGATAATATTCAGTTGGGACTACCAGCGAGGCGCTCGCTTTGCTCACGCAATGCCTGAGAC
AGTTGCAGAATGAATGGTAACCGACAAACGCGTTCATATGCGTTTTCAAACTTAGTAGACGCGGTACTGTCTGAAACTGGCGGTCACGCAGC
ACCAGATAACGCCCTTGGCATCGGCATGTCTCGTACAGAGGTCCGTATGTAGTGCCACGACTTCTAAATCCGGCGACAGGCTGGTCTTTTGT
CTTACCACGTATTAGCCCGCGTGCGATTTCTCGGAGCGCACCTGTTCAACACTAGAAAACGGAGTTTCCTGATCGAGAAGCCACCACCTTTC
CAGAAGTTGAACGCTAGCATGTCATTCGATTTTCACCCCCCGCGTAGTTCCTGTGTGTCATTCGTTGTCGAGACAACTCTGTCCCGCCCCGG
TGCTGTTCCATATGCGTGACTTTCCCGCAATTTTTTCAGACTTTCAGGAAAGACAGGCTCCGGAACGATCTCGTCCATGACTGGTAAATCCA
CGACACCGCAATGGCCCCCAGCACCTCTATCTCTCGTGCCAGGGGACTAACGTTGTATGCGTCTGCGTCTTGTCTTTTTGCATTCGCTTTCC
AAAAAAGAGAGCCATCCGTTCCCCCGCACATTCAACGCCGCGAGTGCGGTTTTTGTCTTTTTTGAGTGGTAGGACGCTTTTCATGCGCGAAC
TACGTGGACATTAAGTTCCATTCTCTTTTTCGACAGCACGAAACCTTGCATTCAAACCCGCCCGCGGAAGATCCGATCTTGCTGCTGTTCGC
AGTCCCAGTAGCGTCCTGTCGGCCGCGCCGTCTCTGTTGGTGGGCAGCCGCTACACCTGTTATCTGACTGCCGTGCGCGAAAATGACGCCAT
TTTTGGGAAAATCGGGGAACTTCATTCTTTAAAAGTATGCGGAGGTTTCCTTTTTCTTCTGTTCGTTTCTTTTTCTCGGGTTTGATAACCGT
GTTCGATGTAAGCACTTTCCGTCTCTCCTCCGTGCTTTGTTCGACATCGAGACCAGGTGTGCAGATCCTTCGCTTGTCGATCCGGAGACGCG
TGTCTCGTAGAACCTTTTCATTTTACCACACGGCAGTGCGGAGCACTGCTCTGAGTGCAGCAGGGACGGGTGAAGTTTCGCTTTAGTAGTGC
GTTTCTGCTCTACGGGGCGTTGTCGTGTCTGGGAAGATGCATATGAAAGATAAGGATAATAACCTGAGAGGAGCTTGTTCTAGCTGTAACTG
CCCTGAATACTGTTTTAGCCCAACTTCCACCCTGTGCGACGATTGCAAGTGTTCCGTGACCAAACACCCAATCGTCGAACAGCCCCTGTCCC
GAAACGGATCTTTCCGGAGCTCCGGAGCAAGTCTGCTGCCATCACCTTCTAGTCCCAATGTGAAGATTACCTCTACAGTCGGCCTGCGGAGT
AGAAAAAGCGAGTCCCAGGCAAACGTGCGCGGGTCTATGATCTCTAACAGTAATTCAGGAAGCCGATCCAACAATAGTGGAGGAGCAGGAGG
AGGGTCAGGAGGCTCAAGCTCCTCTAAGGGGGGCAGCGCCCTGGCTAACTACCAGTCCGCTATGTCTGAGCTGTGGTCTTGGAATATGATGC
TGAGTACTCCTTCACTGAAATTCCTGACCGTGCAGTTTACCACATGGATTGTGCTGACTACCGTCGGCGCCATCTACACTCTGTTCTTTCAT
GAAAGACAGGCTTATAATAGGGGGTGGGCAGACATCTGGTACGGCTATGGGGCTTTCGGATTTGGCCTGGGGCTGAGCTTCGCATATATGGG
CTTCACCGGCGCCAGAAACCCAGAGAAGAAAGCTCTGAGCCTGTGCCTGCTGGGGGTGAATTTCATTAGCTTTATGTCCTACATCATCATCA
TGCTGCGGCTGACTCCCACCATCGAAGGCACCATGGCCAACCCAGTGGAGCCCGCTAGATATCTGGAATGGATCGCCACTTGCCCTGTCCTG
ATCCTGCTGATTAGCGAGATCACCCAGTACCCTCACGACCCATATAAAGTGATCGTCAATGATTACGCCCTGTGCCTGGCAGGATTCGTGGG
AGCAATCAGCGCCCAGCAGCCATGGGGCGACCTGGCACATTTCGTGAGCTGCCTGTGCTTTTCCTACGTGGTCTATTCTCTGTGGAGTTGCT
TCACAGGGGCTATCGATGGAGAGACTCAGTGTAACGTGGAAAAAAGCGGCCTGAGGTGGATTCGCTTTTCAACAATCACAACTTGGAGCCTG
TTCCCCATTACCTGGTTTTCATATACAAGCGGCCTGATCTCTTTCACTGTGGCAGAGGCCGGGTTTAGTATGATTGACATCGGAGCCAAGGT
CTTCCTGACCCTGGTGCTGGTCAACAGCACAGTGGAACAGGCACAGAATCAGAAAGTCGACGCCATTACCGCTATCGCAGAGGAACTGGAGA
ACCAGATTAACAATTGTGATGCCATCCTGCAGAAGATGATGCCCGAGGGCGTGCTGGAACAGCTGAAGAATGGGCAGGCTACTGAGGCAAAA
GAGTACGAATCCGTGACCGTCTTCTTTTCTGATATTACTAACTTTACCGTGATCAGTTCAAGGACATCCACTAAGGACATGATGGCCACCCT
GAACAAGCTGTGGCTGGAATATGATGCCATTGCTAAGCGGTGGGGAGTGTATAAAGTCGAGACAATCGGCGACGCTTATCTGGGAGTGACTG
GAGCACCAGACGTGGTCCCTGATCACGCAGAGCGAGCTTGCAACTTCGCCGTGGATATCATCGAAATGATTAAGAGCTTTAAAACCATCACA
GGCGAGTCCATTAACATCCGCATTGGCCTGAATAGCGGACCTGTGACCGCAGGAGTCCTGGGCGACCTGAACCCACACTGGTGTCTGGTGGG
AGATACAGTCAATACTGCCTCCCGGATGGAATCTACAAGTAAAGCTGGCCACATCCATATTTCAGAGAGCACCTACCATTTCATCAAGTCTA
AATTTGTGACACAGCCTCTGGATGTGATGGAGGTGAAAGGCAAAGGCAAAATGCAGACTTATTGGGTGCTGGGCAGAAAATACCCGTACGAC
GTCCCGGACTACGCTGGCTATCCCTATGATGTGCCCGATTATGCGTATCCTTACGATGTTCCAGATTATGCCTAATTAATTAAAGCCCTACA
GAAGCTGCCCGTCTCTCGTTTTCCTCTCTTTTCGGAGGGATCAGGGAGAGTGCCTCGGGTCGGAGAGAGCTGACGAGGGGGTGCCAGAGACC
CCTGTGTCCTTTATCGAAGAAAAGGGATGACTCTTCATGTGGCATTTCACACAGTCTCACCTCGCCTTGTTTTCTTTTTGTCAATCAGAACG
AAAGCGAGTTGCGGGTGACGCAGATGTGCGTGTATCCACTCGTGAATGCGTTATCGTTCTGTATGCCGCTAGAGTGCTGGACTGTTGCTGTC
TGCCCACGACAGCAGACAACTTTCCTTCTATGCACTTGCAGGATGGTGCAGCGCAAACGACGGAGAGAAAGGAGCACCCTCTCAGTTTCCCT
ACGATGTGCTGTCAGTTTCGACTCTTCACCGCGAACGATTGGCGATACGTCTCTGTTGACTTGTTAGGCTCCGACCACGAAGCTCCCTTAAC
TAAATAAGCCGCGACACCTAAGTGTACACCATTTGCAGATCCATAATCTGCGACCGCTGAATCCGTCCAGATCAGTAAAACCGCACCACCTA
AGTGTAAACCTTGTTTAGGTCGATAAAATGCTACCAACCCCCACCCACAATCGAGCCTTGAGCGTTTCTGCGCACGCGTTGGCCTACGTGAC
TTGCTGATGCCTGCCTCTGGCCATTCATGCCAGTCAGTGCGCATAAAAATGTGGACACAGTCGGTTGACAAGTGTTCTGGCAGGCTACAGTG
ACAGCGGCCGCCAGTACCAAGTCTGCTCTGATGAAGTGCGCCACCAGCATTCTGTTTTTTCGCTCCCACGAGGGTGGAACCTCTAGCACACA
ACTTCTCTCTTCTGAGGTTGCCGAAAAACTGTCTGCTAATTTATCGAGTTATTTGAACTACGGGACCAACGGGCAGAGACTGTTTTCACTCG
GATGTCGTACAGTTGACGTCGCGACGAAAGGCACATGACCAAGGCGATTTTTTTTATTTTCTGGTTCATCCGGCTATCCACCAGTGTTGCTT
CGGTCGATCGAACGCCAGAAACCAAAACACCTGTTAGTAACATCTGACCAGTGTCGAACCTGGAAGAAACGCAGCAGTTTGCTTACAACGAA
ATTTTCATTCCACCGGAGACGAGGGTCTGATTCCCGTGGCAATCATTGCAAGGCATCCCGTAGGAAAGGTAGGCAATATCGAAATAGATCCA
GTCGTGCTATGCAGCGTGTCCCTCGACGTTACTACGCACATCCTGTGAACAATTGCCAGGCAGCTGAACGGGTGGTGTGCTGAAGACGTATT
CCAAGATAACAAACCTCCCTGCACGGTCACTGTTTGCTTCCTGGCGATCAGATGTCGTGTGTACGGATAGCAGGTGTCTTCTGCGGTCATTT
CTCTCTCGGTGTACACAGAAAAGAGAGAAATGTAGAGCGTGGCCTGGGTACGCGTGAAAACACGCAACCGGAGGTTCTGGGAGGTACTCCAA
GGAAGCCTGTTCCGCTCAGGATTCCGAGTGGCATTCTATTTTCTGCTACACTGCATTTCCTCGGCAAAAGTGTAAGCAGGGGCCCCGTACC 
Guanylate Cyclase              Rhodopsin domain              PacI   NsiI 
TgUPRT-5'UTR  Coiled Coil        TgDHFR-3'UTR                3xHA-tag 
TgDHFR-5'UTR   NotI                                    TgUPRT-3'UTR 
157 
 
J) Plasmid of pUPKO-pTgDHFR-RhoGC-3xHA-pTgGra1-GCaMP6s 
(generated by Elena Pies under my lab supervision) 
 
 
CAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTG
CCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTC
CGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCAT
AGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCC
CCCTGGAAGCTCCCTCGTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTT
CTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGC
TGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAG
AGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGC
TGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAG
CAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGG
GATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGT
AAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTT
ATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGG
AAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATG
GCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGAT
CGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCT
TTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAAT
ACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATC
CAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAA
ATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGGTTAT
TGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGC
GCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCG
CTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTA
CGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGA
GTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGC
CGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAATTTCCATTCGC
CATTCAGGCTGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATGTGCTGCAAGGCGA
TTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGTGAGCGCGCGTAATACGACTCACTATAGGGCGAATT
158 
 
GGAGCTTCGAAGGCTGTAGTACTGGTGCTCGTATGCGACACGCGGATTCACGGCGTATGCGACAAGCGGGATTGCTGATGAGCGTCGTTCCC
CACTGAAGCGCGCGGAGTGGTGGGCGACCACCGGTCACCTGGTTGTAAGCGGCAAAAGGACGCGAAAATGGTGGGAGCAGCAAAGACAGCTA
AAACGCCACAGCATTAATATTCTCCATTAAGACTCATATGCCGAAGAAAGATGCAGTGTGTAGAAACCTGTGAAGTCCGTATTCTCATCTGT
AACAGAGAGACTAGCTTTAGTTGTTTTCCGACACGTCCTGGATCACCCGCGTTACTTTGTCTTCTAACCGTTCTGTCACTACTGGCTCTCTC
CCTGAGCTGCACGTGAGCTCATGCTGGAGCTTCGTATGGATAGGGTTACCCTGGTACACTCGGAAATGTTCTTTGAACGCGGCTGGTGTGGC
TTCTTGTCCCTGGGTGTTTCCTCTCCTCCTTCGACACGTGTTTTTTTCTGCTTTTTCCTGCGCCATCCGCTGTGCCTAGTATCGAAAGCTGT
AGAGTTGCCACCCTGATCTTCTCCCTTCCAACTCTCCGCTTCGACACACCCCCCAACGACTTGTTGTGAAGCTCTGGCCCCCCTGTTTCGGT
TGTGACAGGCTCTCCAGGTGCTCTTGCACTCTCCAGTCCAGCTGGTGTCATAGAACCGTTATCTCTAGAGTGCCCCGAAAGAGCCCCCTCCT
TTTATTCGTTGTTTCCCCTGGGTACGAGCTATCTTGTGGCTTTCTTTGCTTGGGGATGACCCTTGTCGTGACCTTCTATGCGTTCTCGATGA
GAAACCGTCGAGTCTTCGTTGCATGCAGGGGTTTCTGCGCGAAGATACTCTCCCACAGAGCCACAGAAAGTGGTAGCCGCTGTTTTCCAACG
CAGCGTACGTACCTATGCAAAGCTTCGCCAGGCTGTAAATCCCGTGAGTCGTCCTCACAAATCATCAAGCAGGTGTCCTCAGGGAGACTGCC
TGACTGAGTTATGCTAATTCCTTTCTACTTTGGCGTGGTCACGTGTAACCATATCCGAATCATTTCTCTAGCCCTACGAACAGGTAAGAGCG
CTAGGGATGTCCGTGGAGTAGTGTGCTTACTCGATAATATTCAGTTGGGACTACCAGCGAGGCGCTCGCTTTGCTCACGCAATGCCTGAGAC
AGTTGCAGAATGAATGGTAACCGACAAACGCGTTCATATGCGTTTTCAAACTTAGTAGACGCGGTACTGTCTGAAACTGGCGGTCACGCAGC
ACCAGATAACGCCCTTGGCATCGGCATGTCTCGTACAGAGGTCCGTATGTAGTGCCACGACTTCTAAATCCGGCGACAGGCTGGTCTTTTGT
CTTACCACGTATTAGCCCGCGTGCGATTTCTCGGAGCGCACCTGTTCAACACTAGAAAACGGAGTTTCCTGATCGAGAAGCCACCACCTTTC
CAGAAGTTGAACGCTAGCATGTCATTCGATTTTCACCCCCCGCGTAGTTCCTGTGTGTCATTCGTTGTCGAGACAACTCTGTCCCGCCCCGG
TGCTGTTCCATATGCGTGACTTTCCCGCAATTTTTTCAGACTTTCAGGAAAGACAGGCTCCGGAACGATCTCGTCCATGACTGGTAAATCCA
CGACACCGCAATGGCCCCCAGCACCTCTATCTCTCGTGCCAGGGGACTAACGTTGTATGCGTCTGCGTCTTGTCTTTTTGCATTCGCTTTCC
AAAAAAGAGAGCCATCCGTTCCCCCGCACATTCAACGCCGCGAGTGCGGTTTTTGTCTTTTTTGAGTGGTAGGACGCTTTTCATGCGCGAAC
TACGTGGACATTAAGTTCCATTCTCTTTTTCGACAGCACGAAACCTTGCATTCAAACCCGCCCGCGGAAGATCCGATCTTGCTGCTGTTCGC
AGTCCCAGTAGCGTCCTGTCGGCCGCGCCGTCTCTGTTGGTGGGCAGCCGCTACACCTGTTATCTGACTGCCGTGCGCGAAAATGACGCCAT
TTTTGGGAAAATCGGGGAACTTCATTCTTTAAAAGTATGCGGAGGTTTCCTTTTTCTTCTGTTCGTTTCTTTTTCTCGGGTTTGATAACCGT
GTTCGATGTAAGCACTTTCCGTCTCTCCTCCGTGCTTTGTTCGACATCGAGACCAGGTGTGCAGATCCTTCGCTTGTCGATCCGGAGACGCG
TGTCTCGTAGAACCTTTTCATTTTACCACACGGCAGTGCGGAGCACTGCTCTGAGTGCAGCAGGGACGGGTGAAGTTTCGCTTTAGTAGTGC
GTTTCTGCTCTACGGGGCGTTGTCGTGTCTGGGAAGATGCATATGAAAGATAAGGATAATAACCTGAGAGGAGCTTGTTCTAGCTGTAACTG
CCCTGAATACTGTTTTAGCCCAACTTCCACCCTGTGCGACGATTGCAAGTGTTCCGTGACCAAACACCCAATCGTCGAACAGCCCCTGTCCC
GAAACGGATCTTTCCGGAGCTCCGGAGCAAGTCTGCTGCCATCACCTTCTAGTCCCAATGTGAAGATTACCTCTACAGTCGGCCTGCGGAGT
AGAAAAAGCGAGTCCCAGGCAAACGTGCGCGGGTCTATGATCTCTAACAGTAATTCAGGAAGCCGATCCAACAATAGTGGAGGAGCAGGAGG
AGGGTCAGGAGGCTCAAGCTCCTCTAAGGGGGGCAGCGCCCTGGCTAACTACCAGTCCGCTATGTCTGAGCTGTGGTCTTGGAATATGATGC
TGAGTACTCCTTCACTGAAATTCCTGACCGTGCAGTTTACCACATGGATTGTGCTGACTACCGTCGGCGCCATCTACACTCTGTTCTTTCAT
GAAAGACAGGCTTATAATAGGGGGTGGGCAGACATCTGGTACGGCTATGGGGCTTTCGGATTTGGCCTGGGGCTGAGCTTCGCATATATGGG
CTTCACCGGCGCCAGAAACCCAGAGAAGAAAGCTCTGAGCCTGTGCCTGCTGGGGGTGAATTTCATTAGCTTTATGTCCTACATCATCATCA
TGCTGCGGCTGACTCCCACCATCGAAGGCACCATGGCCAACCCAGTGGAGCCCGCTAGATATCTGGAATGGATCGCCACTTGCCCTGTCCTG
ATCCTGCTGATTAGCGAGATCACCCAGTACCCTCACGACCCATATAAAGTGATCGTCAATGATTACGCCCTGTGCCTGGCAGGATTCGTGGG
AGCAATCAGCGCCCAGCAGCCATGGGGCGACCTGGCACATTTCGTGAGCTGCCTGTGCTTTTCCTACGTGGTCTATTCTCTGTGGAGTTGCT
TCACAGGGGCTATCGATGGAGAGACTCAGTGTAACGTGGAAAAAAGCGGCCTGAGGTGGATTCGCTTTTCAACAATCACAACTTGGAGCCTG
TTCCCCATTACCTGGTTTTCATATACAAGCGGCCTGATCTCTTTCACTGTGGCAGAGGCCGGGTTTAGTATGATTGACATCGGAGCCAAGGT
CTTCCTGACCCTGGTGCTGGTCAACAGCACAGTGGAACAGGCACAGAATCAGAAAGTCGACGCCATTACCGCTATCGCAGAGGAACTGGAGA
ACCAGATTAACAATTGTGATGCCATCCTGCAGAAGATGATGCCCGAGGGCGTGCTGGAACAGCTGAAGAATGGGCAGGCTACTGAGGCAAAA
GAGTACGAATCCGTGACCGTCTTCTTTTCTGATATTACTAACTTTACCGTGATCAGTTCAAGGACATCCACTAAGGACATGATGGCCACCCT
GAACAAGCTGTGGCTGGAATATGATGCCATTGCTAAGCGGTGGGGAGTGTATAAAGTCGAGACAATCGGCGACGCTTATCTGGGAGTGACTG
GAGCACCAGACGTGGTCCCTGATCACGCAGAGCGAGCTTGCAACTTCGCCGTGGATATCATCGAAATGATTAAGAGCTTTAAAACCATCACA
GGCGAGTCCATTAACATCCGCATTGGCCTGAATAGCGGACCTGTGACCGCAGGAGTCCTGGGCGACCTGAACCCACACTGGTGTCTGGTGGG
AGATACAGTCAATACTGCCTCCCGGATGGAATCTACAAGTAAAGCTGGCCACATCCATATTTCAGAGAGCACCTACCATTTCATCAAGTCTA
AATTTGTGACACAGCCTCTGGATGTGATGGAGGTGAAAGGCAAAGGCAAAATGCAGACTTATTGGGTGCTGGGCAGAAAATACCCGTACGAC
GTCCCGGACTACGCTGGCTATCCCTATGATGTGCCCGATTATGCGTATCCTTACGATGTTCCAGATTATGCCTAATTAATTAAAGCCCTACA
GAAGCTGCCCGTCTCTCGTTTTCCTCTCTTTTCGGAGGGATCAGGGAGAGTGCCTCGGGTCGGAGAGAGCTGACGAGGGGGTGCCAGAGACC
CCTGTGTCCTTTATCGAAGAAAAGGGATGACTCTTCATGTGGCATTTCACACAGTCTCACCTCGCCTTGTTTTCTTTTTGTCAATCAGAACG
AAAGCGAGTTGCGGGTGACGCAGATGTGCGTGTATCCACTCGTGAATGCGTTATCGTTCTGTATGCCGCTAGAGTGCTGGACTGTTGCTGTC
TGCCCACGACAGCAGACAACTTTCCTTCTATGCACTTGCAGGATGGTGCAGCGCAAACGACGGAGAGAAAGGAGCACCCTCTCAGTTTCCCT
ACGATGTGCTGTCAGTTTCGACTCTTCACCGCGAACGATTGGCGATACGTCTCTGTTGACTTGTTAGGCTCCGACCACGAAGCTCCCTTAAC
TAAATAAGCCGCGACACCTAAGTGTACACCATTTGCAGATCCATAATCTGCGACCGCTGAATCCGTCCAGATCAGTAAAACCGCACCACCTA
AGTGTAAACCTTGTTTAGGTCGATAAAATGCTACCAACCCCCACCCACAATCGAGCCTTGAGCGTTTCTGCGCACGCGTTGGCCTACGTGAC
TTGCTGATGCCTGCCTCTGGCCATTCATGCCAGTCAGTGCGCATAAAAATGTGGACACAGTCGGTTGACAAGTGTTCTGGCAGGCTACAGTG
ACAGCGGCCGCCACCGCGGTGGGATCCGTCGACTGGAACTACGGTGTTTGTTCCTTTCTGCGTCCTTGTATCATGTCAATAATTCGTCTGCC
ACTGTCATAAGCTGGCGAAATCAACGCACACCAAAAACTTGCATCCCAGACACACTCACAAGGCATATGACATCTGGGAGCGTCACATACAA
CCAACTGACGTCCGGCATTGGGCTATTGCGTACATACCAGTTTTGCAATCGTCTTTTGGTCCTCTCTACGGAGAAAACAGGTTCTTAACATT
GAAGCAGTGTCCTTCCGCGCACAACTGATACACGCACTGCATTCGAACACGATGCTTAACACCATTGCATTCCTGCAACAAGACCACCTCCC
CACACATTTTTCACTGATCGGCTTTGTAGACTTCTCCCTTCAGCGGCTTTCCAGCCTGCGCATCACTTTCGTCGTAGTCTTAATTAATCACT
TCGCTGTCATCATTTGTACAAACTCTTCGTAGTTTACCTGACCATCCCCATCGATGTCTGCTTCCCTGATCATTTCATCAACCTCTTCATCT
GTTAACTTCTCTCCAAGGTTTGTCATCACGTGGCGAAGCTCTGCTGCACTGATGTAGCCATTGCCATCCTTATCAAACACACCGAACGCTTC
TCTAATTTCTTCTTCCGTGTCCCTGTATTTCATTTTTCTTGCCATCATTGTCAGGAACTCAGGGAAGTCGATTGTGCCGTCACCGTCGGCAT
CTACTTCATTGATCATGTCCTGCAGCTCTGCTTCTGTGGGGTTCTGCCCCAGAGACCGCATCACCGTCCCCAGCTCCTTGGTTGTTATTGTC
CCATCCCCGTCCTTGTCAAATAGGGAGAAAGCCTCTTTAAATTCTGCGATCTGCTCTTCAGTCAGTTGGTCCGGCAGGTTGTACTCCAGCTT
GTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAGCTCGATGCGGTTCACCAGGGTGTCGCCCTCGAACTTCACCTCGGCGC
GGGTCTTGTAGTTGCCGTCGTCCTTGAAGAAGATGGTGCGCTCCTGGATGTAGCCTTCGGGCATGGCGGACTTGAAGAAGTCGTGCTGCTTC
159 
 
ATGTGGTCGGGGTAGCGGCTGAAGCACTGCACGCCGTAGGTCAGGGTGGTCACGAGGGTGGGCCAGGGCACGGGCAGCTTGCCGGTGGTGCA
GATGAACTTCAGGGTCAGCTTGCCGTAGGTGGCATCGCCCTCACCCTCGCCGGACACGCTGAACTTGTGGCCGTTTACGTCGCCGTCCAGCT
CGACCAGGATGGGCACCACCCCGGTGAACAGCTCCTCGCCCTTGCTCACCATGCTCCCTCCGGTACCGCCCTTGTACAGCTCGTCCATGCCG
AGAGTGATCCCGGCGGCGGTCACGAACTCCAGCAGGACCATGTGATCGCGCTTCTCGTTGGGGTCTTTCGAAAGTTTGGACTGCACGCTCAG
GTAGTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGGTAGTGGTAGGCGAGCTGCACGCCGCCGTCCTCGATGT
TGTGGCGGATGTGGAAGTTCGCCTTGATGCCGTTCTTCTGCTTGTCGGCCTTGATATAGACGTTCTCGAGTGAGCTCAGCCGACCTATAGCT
CTGACTGCGTGACCTGTCTTATTCCACTTACGACGTGATGAGTCGACCATGGTGGCGAGATCCTTATCGTCATCGTCGTACAGATCCCGACC
CATTTGCTGTCCACCAGTCATGCTAGCCATACCATGATGATGATGATGATGAGAATGCATATGCATCTTGCTTGATTTCTTCAAAGAACACA
GCAAGTGAAAAATGAATAGCCTTTGATTTGGCCAGCCACCAACCAACACAAGCAAACCGAGTTGCGTCTATACAGACGTGTCGAAACAAGCT
GACACTCACTGTACAACTTAACTGATAAAAGGTGGGAGAAGATAGCACCCAAAAACGCAAGCTCGCTCGGCAGTTTCAACCGATAAAATTGC
AAAGTAATGTTGTGGCTTTACCGACTGCCCAATGCGAAGTGGGGTGGTCACAACCGTCGAGTCGAGACGCAGCGGTGGACCGGGAATTGGTC
CGCAATGAGACGAGGGCAAACAACCTGTGCCCGCTTACGGCGTCTCATACCATGTTTTCGTTCAGCGTGATCGTATGGTCAACAAACAGCAT
ATTCCTCCCGCCGCGACCCCAGCGATTGGTATTCGTGACGAGTACCACGCTATGAGAGGGGTGCCTCGCGCAGCTGAGACGCAGTACCAAGT
CTGCTCTGATGAAGTGCGCCACCAGCATTCTGTTTTTTCGCTCCCACGAGGGTGGAACCTCTAGCACACAACTTCTCTCTTCTGAGGTTGCC
GAAAAACTGTCTGCTAATTTATCGAGTTATTTGAACTACGGGACCAACGGGCAGAGACTGTTTTCACTCGGATGTCGTACAGTTGACGTCGC
GACGAAAGGCACATGACCAAGGCGATTTTTTTTATTTTCTGGTTCATCCGGCTATCCACCAGTGTTGCTTCGGTCGATCGAACGCCAGAAAC
CAAAACACCTGTTAGTAACATCTGACCAGTGTCGAACCTGGAAGAAACGCAGCAGTTTGCTTACAACGAAATTTTCATTCCACCGGAGACGA
GGGTCTGATTCCCGTGGCAATCATTGCAAGGCATCCCGTAGGAAAGGTAGGCAATATCGAAATAGATCCAGTCGTGCTATGCAGCGTGTCCC
TCGACGTTACTACGCACATCCTGTGAACAATTGCCAGGCAGCTGAACGGGTGGTGTGCTGAAGACGTATTCCAAGATAACAAACCTCCCTGC
ACGGTCACTGTTTGCTTCCTGGCGATCAGATGTCGTGTGTACGGATAGCAGGTGTCTTCTGCGGTCATTTCTCTCTCGGTGTACACAGAAAA
GAGAGAAATGTAGAGCGTGGCCTGGGTACGCGTGAAAACACGCAACCGGAGGTTCTGGGAGGTACTCCAAGGAAGCCTGTTCCGCTCAGGAT
TCCGAGTGGCATTCTATTTTCTGCTACACTGCATTTCCTCGGCAAAAGTGTAAGCAGGGGCCCCGTACC 
 
 
NsiI               Rhodopsin domain               PacI   GCaMP6s 
TgUPRT-5'UTR  Coiled Coil                 TgGra1-5'UTR             NotI 
TgDHFR-5'UTR  Guanylate Cyclase domain           3xHA-tag                       
TgDHFR-3'UTR  TgUPRT-3'UTR                            TgGra2-3'UTR 
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